Term,NES,FDR q-val,Perturbation
INTEGRIN_CELL_SURFACE_INTERACTIONS,2.1848249,0.086978503,PD-0325901
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,2.102289308,0.093281293,PD-0325901
ECM_PROTEOGLYCANS,2.020369907,0.128576918,PD-0325901
INTERFERON_GAMMA_SIGNALING,2.006237549,0.10777771,PD-0325901
TNFR2_NON_CANONICAL_NF_KB_PATHWAY,1.947597384,0.131098034,PD-0325901
EUKARYOTIC_TRANSLATION_ELONGATION,1.937843333,0.11618143,PD-0325901
RNA_POLYMERASE_II_TRANSCRIPTION,-1.910995187,0.388086661,PD-0325901
SARS_COV_1_INFECTION,1.880558145,0.154148237,PD-0325901
RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_PATHWAY,1.877718825,0.137243254,PD-0325901
NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION,-1.843651176,0.289534685,PD-0325901
TRANSLATION,2.859834943,0,swainsonine
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.821663471,0,swainsonine
ECM_PROTEOGLYCANS,-2.762163537,0,swainsonine
RRNA_PROCESSING,2.670803152,0.000891793,swainsonine
METABOLISM_OF_RNA,2.665926451,0.000594529,swainsonine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.596444067,0.001337689,swainsonine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.594892113,0.001070152,swainsonine
RESPIRATORY_ELECTRON_TRANSPORT,2.556360761,0.001486322,swainsonine
CELLULAR_RESPONSE_TO_STARVATION,2.50918803,0.00127399,swainsonine
GPCR_LIGAND_BINDING,-2.505951143,0.001635253,swainsonine
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,-2.098132702,0.147362743,PLX-4720
ECM_PROTEOGLYCANS,1.983687743,0.311786182,PLX-4720
INTEGRIN_CELL_SURFACE_INTERACTIONS,1.935648666,0.225118345,PLX-4720
TCR_SIGNALING,-1.928840015,0.194502975,PLX-4720
VESICLE_MEDIATED_TRANSPORT,1.927052236,0.162797447,PLX-4720
EXTRACELLULAR_MATRIX_ORGANIZATION,1.913826821,0.134907483,PLX-4720
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,1.891961353,0.129293151,PLX-4720
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,1.853032472,0.150442284,PLX-4720
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,1.77522844,0.233138818,PLX-4720
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,1.770304912,0.212308947,PLX-4720
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,-2.339837325,0.011339029,pelitinib
INTEGRIN_CELL_SURFACE_INTERACTIONS,2.283656183,0.010222738,pelitinib
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.114562575,0.042521359,pelitinib
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,2.113950247,0.029390371,pelitinib
METABOLISM_OF_RNA,-2.014148818,0.054175361,pelitinib
KEAP1_NFE2L2_PATHWAY,-1.994689356,0.045828576,pelitinib
ECM_PROTEOGLYCANS,2.056092241,0.036347512,pelitinib
HIV_INFECTION,-1.861446028,0.073325721,pelitinib
COLLAGEN_DEGRADATION,1.95916015,0.066660769,pelitinib
COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES,1.923253127,0.07224068,pelitinib
INFLUENZA_INFECTION,-2.758686481,0,gefitinib
METABOLISM_OF_RNA,-2.481933028,0.001527411,gefitinib
AMINE_LIGAND_BINDING_RECEPTORS,2.079294336,0.025116425,gefitinib
CELL_CYCLE_CHECKPOINTS,-1.891057116,0.063132981,gefitinib
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-1.870351473,0.053459379,gefitinib
GPCR_LIGAND_BINDING,1.978975031,0.04311653,gefitinib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.958715676,0.035162995,gefitinib
HCMV_INFECTION,-1.780275096,0.076370542,gefitinib
HCMV_EARLY_EVENTS,-1.650855937,0.137976112,gefitinib
TRANSLATION,-1.622939769,0.130484525,gefitinib
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.340900931,0.014792209,vorinostat
EUKARYOTIC_TRANSLATION_INITIATION,2.22984702,0.027735392,vorinostat
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.218698059,0.022188313,vorinostat
EUKARYOTIC_TRANSLATION_ELONGATION,2.204393621,0.01818209,vorinostat
SARS_COV_1_HOST_INTERACTIONS,2.202346631,0.014545672,vorinostat
SARS_COV_1_INFECTION,2.194317911,0.012943183,vorinostat
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,2.190780415,0.011270254,vorinostat
SIGNALING_BY_ROBO_RECEPTORS,2.17656464,0.011710499,vorinostat
INTEGRIN_CELL_SURFACE_INTERACTIONS,2.155867442,0.012463806,vorinostat
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,2.148497212,0.012573378,vorinostat
RNA_POLYMERASE_II_TRANSCRIPTION,-2.96430458,0,BMS-387032
GPCR_LIGAND_BINDING,2.91398093,0,BMS-387032
METABOLISM_OF_RNA,-2.742080286,0,BMS-387032
SIGNALING_BY_GPCR,2.647494281,0,BMS-387032
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.616107681,0,BMS-387032
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.696142132,0.000470225,BMS-387032
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,-2.610009859,0.000352669,BMS-387032
HATS_ACETYLATE_HISTONES,-2.588880403,0.000282135,BMS-387032
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,-2.53186652,0.000235113,BMS-387032
CELL_CYCLE_CHECKPOINTS,-2.531404679,0.000201525,BMS-387032
NEUTROPHIL_DEGRANULATION,-2.305182834,0.010288806,zolpidem
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.156944348,0.065724993,zolpidem
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,1.92381632,0.148794081,zolpidem
HOST_INTERACTIONS_OF_HIV_FACTORS,1.656281256,0.453380737,zolpidem
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.546115906,0.598371289,zolpidem
AUTOPHAGY,-1.786793749,0.815816549,zolpidem
UB_SPECIFIC_PROCESSING_PROTEASES,1.467333043,0.699240896,zolpidem
MRNA_SPLICING,1.462715297,0.595784888,zolpidem
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,-1.757958115,0.657911962,zolpidem
MITF_M_DEPENDENT_GENE_EXPRESSION,1.450311554,0.539362242,zolpidem
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.754460789,0,zafirlukast
EUKARYOTIC_TRANSLATION_ELONGATION,-2.093652967,0.308792721,zafirlukast
EUKARYOTIC_TRANSLATION_INITIATION,-2.08416826,0.166233415,zafirlukast
CELLULAR_RESPONSE_TO_STARVATION,-2.052597501,0.151651536,zafirlukast
GASTRULATION,-2.018571915,0.147705852,zafirlukast
SELENOAMINO_ACID_METABOLISM,-1.978946705,0.159131182,zafirlukast
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-1.978099741,0.133123973,zafirlukast
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-1.975954082,0.116017837,zafirlukast
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-1.957799268,0.117727225,zafirlukast
TRANSLATION,-1.945935318,0.114367675,zafirlukast
INTEGRIN_CELL_SURFACE_INTERACTIONS,-3.169630686,0,alvimopan
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.971578945,0.018078772,alvimopan
ECM_PROTEOGLYCANS,-2.909277658,0.065474471,alvimopan
COLLAGEN_FORMATION,-2.152894458,0.99286661,alvimopan
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.107241423,0.823805662,alvimopan
SARS_COV_1_HOST_INTERACTIONS,-2.043730989,0.719404825,alvimopan
ESTROGEN_DEPENDENT_GENE_EXPRESSION,1.332642162,1,alvimopan
SIGNALING_BY_NTRKS,1.325705879,1,alvimopan
SELENOAMINO_ACID_METABOLISM,-1.9599824,0.662422956,alvimopan
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-1.95591973,0.582185318,alvimopan
TRANSLATION,3.608538174,0,theobromine
METABOLISM_OF_RNA,3.395352393,0,theobromine
EUKARYOTIC_TRANSLATION_ELONGATION,3.341755373,0,theobromine
RRNA_PROCESSING,3.312444521,0,theobromine
EUKARYOTIC_TRANSLATION_INITIATION,3.256519448,0,theobromine
CELLULAR_RESPONSE_TO_STARVATION,3.225813063,0,theobromine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.21471878,0,theobromine
SELENOAMINO_ACID_METABOLISM,3.193169583,0,theobromine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.18618254,0,theobromine
NONSENSE_MEDIATED_DECAY_NMD,3.164120899,0,theobromine
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.277238032,0.032622438,risperidone
NEURONAL_SYSTEM,-2.140874255,0.069980392,risperidone
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,-2.122020744,0.056124625,risperidone
RESPIRATORY_ELECTRON_TRANSPORT,2.010917076,0.19637005,risperidone
GPCR_LIGAND_BINDING,-2.060070385,0.072348149,risperidone
GASTRULATION,1.944927804,0.162877027,risperidone
SENSORY_PERCEPTION,-2.010955783,0.089238154,risperidone
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,-1.862665004,0.211344291,risperidone
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.740753674,0.405892611,risperidone
SIGNALING_BY_GPCR,-1.838446232,0.208813672,risperidone
TRANSLATION,3.135800394,0,ampalex
EUKARYOTIC_TRANSLATION_ELONGATION,3.123710561,0,ampalex
CELLULAR_RESPONSE_TO_STARVATION,3.104560514,0,ampalex
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.094041885,0,ampalex
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.086382699,0,ampalex
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.074927573,0,ampalex
NONSENSE_MEDIATED_DECAY_NMD,3.009046972,0,ampalex
SELENOAMINO_ACID_METABOLISM,2.940740483,0,ampalex
RRNA_PROCESSING,2.805086427,0,ampalex
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.62505485,0,ampalex
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,4.052013031,0,conivaptan
RESPIRATORY_ELECTRON_TRANSPORT,4.013855383,0,conivaptan
MITOCHONDRIAL_PROTEIN_DEGRADATION,3.085612577,0,conivaptan
METABOLISM_OF_RNA,3.062050574,0,conivaptan
PROTEIN_LOCALIZATION,2.976433831,0,conivaptan
TRANSLATION,2.934505764,0,conivaptan
COMPLEX_I_BIOGENESIS,2.888411542,0,conivaptan
GPCR_LIGAND_BINDING,-2.805971155,0,conivaptan
SIGNALING_BY_GPCR,-2.8034067,0,conivaptan
RRNA_PROCESSING,2.771523381,0,conivaptan
TRANSLATION,3.069552924,0,tolazamide
COLLAGEN_FORMATION,-2.948136916,0,tolazamide
METABOLISM_OF_RNA,2.785062524,0,tolazamide
CELLULAR_RESPONSE_TO_STARVATION,2.75053838,0,tolazamide
RRNA_PROCESSING,2.682112283,0,tolazamide
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,-2.803315323,0.00033614,tolazamide
ECM_PROTEOGLYCANS,-2.771759511,0.000224093,tolazamide
DEVELOPMENTAL_CELL_LINEAGES,-2.76123502,0.00016807,tolazamide
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.741349764,0.000134456,tolazamide
SIGNALING_BY_MET,-2.718108839,0.000784327,tolazamide
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.278671296,0.043385071,tivozanib
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,2.141383128,0.055625061,tivozanib
INNATE_IMMUNE_SYSTEM,-2.034689137,0.150351713,tivozanib
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.004660396,0.089741765,tivozanib
RESPIRATORY_ELECTRON_TRANSPORT,1.987978742,0.068727853,tivozanib
RAB_GERANYLGERANYLATION,-1.815399992,0.383982815,tivozanib
INTERFERON_GAMMA_SIGNALING,1.864242924,0.149445997,tivozanib
TCR_SIGNALING,-1.796005047,0.325388035,tivozanib
PEPTIDE_HORMONE_METABOLISM,-1.667872086,0.540368543,tivozanib
NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION,-1.642677806,0.510647276,tivozanib
CELL_CYCLE,-5.648711234,0,palbociclib
CHROMOSOME_MAINTENANCE,-3.515520233,0,palbociclib
HOMOLOGOUS_DNA_PAIRING_AND_STRAND_EXCHANGE,-3.479221923,0,palbociclib
ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX,-3.399764814,0,palbociclib
DNA_REPLICATION_PRE_INITIATION,-3.396992665,0,palbociclib
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-3.380621768,0,palbociclib
HDR_THROUGH_HOMOLOGOUS_RECOMBINATION_HRR,-3.336733991,0,palbociclib
RHO_GTPASE_EFFECTORS,-3.311064778,0,palbociclib
TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM,-3.189957816,0,palbociclib
HDR_THROUGH_SINGLE_STRAND_ANNEALING_SSA,-3.123165032,0,palbociclib
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,-2.141326718,0.135341771,fostamatinib
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-1.96158654,0.215505742,fostamatinib
SEPARATION_OF_SISTER_CHROMATIDS,-1.94905058,0.151999219,fostamatinib
INTEGRIN_CELL_SURFACE_INTERACTIONS,1.997277571,0.160371189,fostamatinib
CELL_CYCLE_CHECKPOINTS,-1.919377215,0.133780135,fostamatinib
G_ALPHA_Q_SIGNALLING_EVENTS,1.97858526,0.09252184,fostamatinib
GPCR_LIGAND_BINDING,1.975586487,0.063223257,fostamatinib
NEDDYLATION,-1.900550518,0.115769268,fostamatinib
RESOLUTION_OF_SISTER_CHROMATID_COHESION,-1.853740789,0.124930865,fostamatinib
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-1.852421563,0.108273416,fostamatinib
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.118253509,0.083075734,capsaicin
NUCLEOTIDE_EXCISION_REPAIR,2.024619103,0.064383694,capsaicin
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,2.000579173,0.047076249,capsaicin
MRNA_SPLICING,1.938174548,0.050364664,capsaicin
MITOTIC_PROMETAPHASE,1.750987761,0.115059892,capsaicin
INFLUENZA_INFECTION,1.74455692,0.10003703,capsaicin
NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION,1.720850652,0.094943696,capsaicin
MITOTIC_SPINDLE_CHECKPOINT,1.555715507,0.201977879,capsaicin
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.50672051,0.226612142,capsaicin
HIV_LIFE_CYCLE,1.504634526,0.205820131,capsaicin
SARS_COV_1_HOST_INTERACTIONS,-2.342855234,0.003916833,bexarotene
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.309561934,0.003427229,bexarotene
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.23859026,0.004243236,bexarotene
EUKARYOTIC_TRANSLATION_ELONGATION,-2.235528503,0.003427229,bexarotene
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.229706512,0.002741783,bexarotene
EUKARYOTIC_TRANSLATION_INITIATION,-2.167577489,0.005059243,bexarotene
SELENOAMINO_ACID_METABOLISM,-2.159723281,0.005035928,bexarotene
NONSENSE_MEDIATED_DECAY_NMD,-2.130233528,0.00587525,bexarotene
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.117364058,0.006636856,bexarotene
LEISHMANIA_INFECTION,1.92039655,0.087987758,bexarotene
TRANSLATION,2.807790325,0,seocalcitol
GPCR_LIGAND_BINDING,-2.588615325,0.00072641,seocalcitol
RRNA_PROCESSING,2.678648531,0.001497341,seocalcitol
NEDDYLATION,2.559422945,0.002495569,seocalcitol
NEURONAL_SYSTEM,-2.506982457,0.003632048,seocalcitol
METABOLISM_OF_RNA,2.453530426,0.004866359,seocalcitol
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,-2.445078938,0.005811276,seocalcitol
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,-2.382793435,0.009443324,seocalcitol
COLLAGEN_FORMATION,-2.367162984,0.008571632,seocalcitol
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.366439599,0.007143027,seocalcitol
RESPIRATORY_ELECTRON_TRANSPORT,3.66342458,0,lenvatinib
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,3.219253567,0,lenvatinib
CELLULAR_RESPONSE_TO_STARVATION,2.962521622,0,lenvatinib
TRANSLATION,2.471488973,0.005372919,lenvatinib
COMPLEX_I_BIOGENESIS,2.458840626,0.004298335,lenvatinib
NEURONAL_SYSTEM,-2.290573638,0.017423984,lenvatinib
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,2.16224757,0.02474799,lenvatinib
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,-2.136335452,0.051182952,lenvatinib
PROTEIN_LOCALIZATION,1.990844662,0.053031406,lenvatinib
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.97686847,0.050065834,lenvatinib
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.930188668,0.166036689,clomethiazole
SUMOYLATION,1.90097168,0.104761244,clomethiazole
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.892801626,0.074233334,clomethiazole
RAB_REGULATION_OF_TRAFFICKING,1.888625159,0.057651628,clomethiazole
GPCR_LIGAND_BINDING,-2.068417479,0.249441813,clomethiazole
TCR_SIGNALING,1.721807638,0.130193848,clomethiazole
ECM_PROTEOGLYCANS,-1.972153644,0.284873889,clomethiazole
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-1.960423674,0.209442937,clomethiazole
INTEGRIN_CELL_SURFACE_INTERACTIONS,-1.948708608,0.171255033,clomethiazole
RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS,1.659311306,0.151761048,clomethiazole
GPCR_LIGAND_BINDING,-3.142081713,0,dipyridamole
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-3.054535942,0,dipyridamole
SIGNALING_BY_GPCR,-2.944721382,0,dipyridamole
NEURONAL_SYSTEM,-2.830062783,0,dipyridamole
RESPIRATORY_ELECTRON_TRANSPORT,2.766693808,0,dipyridamole
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,-2.52264923,0.000148879,dipyridamole
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.474305847,0.000248132,dipyridamole
G_ALPHA_Q_SIGNALLING_EVENTS,-2.443209561,0.000212685,dipyridamole
G_ALPHA_I_SIGNALLING_EVENTS,-2.252914726,0.002791486,dipyridamole
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.197157663,0.030920549,dipyridamole
CELLULAR_RESPONSE_TO_STARVATION,3.643382285,0,resatorvid
NEURONAL_SYSTEM,-2.678431416,0,resatorvid
SENSORY_PERCEPTION,-2.740619078,0,resatorvid
G_ALPHA_S_SIGNALLING_EVENTS,-2.759390619,0,resatorvid
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.903999995,0,resatorvid
METABOLISM_OF_RNA,2.994873649,0,resatorvid
SIGNALING_BY_ROBO_RECEPTORS,2.996894874,0,resatorvid
INFLUENZA_INFECTION,3.070233974,0,resatorvid
TRANSLATION,3.29413622,0,resatorvid
SELENOAMINO_ACID_METABOLISM,3.314233078,0,resatorvid
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.366076964,0.013482463,lapatinib
GPCR_LIGAND_BINDING,2.156865606,0.033122969,lapatinib
CELLULAR_RESPONSE_TO_STARVATION,-2.1761946,0.036595256,lapatinib
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,-2.174577924,0.024396837,lapatinib
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,-2.125996429,0.023112793,lapatinib
G_ALPHA_Q_SIGNALLING_EVENTS,2.053664593,0.045130045,lapatinib
KEAP1_NFE2L2_PATHWAY,-1.900223361,0.091295533,lapatinib
SENSORY_PERCEPTION,1.993799615,0.061277493,lapatinib
SIGNALING_BY_GPCR,1.960828808,0.062726623,lapatinib
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-1.845994414,0.10111847,lapatinib
CELL_CYCLE,-4.550023411,0,dasatinib
RHO_GTPASES_ACTIVATE_FORMINS,-3.107513108,0,dasatinib
PROCESSING_OF_DNA_DOUBLE_STRAND_BREAK_ENDS,-3.103990696,0,dasatinib
HDR_THROUGH_HOMOLOGOUS_RECOMBINATION_HRR,-3.082185776,0,dasatinib
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-3.053362781,0,dasatinib
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,-3.028609259,0,dasatinib
ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX,-3.026015659,0,dasatinib
REGULATION_OF_TP53_ACTIVITY,-2.989586773,0,dasatinib
RRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL,-2.949765896,0,dasatinib
TRNA_PROCESSING_IN_THE_NUCLEUS,-2.886203744,0,dasatinib
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.571204505,0.001066353,quizartinib
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.502981148,0.002132706,quizartinib
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.489398738,0.001421804,quizartinib
PEPTIDE_HORMONE_METABOLISM,-2.482058575,0.001066353,quizartinib
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,-2.197599049,0.018128002,quizartinib
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,1.928844469,0.392317607,quizartinib
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-1.978861922,0.093305894,quizartinib
HEMOSTASIS,-1.95057009,0.096428785,quizartinib
ADIPOGENESIS,1.877371125,0.288660229,quizartinib
MITF_M_DEPENDENT_GENE_EXPRESSION,-1.917468516,0.104369307,quizartinib
EUKARYOTIC_TRANSLATION_ELONGATION,-2.210305031,0.031364043,candesartan
EUKARYOTIC_TRANSLATION_INITIATION,-2.061099521,0.091562769,candesartan
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.055924107,0.065763315,candesartan
NONSENSE_MEDIATED_DECAY_NMD,-2.049420523,0.051851845,candesartan
SELENOAMINO_ACID_METABOLISM,-2.032572832,0.049777771,candesartan
COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC,1.903609269,0.168650588,candesartan
SIGNALING_BY_ROBO_RECEPTORS,-1.988051059,0.062390837,candesartan
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-1.982529938,0.056079486,candesartan
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-1.976307227,0.052990056,candesartan
INFLUENZA_INFECTION,-1.955442441,0.056657625,candesartan
GPCR_LIGAND_BINDING,-2.074832492,0.507901181,almitrine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.067724522,0.269326505,almitrine
RHOA_GTPASE_CYCLE,1.694505095,0.604737823,almitrine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.027257663,0.240393333,almitrine
NONSENSE_MEDIATED_DECAY_NMD,-1.892384005,0.475165363,almitrine
SIGNALING_BY_ROBO_RECEPTORS,-1.88551421,0.395805803,almitrine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.485422938,0.940644131,almitrine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-1.828102906,0.471032053,almitrine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-1.82288943,0.416495974,almitrine
MITOCHONDRIAL_PROTEIN_IMPORT,1.41094272,0.932304143,almitrine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.568401276,0.003476188,colchicine
HOST_INTERACTIONS_OF_HIV_FACTORS,2.003281034,0.043452351,colchicine
SIGNALING_BY_NTRKS,1.669154397,0.216103028,colchicine
HEMOSTASIS,1.566611526,0.288958137,colchicine
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,1.505832746,0.317723593,colchicine
INFLUENZA_INFECTION,1.496402959,0.280412508,colchicine
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,1.49130166,0.244822963,colchicine
RRNA_PROCESSING,1.481049822,0.224214133,colchicine
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,1.468901939,0.214558055,colchicine
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,1.460000226,0.202140339,colchicine
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.939615408,0,pentamidine
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.642829222,0.000644899,pentamidine
GPCR_LIGAND_BINDING,-2.63241267,0.000429932,pentamidine
ECM_PROTEOGLYCANS,-2.608205869,0.000322449,pentamidine
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,-2.596315068,0.000257959,pentamidine
COLLAGEN_FORMATION,-2.557330582,0.000644899,pentamidine
DEVELOPMENTAL_CELL_LINEAGES,-2.533607148,0.000829156,pentamidine
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.533191021,0.000725511,pentamidine
NEURONAL_SYSTEM,-2.524581009,0.000644899,pentamidine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.470083701,0.001612247,pentamidine
TRANSLATION,3.157105585,0,carglumic-acid
INFLUENZA_INFECTION,2.644920905,0,carglumic-acid
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.68764639,0,carglumic-acid
NONSENSE_MEDIATED_DECAY_NMD,2.805320506,0,carglumic-acid
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.942016102,0,carglumic-acid
EUKARYOTIC_TRANSLATION_ELONGATION,2.942158294,0,carglumic-acid
SIGNALING_BY_GPCR,-2.77613356,0,carglumic-acid
GPCR_LIGAND_BINDING,-2.978304583,0,carglumic-acid
SELENOAMINO_ACID_METABOLISM,3.03777972,0,carglumic-acid
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.044387229,0,carglumic-acid
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.841486952,0,diphenidol
METABOLISM_OF_RNA,2.276801331,0.006730632,diphenidol
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.235923736,0.006730632,diphenidol
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1.842889576,0.08749821,diphenidol
HIV_LIFE_CYCLE,1.783497667,0.092882715,diphenidol
MRNA_SPLICING,1.765812646,0.085815552,diphenidol
TRNA_PROCESSING,1.673325039,0.11922833,diphenidol
HIV_INFECTION,1.585328332,0.168686453,diphenidol
MITOTIC_METAPHASE_AND_ANAPHASE,1.55181386,0.178361736,diphenidol
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,1.514333785,0.199226693,diphenidol
RHOA_GTPASE_CYCLE,2.01946959,0.086257928,betrixaban
NEURONAL_SYSTEM,1.68798668,0.225792812,betrixaban
MUSCLE_CONTRACTION,1.677117505,0.158985201,betrixaban
EUKARYOTIC_TRANSLATION_ELONGATION,-1.94908206,1,betrixaban
TP53_REGULATES_TRANSCRIPTION_OF_DNA_REPAIR_GENES,-1.908100173,1,betrixaban
NONSENSE_MEDIATED_DECAY_NMD,-1.907493846,1,betrixaban
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-1.888443765,1,betrixaban
RHOC_GTPASE_CYCLE,1.282379265,0.87577167,betrixaban
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.274005527,0.728016913,betrixaban
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-1.854860943,1,betrixaban
TRANSLATION,3.444917313,0,KX-2391
RRNA_PROCESSING,2.665305065,0,KX-2391
SIGNALING_BY_ROBO_RECEPTORS,2.782586989,0,KX-2391
METABOLISM_OF_RNA,2.819417244,0,KX-2391
INFLUENZA_INFECTION,2.587767969,0,KX-2391
NONSENSE_MEDIATED_DECAY_NMD,2.83876396,0,KX-2391
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.819631358,0,KX-2391
EUKARYOTIC_TRANSLATION_ELONGATION,2.963870463,0,KX-2391
CELLULAR_RESPONSE_TO_STARVATION,3.010920297,0,KX-2391
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.02223463,0,KX-2391
RESPIRATORY_ELECTRON_TRANSPORT,3.803671722,0,cyclobenzaprine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,3.207138231,0,cyclobenzaprine
PROTEIN_LOCALIZATION,2.89324768,0,cyclobenzaprine
GPCR_LIGAND_BINDING,-2.485310948,0,cyclobenzaprine
METABOLISM_OF_RNA,2.457519652,0.004853179,cyclobenzaprine
MITOTIC_G2_G2_M_PHASES,2.379088796,0.005338497,cyclobenzaprine
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,-2.328213236,0.003562306,cyclobenzaprine
DEVELOPMENTAL_CELL_LINEAGES,-2.31178752,0.00323846,cyclobenzaprine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.327510169,0.006875337,cyclobenzaprine
DOWNSTREAM_TCR_SIGNALING,2.309629955,0.006933113,cyclobenzaprine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.731149338,0,BRD-K97440753
SARS_COV_1_HOST_INTERACTIONS,-2.668560792,0,BRD-K97440753
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.607691638,0.000316574,BRD-K97440753
EUKARYOTIC_TRANSLATION_ELONGATION,-2.603600312,0.000237431,BRD-K97440753
NONSENSE_MEDIATED_DECAY_NMD,-2.568499609,0.000189944,BRD-K97440753
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.562220936,0.000158287,BRD-K97440753
CELLULAR_RESPONSE_TO_STARVATION,-2.54306714,0.000135675,BRD-K97440753
SELENOAMINO_ACID_METABOLISM,-2.540421981,0.000118715,BRD-K97440753
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.498826038,0.000105525,BRD-K97440753
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.470137157,0.000284917,BRD-K97440753
SIGNALING_BY_FGFR,1.365348093,1,PH-797804
TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,1.364286133,1,PH-797804
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,1.336243779,1,PH-797804
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-1.832040728,1,PH-797804
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-1.77159541,1,PH-797804
SELENOAMINO_ACID_METABOLISM,-1.762027646,1,PH-797804
EUKARYOTIC_TRANSLATION_ELONGATION,-1.752032589,1,PH-797804
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-1.745046628,1,PH-797804
INFLUENZA_INFECTION,-1.737364115,1,PH-797804
EUKARYOTIC_TRANSLATION_INITIATION,-1.734077425,0.875333165,PH-797804
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,-2.395406542,0.019203272,ripasudil
GPCR_LIGAND_BINDING,-2.255838927,0.033605725,ripasudil
ECM_PROTEOGLYCANS,-2.193695524,0.038406543,ripasudil
SIGNALING_BY_GPCR,-2.183153257,0.030938604,ripasudil
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.166739699,0.026244471,ripasudil
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.161412326,0.022937241,ripasudil
COLLAGEN_FORMATION,-2.15407261,0.020879748,ripasudil
RESPIRATORY_ELECTRON_TRANSPORT,2.068247454,0.163253065,ripasudil
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,-2.089088295,0.030271824,ripasudil
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,-2.077712238,0.029871756,ripasudil
METABOLISM_OF_RNA,-3.80315896,0,alvocidib
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-3.630048841,0,alvocidib
CELL_CYCLE_CHECKPOINTS,-3.128539457,0,alvocidib
MRNA_SPLICING,-2.883993049,0,alvocidib
CELL_CYCLE,-2.774446882,0,alvocidib
MITOTIC_SPINDLE_CHECKPOINT,-2.758514058,0,alvocidib
SIGNALING_BY_GPCR,2.59007523,0.00044128,alvocidib
GPCR_LIGAND_BINDING,2.605617416,0.000882561,alvocidib
EXTRACELLULAR_MATRIX_ORGANIZATION,2.549528166,0.000294187,alvocidib
TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM,-2.677781305,0.000167491,alvocidib
MUSCLE_CONTRACTION,1.605695345,0.482774329,fenoterol
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,1.303346965,1,fenoterol
PROTEIN_FOLDING,1.290820732,0.781390581,fenoterol
NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION,1.280837501,0.614999146,fenoterol
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.381562177,1,fenoterol
NEUTROPHIL_DEGRANULATION,-2.124705655,1,fenoterol
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.913474319,1,fenoterol
VESICLE_MEDIATED_TRANSPORT,-1.814292851,1,fenoterol
SELENOAMINO_ACID_METABOLISM,-1.798564373,1,fenoterol
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.769499158,1,fenoterol
SELENOAMINO_ACID_METABOLISM,3.385671208,0,propentofylline
NONSENSE_MEDIATED_DECAY_NMD,2.861320052,0,propentofylline
INFLUENZA_INFECTION,2.922464862,0,propentofylline
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.938740604,0,propentofylline
SIGNALING_BY_GPCR,-2.954276623,0,propentofylline
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.01449448,0,propentofylline
EUKARYOTIC_TRANSLATION_ELONGATION,3.044688301,0,propentofylline
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.906153566,0,propentofylline
METABOLISM_OF_RNA,3.12248127,0,propentofylline
EUKARYOTIC_TRANSLATION_INITIATION,3.148009924,0,propentofylline
GPCR_LIGAND_BINDING,-2.98255593,0,loperamide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.724961142,0,loperamide
SIGNALING_BY_GPCR,-2.573543679,0,loperamide
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.507198931,0,loperamide
MITOCHONDRIAL_BIOGENESIS,2.491271637,0.005502387,loperamide
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,2.401406328,0.005502387,loperamide
SENSORY_PERCEPTION,-2.192706815,0.002633267,loperamide
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-2.166373009,0.003191839,loperamide
CELLULAR_RESPONSE_TO_STARVATION,2.218177684,0.025677805,loperamide
G_ALPHA_S_SIGNALLING_EVENTS,-2.14332611,0.003590819,loperamide
METABOLISM_OF_VITAMINS_AND_COFACTORS,-2.471465469,0.016597795,doramapimod
NEURONAL_SYSTEM,2.296814326,0.005376448,doramapimod
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.459380075,0.00933626,doramapimod
GPCR_LIGAND_BINDING,2.115702241,0.018518875,doramapimod
POTASSIUM_CHANNELS,2.105470106,0.013540683,doramapimod
NEUREXINS_AND_NEUROLIGINS,2.072483703,0.013441119,doramapimod
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,2.044754429,0.01445667,doramapimod
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.122350511,0.134165509,doramapimod
PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES,1.980858117,0.023895323,doramapimod
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.978676919,0.021249769,doramapimod
HATS_ACETYLATE_HISTONES,2.352156091,0.01004955,ixabepilone
EUKARYOTIC_TRANSLATION_ELONGATION,-3.091992633,0.151645456,ixabepilone
UNFOLDED_PROTEIN_RESPONSE_UPR,1.699469063,0.28264359,ixabepilone
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,1.672900413,0.216902785,ixabepilone
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.560340022,0.310907949,ixabepilone
SELENOAMINO_ACID_METABOLISM,-3.03300119,0.329643934,ixabepilone
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-3.023628596,0.265379548,ixabepilone
NONSENSE_MEDIATED_DECAY_NMD,-2.999863588,0.293813071,ixabepilone
EUKARYOTIC_TRANSLATION_INITIATION,-2.984091884,0.294414105,ixabepilone
RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES,1.42067111,0.534636053,ixabepilone
GPCR_LIGAND_BINDING,-2.789999302,0,econazole
SIGNALING_BY_GPCR,-2.618311936,0,econazole
NEURONAL_SYSTEM,-2.483080714,0.001734901,econazole
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.392829809,0.002819215,econazole
RESPIRATORY_ELECTRON_TRANSPORT,2.309130535,0.037770332,econazole
CELLULAR_RESPONSE_TO_STARVATION,2.258740747,0.026804752,econazole
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,-2.217742991,0.009715448,econazole
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,-2.217227818,0.008240782,econazole
POTASSIUM_CHANNELS,-2.171652255,0.010905094,econazole
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.050829219,0.086506244,econazole
INTEGRIN_CELL_SURFACE_INTERACTIONS,2.40514649,0.003910311,vemurafenib
EXTRACELLULAR_MATRIX_ORGANIZATION,2.167130539,0.032260063,vemurafenib
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,-1.936089812,0.40809802,vemurafenib
TCR_SIGNALING,-1.880369509,0.28102874,vemurafenib
COLLAGEN_DEGRADATION,1.882122072,0.256777069,vemurafenib
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1.869338321,0.212378749,vemurafenib
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,1.866590327,0.173422279,vemurafenib
SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX,-1.704864064,0.505816581,vemurafenib
ECM_PROTEOGLYCANS,1.752521029,0.330421253,vemurafenib
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,1.744532053,0.301652539,vemurafenib
CELL_CYCLE_CHECKPOINTS,-4.528606536,0,AZD-8330
MRNA_SPLICING,-2.784632878,0,AZD-8330
SEPARATION_OF_SISTER_CHROMATIDS,-3.013024284,0,AZD-8330
RRNA_PROCESSING,-3.178633416,0,AZD-8330
MITOTIC_SPINDLE_CHECKPOINT,-3.197982833,0,AZD-8330
M_PHASE,-3.199503844,0,AZD-8330
PROCESSING_OF_DNA_DOUBLE_STRAND_BREAK_ENDS,-3.225793316,0,AZD-8330
RESOLUTION_OF_SISTER_CHROMATID_COHESION,-3.23426064,0,AZD-8330
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-3.254204651,0,AZD-8330
SYNTHESIS_OF_DNA,-3.255094822,0,AZD-8330
METABOLISM_OF_RNA,-3.304429962,0,neratinib
EXTRACELLULAR_MATRIX_ORGANIZATION,2.696787615,0,neratinib
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.686384284,0,neratinib
SENSORY_PERCEPTION,2.516174219,0,neratinib
MRNA_SPLICING,-2.587973427,0.000435829,neratinib
CELL_CYCLE,-2.535465329,0.000980614,neratinib
RRNA_PROCESSING,-2.496167659,0.000784491,neratinib
CELL_CYCLE_CHECKPOINTS,-2.333091644,0.002614971,neratinib
VISUAL_PHOTOTRANSDUCTION,2.300377834,0.005084732,neratinib
CELL_CYCLE_MITOTIC,-2.299051721,0.00354889,neratinib
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.497470927,0.000619625,aclidinium
FATTY_ACID_METABOLISM,1.517178719,0.590812204,aclidinium
EUKARYOTIC_TRANSLATION_ELONGATION,-2.029546238,1,aclidinium
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-1.992143491,1,aclidinium
SELENOAMINO_ACID_METABOLISM,-1.973016493,1,aclidinium
NONSENSE_MEDIATED_DECAY_NMD,-1.945905539,1,aclidinium
SIGNALING_BY_ROBO_RECEPTORS,-1.928183686,0.996025279,aclidinium
EUKARYOTIC_TRANSLATION_INITIATION,-1.884090151,0.901251579,aclidinium
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-1.883062923,0.77431936,aclidinium
INFLUENZA_INFECTION,-1.812479718,0.790738233,aclidinium
EUKARYOTIC_TRANSLATION_ELONGATION,-2.704408453,0,cyclizine
NONSENSE_MEDIATED_DECAY_NMD,-2.629326399,0,cyclizine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.561268425,0,cyclizine
SELENOAMINO_ACID_METABOLISM,-2.553011638,0,cyclizine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.469046483,0.00018966,cyclizine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.439553569,0.00015805,cyclizine
INFLUENZA_INFECTION,-2.41094018,0.000406414,cyclizine
CELLULAR_RESPONSE_TO_STARVATION,-2.350193403,0.00047415,cyclizine
SIGNALING_BY_ROBO_RECEPTORS,-2.276702151,0.000948299,cyclizine
EUKARYOTIC_TRANSLATION_INITIATION,-2.273811943,0.000853469,cyclizine
NEUTROPHIL_DEGRANULATION,2.442455129,0.007269423,carbamazepine
GPCR_LIGAND_BINDING,-2.220692659,0.005784724,carbamazepine
MHC_CLASS_II_ANTIGEN_PRESENTATION,2.1302241,0.029077692,carbamazepine
RAB_REGULATION_OF_TRAFFICKING,2.112076112,0.020596698,carbamazepine
MEMBRANE_TRAFFICKING,2.090630921,0.01726488,carbamazepine
VESICLE_MEDIATED_TRANSPORT,2.057757924,0.0189005,carbamazepine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.05635149,0.018800352,carbamazepine
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.056295865,0.012533568,carbamazepine
G_ALPHA_I_SIGNALLING_EVENTS,-1.961947244,0.022560422,carbamazepine
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-1.963451249,0.028200528,carbamazepine
KEAP1_NFE2L2_PATHWAY,2.028292047,0.219775512,esmolol
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,2.01504316,0.122097507,esmolol
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.918917298,0.162796676,esmolol
ABC_TRANSPORTER_DISORDERS,1.895690894,0.146517008,esmolol
CELL_CYCLE_MITOTIC,1.877139471,0.128609374,esmolol
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,1.853652649,0.122097507,esmolol
DNA_REPLICATION,1.842058114,0.111632006,esmolol
DNA_REPLICATION_PRE_INITIATION,1.832823969,0.102765401,esmolol
MRNA_SPLICING,1.792412618,0.112148821,esmolol
SYNTHESIS_OF_DNA,1.770237539,0.113957673,esmolol
RESPIRATORY_ELECTRON_TRANSPORT,3.36023121,0,imipramine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,3.049253014,0,imipramine
METABOLISM_OF_RNA,3.021686077,0,imipramine
TRANSLATION,2.774665185,0,imipramine
CELLULAR_RESPONSE_TO_STARVATION,2.640205049,0.00042494,imipramine
MRNA_SPLICING,2.586614959,0.000708234,imipramine
SENSORY_PERCEPTION,-2.564313071,0.001486125,imipramine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.541844014,0.000607058,imipramine
NEURONAL_SYSTEM,-2.479837873,0.001857656,imipramine
RRNA_PROCESSING,2.348090195,0.002655877,imipramine
SENSORY_PERCEPTION,-2.480917464,0.004303662,cabozantinib
GPCR_LIGAND_BINDING,-2.353791653,0.008069367,cabozantinib
COLLAGEN_FORMATION,-2.2129943,0.021518312,cabozantinib
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,-2.155001543,0.0293187,cabozantinib
CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM,-2.048652656,0.054441329,cabozantinib
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.041053943,0.047519605,cabozantinib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.9912499,0.055332802,cabozantinib
CELLULAR_RESPONSE_TO_STARVATION,1.907424187,0.56988996,cabozantinib
GASTRULATION,1.882947347,0.338085844,cabozantinib
ECM_PROTEOGLYCANS,-1.870887045,0.121578461,cabozantinib
TRANSLATION,3.5587457,0,LY-215490
INFLUENZA_INFECTION,2.784148626,0,LY-215490
NONSENSE_MEDIATED_DECAY_NMD,2.883256143,0,LY-215490
EUKARYOTIC_TRANSLATION_INITIATION,3.032302933,0,LY-215490
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.066544454,0,LY-215490
RRNA_PROCESSING,3.103866113,0,LY-215490
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.907578474,0,LY-215490
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.15670609,0,LY-215490
METABOLISM_OF_RNA,3.164632971,0,LY-215490
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.233764392,0,LY-215490
MITOCHONDRIAL_BIOGENESIS,2.520942562,0.012377514,dexfenfluramine
GPCR_LIGAND_BINDING,-2.399728251,0.017747594,dexfenfluramine
SENSORY_PERCEPTION,-2.376497746,0.010944349,dexfenfluramine
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,2.133619971,0.083548221,dexfenfluramine
TRNA_PROCESSING,2.058852475,0.096957194,dexfenfluramine
METABOLISM_OF_RNA,2.044976164,0.079680248,dexfenfluramine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.257621804,0.026029804,dexfenfluramine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.978997326,0.090355854,dexfenfluramine
VISUAL_PHOTOTRANSDUCTION,-2.193509961,0.039636293,dexfenfluramine
PROCESSING_OF_DNA_DOUBLE_STRAND_BREAK_ENDS,1.897784067,0.115007736,dexfenfluramine
GPCR_LIGAND_BINDING,2.267573233,0.021082423,enzastaurin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.147381889,0.034373515,enzastaurin
HIV_INFECTION,-2.121044594,0.103192211,enzastaurin
HIV_LIFE_CYCLE,-2.047225603,0.086607749,enzastaurin
TCR_SIGNALING,-2.043842826,0.058966978,enzastaurin
NEDDYLATION,-2.011295505,0.055895781,enzastaurin
SIGNALING_BY_GPCR,2.007769087,0.084940776,enzastaurin
INTEGRIN_CELL_SURFACE_INTERACTIONS,1.943747111,0.111828504,enzastaurin
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,1.940774937,0.091479383,enzastaurin
HOST_INTERACTIONS_OF_HIV_FACTORS,-1.854041572,0.128744568,enzastaurin
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.389607985,0.149589913,ALW-II-49-7
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,-2.310292634,0.131050992,ALW-II-49-7
CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,-2.26485203,0.110381161,ALW-II-49-7
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.26190511,0.084384054,ALW-II-49-7
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.140117849,0.137315869,ALW-II-49-7
CLATHRIN_MEDIATED_ENDOCYTOSIS,-2.05474551,0.190929576,ALW-II-49-7
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.05419583,0.163836571,ALW-II-49-7
TCR_SIGNALING,-1.953171292,0.234932876,ALW-II-49-7
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-1.935109846,0.22644475,ALW-II-49-7
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-1.888399289,0.245480883,ALW-II-49-7
METABOLISM_OF_RNA,-3.589097838,0,canertinib
CELL_CYCLE_CHECKPOINTS,-2.608440365,0.006151575,canertinib
UCH_PROTEINASES,-2.495788115,0.00410105,canertinib
TCR_SIGNALING,-2.478725384,0.004613681,canertinib
G2_M_CHECKPOINTS,-2.463876805,0.00492126,canertinib
VIRAL_INFECTION_PATHWAYS,-2.462612299,0.00410105,canertinib
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,-2.452164282,0.003515186,canertinib
ANTIGEN_PROCESSING_CROSS_PRESENTATION,-2.3932027,0.004613681,canertinib
SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR,-2.364401474,0.004784558,canertinib
HOST_INTERACTIONS_OF_HIV_FACTORS,-2.342669349,0.005536417,canertinib
NEUTROPHIL_DEGRANULATION,-2.193146814,0.043090308,BRD-K45330754
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.762365219,0.561503559,BRD-K45330754
NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION,1.746774906,0.30293885,BRD-K45330754
CARDIAC_CONDUCTION,-1.936626949,0.272905282,BRD-K45330754
BIOLOGICAL_OXIDATIONS,1.546417967,0.575157141,BRD-K45330754
MRNA_SPLICING,1.514556318,0.508169254,BRD-K45330754
SUMOYLATION,1.498792053,0.434525247,BRD-K45330754
GENE_SILENCING_BY_RNA,-1.807335692,0.488356821,BRD-K45330754
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,-1.782691924,0.435616079,BRD-K45330754
MUSCLE_CONTRACTION,-1.773269445,0.372551619,BRD-K45330754
GPCR_LIGAND_BINDING,2.40799099,0.000704181,AT-7867
METABOLISM_OF_VITAMINS_AND_COFACTORS,-2.207777677,0.060704746,AT-7867
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.209229703,0.007393901,AT-7867
M_PHASE,-2.109313816,0.065040799,AT-7867
CELL_CYCLE_MITOTIC,-2.075223883,0.059741178,AT-7867
S_PHASE,-2.011518105,0.063595448,AT-7867
SEPARATION_OF_SISTER_CHROMATIDS,-1.902914739,0.089033627,AT-7867
SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX,-1.896043828,0.077085392,AT-7867
CELL_CYCLE,-1.84385275,0.090024725,AT-7867
MITOTIC_METAPHASE_AND_ANAPHASE,-1.833016852,0.083469026,AT-7867
MHC_CLASS_II_ANTIGEN_PRESENTATION,2.2998239,0.029974308,BRD-K72166146
NEUTROPHIL_DEGRANULATION,2.139845753,0.036397374,BRD-K72166146
RAB_REGULATION_OF_TRAFFICKING,2.05436472,0.039965744,BRD-K72166146
DNA_REPAIR,2.009294877,0.039608907,BRD-K72166146
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,1.950157914,0.041107622,BRD-K72166146
VESICLE_MEDIATED_TRANSPORT,1.940081137,0.03925207,BRD-K72166146
RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS,1.890810053,0.042208719,BRD-K72166146
PROTEIN_LOCALIZATION,1.818196957,0.056201827,BRD-K72166146
AUTOPHAGY,1.746465347,0.079455705,BRD-K72166146
GPCR_LIGAND_BINDING,-1.942828544,0.178886284,BRD-K72166146
GPCR_LIGAND_BINDING,-2.646297795,0,lidocaine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.476961373,0.001395775,lidocaine
MRNA_SPLICING,2.435741,0.00222638,lidocaine
ECM_PROTEOGLYCANS,-2.443307383,0.001240689,lidocaine
METABOLISM_OF_RNA,2.365808949,0.002782975,lidocaine
SIGNALING_BY_GPCR,-2.353326428,0.002093662,lidocaine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.348051718,0.002968507,lidocaine
RESPIRATORY_ELECTRON_TRANSPORT,2.211873721,0.010018711,lidocaine
NEURONAL_SYSTEM,-2.247630027,0.006885823,lidocaine
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.233641244,0.00635853,lidocaine
GPCR_LIGAND_BINDING,2.918982088,0,OSI-930
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.588426777,0,OSI-930
SIGNALING_BY_GPCR,2.405971874,0.000787351,OSI-930
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.396008722,0.000590513,OSI-930
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-3.139988631,0.051091783,OSI-930
G_ALPHA_Q_SIGNALLING_EVENTS,2.210556251,0.002834463,OSI-930
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.975396598,0.127729457,OSI-930
CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,-2.777129942,0.435344565,OSI-930
CLATHRIN_MEDIATED_ENDOCYTOSIS,-2.695422624,0.483775318,OSI-930
G_ALPHA_I_SIGNALLING_EVENTS,1.884147619,0.056394009,OSI-930
GPCR_LIGAND_BINDING,-2.670267562,0,ilomastat
RESPIRATORY_ELECTRON_TRANSPORT,2.543845832,0.001324016,ilomastat
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.414033163,0.006620081,ilomastat
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.323590651,0.009380883,ilomastat
METABOLISM_OF_RNA,2.300549515,0.011033468,ilomastat
SIGNALING_BY_GPCR,-2.196636815,0.020393223,ilomastat
SENSORY_PERCEPTION,-2.109202549,0.033037022,ilomastat
NEURONAL_SYSTEM,-2.104934147,0.027571638,ilomastat
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.104345142,0.02311232,ilomastat
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.03690331,0.0572637,ilomastat
ESTROGEN_DEPENDENT_GENE_EXPRESSION,2.085169437,0.098552813,temazepam
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-3.017096144,0.183878848,temazepam
MHC_CLASS_II_ANTIGEN_PRESENTATION,1.568075964,0.760264554,temazepam
FATTY_ACID_METABOLISM,1.441622176,0.954554384,temazepam
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,1.424559803,0.787718552,temazepam
DUAL_INCISION_IN_TC_NER,1.377205865,0.796869884,temazepam
HCMV_EARLY_EVENTS,1.336151889,0.802032174,temazepam
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,1.26159571,0.958576948,temazepam
COPI_MEDIATED_ANTEROGRADE_TRANSPORT,1.25003809,0.884511492,temazepam
TRNA_PROCESSING,1.245501648,0.80437867,temazepam
GPCR_LIGAND_BINDING,-3.012422322,0,doxazosin
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.766525739,0,doxazosin
SIGNALING_BY_GPCR,-2.765151578,0,doxazosin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.723286095,0.000181266,doxazosin
ECM_PROTEOGLYCANS,-2.581924556,0.001885169,doxazosin
NEURONAL_SYSTEM,-2.577335078,0.001691819,doxazosin
TRANSLATION,2.46201297,0.012862569,doxazosin
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,-2.553735718,0.001657292,doxazosin
METABOLISM_OF_RNA,2.377323071,0.010718808,doxazosin
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.505605812,0.002447095,doxazosin
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,3.939657227,0,paracetamol
RESPIRATORY_ELECTRON_TRANSPORT,3.733364102,0,paracetamol
TRANSLATION,3.220175919,0,paracetamol
METABOLISM_OF_RNA,3.089374036,0,paracetamol
GPCR_LIGAND_BINDING,-2.837557471,0,paracetamol
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.741123353,0,paracetamol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.670017855,0,paracetamol
MRNA_SPLICING,2.697458879,0.000601699,paracetamol
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,-2.521807898,0.000521339,paracetamol
ECM_PROTEOGLYCANS,-2.481186596,0.000391004,paracetamol
RESPIRATORY_ELECTRON_TRANSPORT,3.413582965,0,valproic-acid
METABOLISM_OF_RNA,3.163083027,0,valproic-acid
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,3.029567736,0,valproic-acid
CELLULAR_RESPONSE_TO_STARVATION,2.995049752,0,valproic-acid
RRNA_PROCESSING,2.725585926,0,valproic-acid
TRANSLATION,2.680543424,0.000403038,valproic-acid
PROTEIN_LOCALIZATION,2.614322394,0.000345461,valproic-acid
MRNA_SPLICING,2.564480564,0.001209113,valproic-acid
NEURONAL_SYSTEM,-2.368289248,0.008571381,valproic-acid
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.544718901,0.001343459,valproic-acid
SYNTHESIS_OF_DNA,2.740126216,0,gemcitabine
CELL_CYCLE_CHECKPOINTS,2.479259775,0,gemcitabine
DNA_REPAIR,2.489026795,0,gemcitabine
HOMOLOGY_DIRECTED_REPAIR,2.515375317,0,gemcitabine
REPRODUCTION,2.543522668,0,gemcitabine
MEIOSIS,2.55674149,0,gemcitabine
HDR_THROUGH_HOMOLOGOUS_RECOMBINATION_HRR,2.480958256,0,gemcitabine
DISEASES_OF_DNA_REPAIR,2.651243622,0,gemcitabine
HOMOLOGOUS_DNA_PAIRING_AND_STRAND_EXCHANGE,2.682724774,0,gemcitabine
G2_M_CHECKPOINTS,2.685284616,0,gemcitabine
RESPIRATORY_ELECTRON_TRANSPORT,-2.756869287,0,PIK-93
GPCR_LIGAND_BINDING,2.516585887,0.000939189,PIK-93
INTEGRIN_CELL_SURFACE_INTERACTIONS,2.509548169,0.000469595,PIK-93
ECM_PROTEOGLYCANS,2.367177668,0.001878379,PIK-93
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.27205168,0.004930745,PIK-93
G_ALPHA_Q_SIGNALLING_EVENTS,2.211781737,0.00713784,PIK-93
SIGNALING_BY_GPCR,2.143715409,0.01095721,PIK-93
METABOLISM_OF_RNA,-2.162461216,0.035028249,PIK-93
EXTRACELLULAR_MATRIX_ORGANIZATION,2.120487557,0.011404443,PIK-93
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.117088927,0.010213685,PIK-93
ESTROGEN_DEPENDENT_GENE_EXPRESSION,1.888392826,0.186764502,tamoxifen
RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES,1.520335712,0.899626194,tamoxifen
DISEASES_OF_METABOLISM,-2.994760038,1,tamoxifen
OPIOID_SIGNALLING,1.417668794,1,tamoxifen
METABOLISM_OF_NUCLEOTIDES,1.371222163,0.962100235,tamoxifen
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.608454955,1,tamoxifen
SARS_COV_1_HOST_INTERACTIONS,-2.585729629,1,tamoxifen
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.474858015,1,tamoxifen
EUKARYOTIC_TRANSLATION_ELONGATION,-2.378500772,0.865041944,tamoxifen
SELENOAMINO_ACID_METABOLISM,-2.350834007,0.730914171,tamoxifen
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.373888057,0.00396144,rosuvastatin
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.348190101,0.00346626,rosuvastatin
EUKARYOTIC_TRANSLATION_ELONGATION,-2.323270543,0.00396144,rosuvastatin
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.300270907,0.00445662,rosuvastatin
COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC,2.394085654,0.010766703,rosuvastatin
EUKARYOTIC_TRANSLATION_INITIATION,-2.226330309,0.010695888,rosuvastatin
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.164353408,0.01700118,rosuvastatin
HEMOSTASIS,2.079511008,0.027993427,rosuvastatin
INFLUENZA_INFECTION,-2.138204334,0.01924128,rosuvastatin
SARS_COV_1_HOST_INTERACTIONS,-2.137400979,0.016959915,rosuvastatin
GPCR_LIGAND_BINDING,-2.80240511,0,milnacipran
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.683269265,0,milnacipran
SIGNALING_BY_GPCR,-2.681281524,0,milnacipran
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.602329897,0.000159186,milnacipran
METABOLISM_OF_RNA,2.535973904,0.00327845,milnacipran
NEURONAL_SYSTEM,-2.485719154,0.00101879,milnacipran
RESPIRATORY_ELECTRON_TRANSPORT,2.399368938,0.007376513,milnacipran
ECM_PROTEOGLYCANS,-2.464670344,0.001485735,milnacipran
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.419144721,0.001910231,milnacipran
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.394824918,0.002308196,milnacipran
RESPIRATORY_ELECTRON_TRANSPORT,3.984856176,0,clozapine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.702819425,0,clozapine
GPCR_LIGAND_BINDING,-2.891609795,0,clozapine
SIGNALING_BY_GPCR,-2.672383163,0,clozapine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,3.489565635,0,clozapine
METABOLISM_OF_RNA,3.677969581,0,clozapine
TRANSLATION,3.136377203,0,clozapine
RRNA_PROCESSING,3.016599711,0.000536808,clozapine
CELLULAR_RESPONSE_TO_STARVATION,2.996264373,0.00044734,clozapine
COMPLEX_I_BIOGENESIS,2.97297475,0.000383434,clozapine
METABOLISM_OF_RNA,3.973826386,0,cholic-acid
RESPIRATORY_ELECTRON_TRANSPORT,3.624264501,0,cholic-acid
MRNA_SPLICING,3.45746835,0,cholic-acid
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,3.433991772,0,cholic-acid
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,3.213517512,0,cholic-acid
MITOTIC_G2_G2_M_PHASES,2.752571708,0,cholic-acid
MITOCHONDRIAL_PROTEIN_DEGRADATION,2.562676309,0.001239818,cholic-acid
G2_M_CHECKPOINTS,2.560841856,0.001084841,cholic-acid
CELL_CYCLE_MITOTIC,2.509198256,0.001607171,cholic-acid
INTERLEUKIN_1_SIGNALING,2.488940046,0.002314327,cholic-acid
METABOLISM_OF_VITAMINS_AND_COFACTORS,-3.136110428,0.315471449,ciglitazone
ESTROGEN_DEPENDENT_GENE_EXPRESSION,1.728262692,0.247041048,ciglitazone
GLUCOSE_METABOLISM,1.611766176,0.234009066,ciglitazone
ADIPOGENESIS,1.462666051,0.345630823,ciglitazone
TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION,1.444985138,0.282737346,ciglitazone
SENSORY_PERCEPTION,-2.98009012,1,ciglitazone
VISUAL_PHOTOTRANSDUCTION,-2.972832465,1,ciglitazone
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.777818538,1,ciglitazone
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.642555628,0.886097792,ciglitazone
SARS_COV_1_HOST_INTERACTIONS,-2.638085819,0.740233582,ciglitazone
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-3.141887436,0,imatinib
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.980409254,0,imatinib
MRNA_SPLICING,-2.72753695,0,imatinib
METABOLISM_OF_RNA,-2.693296539,0.000467454,imatinib
GPCR_LIGAND_BINDING,2.153839914,0.018659838,imatinib
NEURONAL_SYSTEM,2.140666388,0.010546865,imatinib
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,-2.176216653,0.010844922,imatinib
SIGNALING_BY_GPCR,2.133194862,0.007842541,imatinib
G_ALPHA_Q_SIGNALLING_EVENTS,2.11697911,0.007910149,imatinib
TCR_SIGNALING,-2.011670074,0.032098477,imatinib
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.1799096,0.049492556,valsartan
FORMATION_OF_THE_CORNIFIED_ENVELOPE,1.733981089,0.274958644,valsartan
KERATINIZATION,1.620482379,0.344614834,valsartan
NEUTROPHIL_DEGRANULATION,-1.770708726,1,valsartan
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,-1.71943894,1,valsartan
PI3K_AKT_SIGNALING_IN_CANCER,-1.718847281,0.696692415,valsartan
SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX,-1.696150991,0.622580974,valsartan
PROTEIN_LOCALIZATION,1.321861703,1,valsartan
INTERFERON_GAMMA_SIGNALING,-1.674296674,0.592831699,valsartan
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,-1.671084377,0.510179868,valsartan
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.455661314,0.004081831,thioridazine
GPCR_LIGAND_BINDING,2.393075381,0.004081831,thioridazine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.310952943,0.009551819,thioridazine
SIGNALING_BY_GPCR,2.102897224,0.011856747,thioridazine
RRNA_PROCESSING,-2.156933817,0.055188285,thioridazine
SELENOAMINO_ACID_METABOLISM,-2.147832637,0.042452527,thioridazine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.132109285,0.037676618,thioridazine
NEURONAL_SYSTEM,1.962897354,0.021866952,thioridazine
SARS_COV_1_HOST_INTERACTIONS,-2.109697848,0.036509173,thioridazine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.102394627,0.032546937,thioridazine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.942853848,0.005173923,trimebutine
COLLAGEN_FORMATION,-2.80656192,0.136074186,trimebutine
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.76929538,0.201783014,trimebutine
UNFOLDED_PROTEIN_RESPONSE_UPR,1.620406513,0.310942249,trimebutine
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.748088426,0.221185226,trimebutine
DEVELOPMENTAL_CELL_LINEAGES,1.591773885,0.184726444,trimebutine
ESTROGEN_DEPENDENT_GENE_EXPRESSION,1.443934882,0.2438872,trimebutine
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.442031611,0.585688132,trimebutine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.020142123,0.614218624,trimebutine
TP53_REGULATES_METABOLIC_GENES,-2.02158011,0.715726074,trimebutine
EUKARYOTIC_TRANSLATION_ELONGATION,-3.004141696,0,afatinib
SELENOAMINO_ACID_METABOLISM,-2.958637745,0,afatinib
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.943289572,0,afatinib
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.886923648,0,afatinib
NONSENSE_MEDIATED_DECAY_NMD,-2.833667439,0,afatinib
INFLUENZA_INFECTION,-2.803098692,0,afatinib
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.79170951,0,afatinib
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.716260133,0,afatinib
EUKARYOTIC_TRANSLATION_INITIATION,-2.698669365,0,afatinib
CELLULAR_RESPONSE_TO_STARVATION,-2.647397811,0,afatinib
METABOLISM_OF_RNA,-2.623145057,0.002506417,crizotinib
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.619958321,0.001879813,crizotinib
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.428459261,0.005012834,crizotinib
TRNA_PROCESSING,-2.366161389,0.007205949,crizotinib
HIV_LIFE_CYCLE,-2.207215072,0.021555186,crizotinib
CELL_CYCLE_CHECKPOINTS,-2.184158764,0.020677941,crizotinib
HIV_INFECTION,-2.167106781,0.019872306,crizotinib
SENSORY_PERCEPTION,2.098023797,0.110713466,crizotinib
TP53_REGULATES_TRANSCRIPTION_OF_DNA_REPAIR_GENES,-2.089641274,0.026943983,crizotinib
MITOTIC_SPINDLE_CHECKPOINT,-2.088767477,0.023950207,crizotinib
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.382359401,0.019672345,MLN-8054
SENSORY_PERCEPTION,2.334285476,0.012991837,MLN-8054
METABOLISM_OF_RNA,-2.263295905,0.035410221,MLN-8054
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-2.149181579,0.061202851,MLN-8054
INFLUENZA_INFECTION,-2.123643934,0.055410438,MLN-8054
SELENOAMINO_ACID_METABOLISM,-2.088842752,0.062951504,MLN-8054
RRNA_PROCESSING,-2.069088672,0.05967278,MLN-8054
NEURONAL_SYSTEM,2.058405702,0.07588414,MLN-8054
CELLULAR_RESPONSE_TO_STARVATION,-2.02244739,0.079438802,MLN-8054
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.017257058,0.071804059,MLN-8054
RESPIRATORY_ELECTRON_TRANSPORT,4.002506298,0,dexniguldipine
METABOLISM_OF_RNA,3.337509781,0,dexniguldipine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,3.203253708,0,dexniguldipine
TRANSLATION,3.079733144,0,dexniguldipine
MITOCHONDRIAL_TRANSLATION,3.032528544,0,dexniguldipine
NEURONAL_SYSTEM,-2.632348082,0,dexniguldipine
MITOCHONDRIAL_PROTEIN_IMPORT,2.914283658,0.000426379,dexniguldipine
GPCR_LIGAND_BINDING,-2.48511829,0.000310731,dexniguldipine
DNA_REPLICATION,2.713140007,0.000730935,dexniguldipine
RRNA_PROCESSING,2.664212792,0.000959352,dexniguldipine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.473015307,0.002011859,etizolam
INFLUENZA_INFECTION,-2.398087658,0.002997476,etizolam
EUKARYOTIC_TRANSLATION_ELONGATION,-2.370562297,0.001498738,etizolam
CELLULAR_RESPONSE_TO_STARVATION,-2.2883408,0.005661899,etizolam
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.247288679,0.009556332,etizolam
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.24317826,0.006244741,etizolam
SELENOAMINO_ACID_METABOLISM,-2.220954637,0.006794279,etizolam
EUKARYOTIC_TRANSLATION_INITIATION,-2.209606456,0.00699411,etizolam
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.204146433,0.006280426,etizolam
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.141425806,0.010116481,etizolam
METABOLISM_OF_VITAMINS_AND_COFACTORS,-3.016246856,1,gestrinone
SENSORY_PERCEPTION,-2.910982058,1,gestrinone
ION_CHANNEL_TRANSPORT,-2.880542517,1,gestrinone
VISUAL_PHOTOTRANSDUCTION,-2.859527534,1,gestrinone
RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_PATHWAY,1.206172856,1,gestrinone
SARS_COV_2_INFECTION,-2.62449379,1,gestrinone
SARS_COV_INFECTIONS,-2.428633843,1,gestrinone
ADIPOGENESIS,1.17985827,1,gestrinone
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.334644111,1,gestrinone
TRANSPORT_OF_SMALL_MOLECULES,-2.279764385,1,gestrinone
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-3.377000629,0,amuvatinib
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.737686078,0,amuvatinib
BIOLOGICAL_OXIDATIONS,-2.670870392,0.000581917,amuvatinib
DRUG_ADME,-2.634382163,0.000436438,amuvatinib
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.389122842,0.006633858,amuvatinib
NEURONAL_SYSTEM,2.13991354,0.031254542,amuvatinib
INNATE_IMMUNE_SYSTEM,-2.194326767,0.032005453,amuvatinib
HEMOSTASIS,-2.099902134,0.046885911,amuvatinib
METABOLISM_OF_VITAMINS_AND_COFACTORS,-2.09761038,0.041243391,amuvatinib
SIGNALING_BY_NTRKS,1.984535217,0.064422627,amuvatinib
CELL_CYCLE_CHECKPOINTS,-3.871186149,0,AT-7519
GPCR_LIGAND_BINDING,2.63381043,0,AT-7519
MITOTIC_PROMETAPHASE,-2.664596677,0,AT-7519
CHROMOSOME_MAINTENANCE,-2.685075771,0,AT-7519
G2_M_CHECKPOINTS,-2.771984848,0,AT-7519
DNA_REPAIR,-2.887031368,0,AT-7519
RESOLUTION_OF_SISTER_CHROMATID_COHESION,-2.907639139,0,AT-7519
SIGNALING_BY_GPCR,2.551059522,0,AT-7519
SEPARATION_OF_SISTER_CHROMATIDS,-2.911953843,0,AT-7519
M_PHASE,-2.978008095,0,AT-7519
GPCR_LIGAND_BINDING,2.508305209,0,pilocarpine
MUSCLE_CONTRACTION,2.271893383,0.004671993,pilocarpine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.176333966,0.05181773,pilocarpine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.095339691,0.012458648,pilocarpine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.088139868,0.009523678,pilocarpine
NONSENSE_MEDIATED_DECAY_NMD,-2.066275603,0.090681028,pilocarpine
SIGNALING_BY_GPCR,1.93111901,0.020125508,pilocarpine
SELENOAMINO_ACID_METABOLISM,-2.050086831,0.073926628,pilocarpine
SARS_COV_1_HOST_INTERACTIONS,-1.992994472,0.103376372,pilocarpine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-1.988164753,0.086431974,pilocarpine
RAB_REGULATION_OF_TRAFFICKING,2.279126794,0.029118655,sertindole
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.062654895,0.051619433,sertindole
RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS,1.934249146,0.079414513,sertindole
MHC_CLASS_II_ANTIGEN_PRESENTATION,1.871013613,0.091988477,sertindole
PROTEIN_LOCALIZATION,1.858152116,0.063090418,sertindole
METABOLISM_OF_STEROIDS,1.864312791,0.075179072,sertindole
VESICLE_MEDIATED_TRANSPORT,1.83016325,0.06353161,sertindole
MEMBRANE_TRAFFICKING,1.787512563,0.068825911,sertindole
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,1.769787272,0.068531783,sertindole
GPCR_LIGAND_BINDING,-1.91360131,0.28928093,sertindole
CELLULAR_RESPONSE_TO_STARVATION,3.676519135,0,oxybenzone
SIGNALING_BY_ROBO_RECEPTORS,2.857201949,0,oxybenzone
SIGNALING_BY_GPCR,-2.941120256,0,oxybenzone
TRANSLATION,2.978766536,0,oxybenzone
EUKARYOTIC_TRANSLATION_INITIATION,3.072043022,0,oxybenzone
METABOLISM_OF_RNA,3.091263148,0,oxybenzone
RRNA_PROCESSING,3.193969169,0,oxybenzone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.814404596,0,oxybenzone
SELENOAMINO_ACID_METABOLISM,3.200107366,0,oxybenzone
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.287558083,0,oxybenzone
COLLAGEN_FORMATION,-3.052695039,0,MK-1775
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.995454596,0,MK-1775
VISUAL_PHOTOTRANSDUCTION,-2.643338497,0,MK-1775
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.598152088,0.000512676,MK-1775
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.495552696,0.002870987,MK-1775
METABOLISM_OF_VITAMINS_AND_COFACTORS,-2.448943121,0.003759625,MK-1775
HCMV_INFECTION,-2.446034478,0.003222536,MK-1775
HCMV_EARLY_EVENTS,-2.433616803,0.003332395,MK-1775
TP53_REGULATES_METABOLIC_GENES,2.212470894,0.014591763,MK-1775
SENSORY_PERCEPTION,-2.177885138,0.014354933,MK-1775
EUKARYOTIC_TRANSLATION_ELONGATION,2.269310474,0.014786595,NVP-BGJ398
NONSENSE_MEDIATED_DECAY_NMD,2.197741127,0.014082471,NVP-BGJ398
SELENOAMINO_ACID_METABOLISM,2.16164893,0.013847763,NVP-BGJ398
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.104350012,0.019539429,NVP-BGJ398
CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,-3.58079487,0.316388164,NVP-BGJ398
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-3.5436136,0.216738349,NVP-BGJ398
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.05031623,0.026334221,NVP-BGJ398
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.014875054,0.031333498,NVP-BGJ398
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.01262371,0.02725964,NVP-BGJ398
EUKARYOTIC_TRANSLATION_INITIATION,2.000210407,0.027196772,NVP-BGJ398
RESPIRATORY_ELECTRON_TRANSPORT,3.932891972,0,dopamine
METABOLISM_OF_RNA,3.593072276,0,dopamine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,3.496514279,0,dopamine
GPCR_LIGAND_BINDING,-2.564532504,0,dopamine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.892219215,0.000700566,dopamine
COMPLEX_I_BIOGENESIS,2.805751914,0.000560453,dopamine
MRNA_SPLICING,2.788446317,0.000467044,dopamine
TRANSLATION,2.713695155,0.000400324,dopamine
SENSORY_PERCEPTION,-2.332293088,0.000660277,dopamine
SIGNALING_BY_GPCR,-2.331716287,0.000440184,dopamine
RRNA_PROCESSING,3.98274798,0,mebendazole
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,2.674382942,0,mebendazole
SENSORY_PERCEPTION,-2.674837362,0,mebendazole
MRNA_SPLICING,2.674847459,0,mebendazole
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,2.683933437,0,mebendazole
VIRAL_INFECTION_PATHWAYS,2.695529809,0,mebendazole
SARS_COV_1_INFECTION,2.737185251,0,mebendazole
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.752878183,0,mebendazole
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.76543823,0,mebendazole
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.80213137,0,mebendazole
EUKARYOTIC_TRANSLATION_ELONGATION,4.032443137,0,aminolevulinic-acid
CELLULAR_RESPONSES_TO_STIMULI,2.633597786,0,aminolevulinic-acid
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.6522878,0,aminolevulinic-acid
SARS_COV_2_HOST_INTERACTIONS,2.674139872,0,aminolevulinic-acid
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.755462506,0,aminolevulinic-acid
VIRAL_INFECTION_PATHWAYS,2.815049278,0,aminolevulinic-acid
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,2.867464207,0,aminolevulinic-acid
SARS_COV_1_INFECTION,2.892307676,0,aminolevulinic-acid
METABOLISM_OF_RNA,2.938188314,0,aminolevulinic-acid
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,2.94154241,0,aminolevulinic-acid
GPCR_LIGAND_BINDING,-2.396764165,0.001704288,febuxostat
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.439302438,0.006029646,febuxostat
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.314693603,0.001704288,febuxostat
PROTEIN_LOCALIZATION,2.131710965,0.030148229,febuxostat
MRNA_SPLICING,2.124420177,0.02076878,febuxostat
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.13354841,0.010793822,febuxostat
PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,2.064813671,0.022611172,febuxostat
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.06105322,0.018088937,febuxostat
METABOLISM_OF_STEROIDS,1.802975075,0.076375513,febuxostat
MITOCHONDRIAL_PROTEIN_DEGRADATION,1.785977131,0.074652757,febuxostat
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.153170094,0.035665739,trovafloxacin
REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION,1.705104515,0.272185902,trovafloxacin
RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES,1.669118717,0.224005869,trovafloxacin
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,1.664373306,0.174574406,trovafloxacin
RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES,1.650526116,0.123891514,trovafloxacin
AURKA_ACTIVATION_BY_TPX2,1.650526116,0.123891514,trovafloxacin
ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE,1.621573108,0.122550697,trovafloxacin
CILIUM_ASSEMBLY,1.461130652,0.22924623,trovafloxacin
SPHINGOLIPID_METABOLISM,-1.788516335,1,trovafloxacin
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,1.34667961,0.339137377,trovafloxacin
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.468432441,0.017207853,meclofenamic-acid
FORMATION_OF_THE_CORNIFIED_ENVELOPE,1.923717255,0.105947726,meclofenamic-acid
KERATINIZATION,1.710933784,0.181559992,meclofenamic-acid
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.072412654,0.29607629,meclofenamic-acid
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-1.987231632,0.374186445,meclofenamic-acid
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,1.447717591,0.5022707,meclofenamic-acid
ISG15_ANTIVIRAL_MECHANISM,1.442667953,0.386890307,meclofenamic-acid
COLLAGEN_DEGRADATION,-1.885818048,0.547108495,meclofenamic-acid
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.85288828,0.521296716,meclofenamic-acid
TRNA_PROCESSING,1.346114063,0.481020786,meclofenamic-acid
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,2.590174851,0,escitalopram
MHC_CLASS_II_ANTIGEN_PRESENTATION,2.320875153,0.016244585,escitalopram
METABOLISM_OF_STEROIDS,2.265028318,0.015642934,escitalopram
GOLGI_TO_ER_RETROGRADE_TRANSPORT,2.157903365,0.027074309,escitalopram
RESPIRATORY_ELECTRON_TRANSPORT,2.10615535,0.025991336,escitalopram
SENSORY_PERCEPTION,-2.097234885,0.029663612,escitalopram
INTERFERON_GAMMA_SIGNALING,2.016733112,0.040310637,escitalopram
TRANSLATION,1.978440854,0.042803193,escitalopram
MEMBRANE_TRAFFICKING,1.883497961,0.063173387,escitalopram
MRNA_SPLICING,1.744023533,0.107093932,escitalopram
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.305407016,0.046609812,bopindolol
REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE,2.243463886,0.03884151,bopindolol
MITOTIC_PROMETAPHASE,2.18890624,0.041430944,bopindolol
MRNA_SPLICING,2.145359493,0.03884151,bopindolol
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.106728953,0.035734189,bopindolol
MHC_CLASS_II_ANTIGEN_PRESENTATION,2.060706872,0.033662642,bopindolol
MITOTIC_G2_G2_M_PHASES,1.889383122,0.079902534,bopindolol
SUMOYLATION,1.860018689,0.082538208,bopindolol
RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES,1.841130125,0.0889039,bopindolol
RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES,1.78858442,0.105648907,bopindolol
SARS_COV_1_HOST_INTERACTIONS,-2.796482084,0,brequinar
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.796429593,0,brequinar
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.664342318,0.00032987,brequinar
SARS_COV_1_INFECTION,-2.564465171,0.000494805,brequinar
EUKARYOTIC_TRANSLATION_ELONGATION,-2.528894455,0.000989611,brequinar
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.466081837,0.002309092,brequinar
SELENOAMINO_ACID_METABOLISM,-2.417594221,0.0052308,brequinar
NONSENSE_MEDIATED_DECAY_NMD,-2.391487323,0.006927276,brequinar
CELLULAR_RESPONSE_TO_STARVATION,-2.371497821,0.007916886,brequinar
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.37031515,0.007620003,brequinar
RESPIRATORY_ELECTRON_TRANSPORT,3.745742066,0,ketorolac
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,3.642618198,0,ketorolac
MRNA_SPLICING,2.764412793,0,ketorolac
METABOLISM_OF_RNA,2.722045415,0,ketorolac
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.587588803,0.000908858,ketorolac
TRANSLATION,2.557247799,0.000757382,ketorolac
COMPLEX_I_BIOGENESIS,2.502878198,0.001622961,ketorolac
CELLULAR_RESPONSE_TO_STARVATION,2.385870878,0.003692235,ketorolac
G2_M_CHECKPOINTS,2.335035086,0.005554132,ketorolac
RRNA_PROCESSING,2.334025847,0.004998719,ketorolac
PI3K_AKT_SIGNALING_IN_CANCER,-2.33810386,0.103828978,olaparib
CONSTITUTIVE_SIGNALING_BY_ABERRANT_PI3K_IN_CANCER,-2.304160541,0.065311776,olaparib
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,2.071844469,0.06244497,olaparib
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.006439496,0.282459477,olaparib
NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,-1.882151098,0.40317462,olaparib
NEURONAL_SYSTEM,1.81401585,0.435898327,olaparib
GPCR_LIGAND_BINDING,1.785181826,0.37061495,olaparib
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-1.735705994,0.616275223,olaparib
SIGNALING_BY_GPCR,1.743426498,0.384401501,olaparib
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-1.680063448,0.630788951,olaparib
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.625825244,0.020244001,sunitinib
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.438334898,0.056683202,sunitinib
COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC,-2.376900039,0.062081602,sunitinib
ECM_PROTEOGLYCANS,-2.211967704,0.165663404,sunitinib
INTERFERON_ALPHA_BETA_SIGNALING,-2.061000962,0.328222729,sunitinib
RNA_POLYMERASE_II_TRANSCRIPTION_TERMINATION,1.809128116,0.725564771,sunitinib
RAB_REGULATION_OF_TRAFFICKING,1.748128792,0.537277185,sunitinib
SELENOAMINO_ACID_METABOLISM,1.731397287,0.400097756,sunitinib
APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS,-1.839687244,0.773770687,sunitinib
ION_CHANNEL_TRANSPORT,-1.826354744,0.693308818,sunitinib
SENSORY_PERCEPTION,2.103718463,0.097359425,roscovitine
TCR_SIGNALING,-2.039387513,0.208350002,roscovitine
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,2.00999673,0.112415006,roscovitine
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,-1.957758882,0.166680002,roscovitine
NEDDYLATION,-1.888598039,0.171971431,roscovitine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-1.885154221,0.130714823,roscovitine
SIGNALING_BY_NTRKS,-1.832377013,0.149218287,roscovitine
EXTRACELLULAR_MATRIX_ORGANIZATION,1.861250036,0.274011577,roscovitine
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,1.807732779,0.298100506,roscovitine
VISUAL_PHOTOTRANSDUCTION,1.798166163,0.258153031,roscovitine
ESTROGEN_DEPENDENT_GENE_EXPRESSION,1.943971688,0.133863157,thiomersal
MITF_M_DEPENDENT_GENE_EXPRESSION,1.673253981,0.27902645,thiomersal
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.739864873,0.485625439,thiomersal
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,1.591636176,0.28395215,thiomersal
ECM_PROTEOGLYCANS,-2.659411879,0.937105338,thiomersal
RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_PATHWAY,1.341073962,0.76927853,thiomersal
CILIUM_ASSEMBLY,1.318799538,0.681137464,thiomersal
SIGNALING_BY_NUCLEAR_RECEPTORS,1.316333432,0.575727472,thiomersal
SIGNALING_BY_FGFR,1.297037169,0.541164783,thiomersal
ESR_MEDIATED_SIGNALING,1.283007149,0.504377251,thiomersal
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.818123184,0.153155558,goserelin-acetate
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.776758543,0.199702835,goserelin-acetate
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.760507896,0.176178943,goserelin-acetate
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.418640168,0.618378078,goserelin-acetate
RHO_GTPASE_EFFECTORS,1.391003671,1,goserelin-acetate
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-1.862482956,0.82383676,goserelin-acetate
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-1.852439137,0.696707636,goserelin-acetate
EUKARYOTIC_TRANSLATION_INITIATION,-1.851003952,0.598321993,goserelin-acetate
SIGNALING_BY_NOTCH1,1.28319645,1,goserelin-acetate
EUKARYOTIC_TRANSLATION_ELONGATION,-1.828825094,0.54004852,goserelin-acetate
EUKARYOTIC_TRANSLATION_ELONGATION,-2.723328454,0,triptorelin
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.451222406,0,triptorelin
INFLUENZA_INFECTION,-2.461232836,0,triptorelin
EUKARYOTIC_TRANSLATION_INITIATION,-2.464144647,0,triptorelin
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.410932943,0,triptorelin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.551944178,0,triptorelin
SELENOAMINO_ACID_METABOLISM,-2.611747062,0,triptorelin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.625443955,0,triptorelin
NONSENSE_MEDIATED_DECAY_NMD,-2.533029263,0,triptorelin
SARS_COV_1_HOST_INTERACTIONS,-2.329731038,9.51E-05,triptorelin
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.967112189,0,BRD-K47869605
GPCR_LIGAND_BINDING,2.787828177,0.000485501,BRD-K47869605
SIGNALING_BY_GPCR,2.508932424,0.000971001,BRD-K47869605
HEMOSTASIS,2.475036219,0.001213751,BRD-K47869605
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.341191281,0.001747802,BRD-K47869605
NEURONAL_SYSTEM,2.27638986,0.002913004,BRD-K47869605
G_ALPHA_Q_SIGNALLING_EVENTS,2.177374375,0.004577577,BRD-K47869605
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,2.102938356,0.006675633,BRD-K47869605
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,1.827741176,0.036034933,BRD-K47869605
SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,1.763602647,0.046608057,BRD-K47869605
TRANSLATION,3.392314846,0,tioconazole
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.691410149,0,tioconazole
METABOLISM_OF_RNA,2.694912232,0,tioconazole
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.707506523,0,tioconazole
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.797284095,0,tioconazole
SELENOAMINO_ACID_METABOLISM,2.868178024,0,tioconazole
NONSENSE_MEDIATED_DECAY_NMD,2.628444477,0,tioconazole
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.099131869,0,tioconazole
RRNA_PROCESSING,3.150277019,0,tioconazole
CELLULAR_RESPONSE_TO_STARVATION,3.186510746,0,tioconazole
GPCR_LIGAND_BINDING,2.249194614,0.013907211,pyrazolanthrone
G_ALPHA_S_SIGNALLING_EVENTS,2.09290108,0.031125663,pyrazolanthrone
CELL_CELL_COMMUNICATION,-3.594057028,1,pyrazolanthrone
SIGNALING_BY_GPCR,1.918900844,0.118542418,pyrazolanthrone
CELL_JUNCTION_ORGANIZATION,-3.507970778,1,pyrazolanthrone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.878749955,0.12764833,pyrazolanthrone
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.84964044,0.13231718,pyrazolanthrone
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,1.827447238,0.131014758,pyrazolanthrone
METABOLISM_OF_NUCLEOTIDES,-2.152409192,1,pyrazolanthrone
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-1.990849314,1,pyrazolanthrone
CELL_CYCLE_CHECKPOINTS,-2.79851212,0,selumetinib
SENSORY_PERCEPTION,2.680361552,0,selumetinib
G2_M_CHECKPOINTS,-2.568164218,0.003422146,selumetinib
CELL_CYCLE,-2.469864168,0.002281431,selumetinib
VISUAL_PHOTOTRANSDUCTION,2.354418592,0.00329327,selumetinib
METABOLISM_OF_RNA,-2.308483094,0.005988756,selumetinib
RRNA_PROCESSING,-2.274741491,0.005475434,selumetinib
NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION,-2.19667147,0.01226269,selumetinib
REGULATION_OF_TP53_ACTIVITY,-2.195725591,0.010510878,selumetinib
SEPARATION_OF_SISTER_CHROMATIDS,-2.128047153,0.013046932,selumetinib
METABOLISM_OF_RNA,-3.437808707,0,foretinib
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-3.221838301,0,foretinib
MRNA_SPLICING,-3.171701981,0,foretinib
COLLAGEN_DEGRADATION,2.491194189,0,foretinib
CELL_CYCLE_CHECKPOINTS,-2.542191563,0.001046572,foretinib
G2_M_CHECKPOINTS,-2.488608506,0.000837258,foretinib
CELL_CYCLE,-2.430549421,0.00139543,foretinib
ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES,2.289826173,0.00288428,foretinib
COLLAGEN_FORMATION,2.253158025,0.004669787,foretinib
GPCR_LIGAND_BINDING,2.237089035,0.00370836,foretinib
EUKARYOTIC_TRANSLATION_ELONGATION,-2.41914428,0,quinapril
NONSENSE_MEDIATED_DECAY_NMD,-2.375892323,0.000517047,quinapril
INFLUENZA_INFECTION,-2.306484841,0.001378791,quinapril
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.583498784,0.012196194,quinapril
EUKARYOTIC_TRANSLATION_INITIATION,-2.297723374,0.001292616,quinapril
RRNA_PROCESSING,-2.253599605,0.002688642,quinapril
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.240494458,0.003102279,quinapril
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.238253354,0.002659096,quinapril
CELLULAR_RESPONSE_TO_STARVATION,-2.226119244,0.002455971,quinapril
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.219297585,0.002527783,quinapril
SUMOYLATION_OF_DNA_REPLICATION_PROTEINS,2.81442818,0.007256309,tizanidine
SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS,2.761033022,0.003628154,tizanidine
TRNA_PROCESSING_IN_THE_NUCLEUS,1.998532912,0.06772555,tizanidine
HOST_INTERACTIONS_OF_HIV_FACTORS,1.943775892,0.076191244,tizanidine
DNA_REPLICATION,1.798363565,0.16979763,tizanidine
SIGNALING_BY_FGFR,1.792184398,0.145126179,tizanidine
SIGNALING_BY_FGFR2,1.755156375,0.158602181,tizanidine
ISG15_ANTIVIRAL_MECHANISM,1.752081764,0.143312102,tizanidine
REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE,1.739072423,0.122631621,tizanidine
MITOTIC_PROPHASE,1.741429838,0.136257357,tizanidine
METABOLISM_OF_RNA,-3.812113604,0,nilotinib
CELL_CYCLE_CHECKPOINTS,-3.154437796,0,nilotinib
RESPIRATORY_ELECTRON_TRANSPORT,-3.084469963,0,nilotinib
RRNA_PROCESSING,-3.044373684,0,nilotinib
CELL_CYCLE,-3.034950985,0,nilotinib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.540409037,0,nilotinib
SIGNALING_BY_GPCR,2.572396078,0,nilotinib
GPCR_LIGAND_BINDING,2.70687414,0,nilotinib
TRANSLATION,-2.585130537,0.000213356,nilotinib
MRNA_SPLICING,-2.637382521,0.000232752,nilotinib
SELENOAMINO_ACID_METABOLISM,3.302572743,0,pentoxifylline
SIGNALING_BY_ROBO_RECEPTORS,2.682427171,0,pentoxifylline
RRNA_PROCESSING,2.810912521,0,pentoxifylline
METABOLISM_OF_RNA,2.9418303,0,pentoxifylline
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.978452838,0,pentoxifylline
EUKARYOTIC_TRANSLATION_ELONGATION,3.009601325,0,pentoxifylline
INFLUENZA_INFECTION,3.014133044,0,pentoxifylline
SIGNALING_BY_GPCR,-2.741357978,0,pentoxifylline
GPCR_LIGAND_BINDING,-3.040809307,0,pentoxifylline
EUKARYOTIC_TRANSLATION_INITIATION,3.084450049,0,pentoxifylline
NEUTROPHIL_DEGRANULATION,3.488879568,0,doxofylline
GOLGI_TO_ER_RETROGRADE_TRANSPORT,2.912759714,0,doxofylline
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,2.82882438,0,doxofylline
MEMBRANE_TRAFFICKING,2.667110073,0,doxofylline
VESICLE_MEDIATED_TRANSPORT,2.658091862,0,doxofylline
MHC_CLASS_II_ANTIGEN_PRESENTATION,2.543993194,0,doxofylline
RESPIRATORY_ELECTRON_TRANSPORT,2.3910317,0.001067898,doxofylline
TCR_SIGNALING,2.308308205,0.001868821,doxofylline
RAB_REGULATION_OF_TRAFFICKING,2.23905173,0.003322348,doxofylline
MITF_M_DEPENDENT_GENE_EXPRESSION,2.208359875,0.003737642,doxofylline
LATE_SARS_COV_2_INFECTION_EVENTS,-2.908779658,1,lamotrigine
ION_CHANNEL_TRANSPORT,-2.873440196,1,lamotrigine
SARS_COV_2_INFECTION,-2.654993018,1,lamotrigine
SARS_COV_INFECTIONS,-2.502975028,1,lamotrigine
TRANSPORT_OF_SMALL_MOLECULES,-2.390807953,0.941308945,lamotrigine
METABOLISM_OF_STEROIDS,1.323702931,1,lamotrigine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.16259822,0.913658746,lamotrigine
SARS_COV_1_HOST_INTERACTIONS,-2.116782044,0.816911673,lamotrigine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.049321893,0.768520247,lamotrigine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.032149891,0.6957075,lamotrigine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.608010817,0,enalapril
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.843117784,0,enalapril
SARS_COV_1_HOST_INTERACTIONS,2.843367226,0,enalapril
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.850010344,0,enalapril
SIGNALING_BY_GPCR,-2.890349781,0,enalapril
NONSENSE_MEDIATED_DECAY_NMD,3.098916726,0,enalapril
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.108613048,0,enalapril
GPCR_LIGAND_BINDING,-3.157870683,0,enalapril
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.669350903,0,enalapril
METABOLISM_OF_RNA,3.20625863,0,enalapril
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,5.462039364,0,probucol
CELL_CYCLE_CHECKPOINTS,2.608867402,0,probucol
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.680282221,0,probucol
SARS_COV_2_HOST_INTERACTIONS,2.714510369,0,probucol
SARS_COV_1_INFECTION,2.747542318,0,probucol
SARS_COV_1_HOST_INTERACTIONS,2.825082036,0,probucol
CELLULAR_RESPONSES_TO_STIMULI,2.917353282,0,probucol
DOWNSTREAM_TCR_SIGNALING,3.02917416,0,probucol
RESPIRATORY_ELECTRON_TRANSPORT,3.23705292,0,probucol
VIRAL_INFECTION_PATHWAYS,3.329192129,0,probucol
METABOLISM_OF_RNA,-2.134625348,0.111831774,ruxolitinib
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,-2.10631401,0.068819553,ruxolitinib
GPCR_LIGAND_BINDING,2.116890202,0.064295948,ruxolitinib
TCR_SIGNALING,-2.007100463,0.075988257,ruxolitinib
INFLUENZA_INFECTION,-1.95429159,0.07795965,ruxolitinib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.97833236,0.106088314,ruxolitinib
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-1.772303044,0.161295828,ruxolitinib
NONSENSE_MEDIATED_DECAY_NMD,-1.768809784,0.137639107,ruxolitinib
G_ALPHA_Q_SIGNALLING_EVENTS,1.937921549,0.109303111,ruxolitinib
CELLULAR_RESPONSE_TO_STARVATION,-1.724128354,0.148699392,ruxolitinib
ECM_PROTEOGLYCANS,-2.737510129,0.802940588,darifenacin
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.711149698,0.506593438,darifenacin
ESTROGEN_DEPENDENT_GENE_EXPRESSION,1.442238649,0.989255234,darifenacin
EPIGENETIC_REGULATION_BY_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES,1.385543556,0.698471173,darifenacin
SELENOAMINO_ACID_METABOLISM,-1.872079311,1,darifenacin
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-1.834875644,1,darifenacin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-1.8343011,0.973540433,darifenacin
EUKARYOTIC_TRANSLATION_ELONGATION,-1.828593878,0.819126215,darifenacin
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-1.818630468,0.717983924,darifenacin
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-1.805153261,0.649385709,darifenacin
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.772711925,0,rilmenidine
GPCR_LIGAND_BINDING,-2.730151832,0,rilmenidine
METABOLISM_OF_RNA,2.520834698,0.001419969,rilmenidine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.555127903,0.000484979,rilmenidine
RESPIRATORY_ELECTRON_TRANSPORT,2.396447626,0.004969892,rilmenidine
ECM_PROTEOGLYCANS,-2.516477681,0.001636806,rilmenidine
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.459300299,0.002182408,rilmenidine
HEMOSTASIS,-2.454877006,0.001818673,rilmenidine
RRNA_PROCESSING,2.35154032,0.006626523,rilmenidine
COLLAGEN_FORMATION,-2.430874416,0.001616598,rilmenidine
NEURONAL_SYSTEM,2.157626316,0.039802834,macitentan
EUKARYOTIC_TRANSLATION_ELONGATION,-2.09567282,0.122566247,macitentan
SIGNALING_BY_GPCR,1.815963177,0.169747381,macitentan
FATTY_ACID_METABOLISM,1.726988436,0.190039022,macitentan
SELENOAMINO_ACID_METABOLISM,-1.942292934,0.291217404,macitentan
GPCR_LIGAND_BINDING,1.684974991,0.183210105,macitentan
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-1.923491936,0.231731918,macitentan
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-1.914369566,0.188752021,macitentan
SIGNALING_BY_ROBO_RECEPTORS,-1.903164491,0.166690096,macitentan
G_ALPHA_Q_SIGNALLING_EVENTS,1.62470285,0.195033888,macitentan
TRANSLATION,3.255023555,0,felodipine
METABOLISM_OF_RNA,3.212619047,0,felodipine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.052951379,0,felodipine
EUKARYOTIC_TRANSLATION_INITIATION,2.934776912,0,felodipine
CELLULAR_RESPONSE_TO_STARVATION,2.898382349,0,felodipine
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,-2.863843706,0,felodipine
EUKARYOTIC_TRANSLATION_ELONGATION,2.806619759,0,felodipine
SELENOAMINO_ACID_METABOLISM,2.670157587,0.000203294,felodipine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.718183245,0.000261378,felodipine
NONSENSE_MEDIATED_DECAY_NMD,2.693779776,0.000228705,felodipine
EXTRACELLULAR_MATRIX_ORGANIZATION,-3.189339886,0,glipizide
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.872616578,0.000333509,glipizide
ECM_PROTEOGLYCANS,-2.872099161,0.00022234,glipizide
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.823536427,0.000166755,glipizide
COLLAGEN_FORMATION,-2.805173809,0.000133404,glipizide
ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES,-2.724021946,0.00011117,glipizide
RESPIRATORY_ELECTRON_TRANSPORT,2.678884412,0.001412867,glipizide
CELLULAR_RESPONSE_TO_STARVATION,2.668712556,0.000706434,glipizide
RRNA_PROCESSING,2.633637502,0.000941912,glipizide
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.614358849,0.000706434,glipizide
METABOLISM_OF_RNA,2.772541679,0,emedastine
TRANSLATION,2.533887183,0,emedastine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.524138411,0,emedastine
RESPIRATORY_ELECTRON_TRANSPORT,2.487804876,0.000422864,emedastine
GPCR_LIGAND_BINDING,-2.748724488,0.001110451,emedastine
NEURONAL_SYSTEM,-2.726180441,0.000555225,emedastine
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.694262198,0.00037015,emedastine
ECM_PROTEOGLYCANS,-2.635697232,0.000277613,emedastine
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,-2.629713845,0.00022209,emedastine
SIGNALING_BY_GPCR,-2.61896751,0.000277613,emedastine
METABOLISM_OF_RNA,-4.03261418,0,mitoxantrone
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.822338269,0.004079327,mitoxantrone
NEURONAL_SYSTEM,2.262325308,0.006599653,mitoxantrone
MRNA_SPLICING,-2.321438942,0.01903686,mitoxantrone
CELL_CYCLE_CHECKPOINTS,-2.248427661,0.020396636,mitoxantrone
HOMOLOGY_DIRECTED_REPAIR,-2.056671639,0.035354169,mitoxantrone
DNA_REPAIR,-2.042159748,0.031728101,mitoxantrone
G_ALPHA_Q_SIGNALLING_EVENTS,2.104638546,0.026031966,mitoxantrone
C_TYPE_LECTIN_RECEPTORS_CLRS,-1.988609593,0.034577155,mitoxantrone
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,-1.951739221,0.036713945,mitoxantrone
RESPIRATORY_ELECTRON_TRANSPORT,2.856317041,0,PCI-24781
CHROMATIN_ORGANIZATION,-2.797018698,0,PCI-24781
MITOTIC_SPINDLE_CHECKPOINT,-2.51431261,0.001222075,PCI-24781
CELL_CYCLE_CHECKPOINTS,-2.467470632,0.001222075,PCI-24781
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.383447954,0.003888795,PCI-24781
CELL_CYCLE,-2.364245147,0.003971742,PCI-24781
CELL_CYCLE_MITOTIC,-2.359398299,0.003177394,PCI-24781
PKMTS_METHYLATE_HISTONE_LYSINES,-2.341985843,0.003666224,PCI-24781
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,-2.305946018,0.004364552,PCI-24781
RESOLUTION_OF_SISTER_CHROMATID_COHESION,-2.273949042,0.005346576,PCI-24781
METABOLISM_OF_RNA,3.303802018,0,aliskiren
TRANSLATION,3.109143588,0,aliskiren
EUKARYOTIC_TRANSLATION_ELONGATION,2.954875087,0,aliskiren
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,-2.925581025,0,aliskiren
GPCR_LIGAND_BINDING,-2.899837851,0,aliskiren
DEVELOPMENTAL_CELL_LINEAGES,-2.886748102,0,aliskiren
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.707212146,0,aliskiren
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.589520693,0.000401245,aliskiren
SIGNALING_BY_GPCR,-2.634196496,0.000102377,aliskiren
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.657776053,0.000222914,aliskiren
GPCR_LIGAND_BINDING,-2.720750514,0,vortioxetine
NEURONAL_SYSTEM,-2.684087585,0,vortioxetine
RESPIRATORY_ELECTRON_TRANSPORT,2.559777078,0,vortioxetine
SIGNALING_BY_GPCR,-2.514502506,0,vortioxetine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.459768125,0.001546826,vortioxetine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.461031856,0.000549718,vortioxetine
MRNA_SPLICING,2.23284012,0.018046303,vortioxetine
METABOLISM_OF_RNA,2.179702021,0.025522628,vortioxetine
POTASSIUM_CHANNELS,-2.173977523,0.012460267,vortioxetine
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,-2.124112362,0.01649153,vortioxetine
SIGNALING_BY_VEGF,1.84205163,0.176756326,buspirone
TP53_REGULATES_METABOLIC_GENES,-1.915006141,0.325411497,buspirone
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-1.769223768,0.699442168,buspirone
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1.375459609,0.966323497,buspirone
SIGNALING_BY_NTRKS,1.353499022,0.71425119,buspirone
PROTEIN_FOLDING,1.35009675,0.545693468,buspirone
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,1.318694755,0.510925832,buspirone
MUSCLE_CONTRACTION,1.307079768,0.452451727,buspirone
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,1.289123724,0.423548177,buspirone
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,1.282287145,0.385820706,buspirone
EXTRACELLULAR_MATRIX_ORGANIZATION,2.694464453,0,dantrolene
EUKARYOTIC_TRANSLATION_ELONGATION,-2.540174121,0,dantrolene
SELENOAMINO_ACID_METABOLISM,-2.39629264,0.001976196,dantrolene
NONSENSE_MEDIATED_DECAY_NMD,-2.384313903,0.001317464,dantrolene
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.337203135,0.001235122,dantrolene
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.334687522,0.000988098,dantrolene
EUKARYOTIC_TRANSLATION_INITIATION,-2.330405232,0.000823415,dantrolene
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.315764236,0.000846941,dantrolene
RRNA_PROCESSING,-2.277596866,0.001358635,dantrolene
CELLULAR_RESPONSE_TO_STARVATION,-2.272152481,0.001317464,dantrolene
EUKARYOTIC_TRANSLATION_ELONGATION,-2.758867589,0,bezafibrate
SELENOAMINO_ACID_METABOLISM,-2.654797731,0,bezafibrate
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.625305543,0,bezafibrate
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.527374108,0,bezafibrate
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.525893639,0,bezafibrate
NONSENSE_MEDIATED_DECAY_NMD,-2.497383207,0,bezafibrate
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.47935409,0,bezafibrate
EUKARYOTIC_TRANSLATION_INITIATION,-2.446699659,0,bezafibrate
CELLULAR_RESPONSE_TO_STARVATION,-2.405095304,0.000114565,bezafibrate
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.358228067,0.000309325,bezafibrate
METABOLISM_OF_RNA,3.757306266,0,nateglinide
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,3.653303594,0,nateglinide
RESPIRATORY_ELECTRON_TRANSPORT,3.641381465,0,nateglinide
TRANSLATION,3.071518117,0,nateglinide
G2_M_CHECKPOINTS,2.985566892,0,nateglinide
S_PHASE,2.80614912,0,nateglinide
DNA_REPLICATION,2.803739069,0,nateglinide
COMPLEX_I_BIOGENESIS,2.737789302,0,nateglinide
RRNA_PROCESSING,2.672402995,0,nateglinide
GPCR_LIGAND_BINDING,-2.608598773,0,nateglinide
GPCR_LIGAND_BINDING,2.622470334,0,sasapyrine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.466768369,0.003143134,sasapyrine
SIGNALING_BY_GPCR,2.398553615,0.001921901,sasapyrine
SELENOAMINO_ACID_METABOLISM,-2.283846731,0.014667961,sasapyrine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.258256255,0.004057346,sasapyrine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.254111843,0.014667961,sasapyrine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.202629778,0.016239528,sasapyrine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.153034342,0.021582856,sasapyrine
EUKARYOTIC_TRANSLATION_INITIATION,-2.151364811,0.018334951,sasapyrine
SARS_COV_1_HOST_INTERACTIONS,-2.146335769,0.016464037,sasapyrine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.171714034,0.069249758,clenbuterol
NONSENSE_MEDIATED_DECAY_NMD,-2.125652986,0.058189033,clenbuterol
SELENOAMINO_ACID_METABOLISM,-2.062200903,0.06604375,clenbuterol
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-1.970430994,0.10555779,clenbuterol
TRANSLATION,-1.951275983,0.095987859,clenbuterol
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-1.941302703,0.087363699,clenbuterol
EUKARYOTIC_TRANSLATION_INITIATION,-1.918990775,0.088485802,clenbuterol
INFLUENZA_INFECTION,-1.891437094,0.096300444,clenbuterol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.881154409,0.093936014,clenbuterol
MUSCLE_CONTRACTION,1.544299671,1,clenbuterol
CELLULAR_RESPONSE_TO_STARVATION,3.415750947,0,cytarabine
ECM_PROTEOGLYCANS,-2.706066393,0,cytarabine
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.758579849,0,cytarabine
SIGNALING_BY_ROBO_RECEPTORS,2.777779558,0,cytarabine
DEVELOPMENTAL_CELL_LINEAGES,-2.789260811,0,cytarabine
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,-2.821395723,0,cytarabine
NONSENSE_MEDIATED_DECAY_NMD,2.862236969,0,cytarabine
INFLUENZA_INFECTION,3.000778431,0,cytarabine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.965821349,0,cytarabine
RRNA_PROCESSING,3.169238696,0,cytarabine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.18655454,0,BRD-K31342827
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.693973724,0,BRD-K31342827
RRNA_PROCESSING,2.707595327,0,BRD-K31342827
NONSENSE_MEDIATED_DECAY_NMD,2.804520206,0,BRD-K31342827
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.938436381,0,BRD-K31342827
EUKARYOTIC_TRANSLATION_INITIATION,3.02176509,0,BRD-K31342827
ECM_PROTEOGLYCANS,-2.907164414,0,BRD-K31342827
TRANSLATION,3.079374271,0,BRD-K31342827
EUKARYOTIC_TRANSLATION_ELONGATION,3.081538014,0,BRD-K31342827
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.102896743,0,BRD-K31342827
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.658391389,0.002187821,agomelatine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.310580936,0.017810313,agomelatine
GPCR_LIGAND_BINDING,2.185124096,0.014220837,agomelatine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.111331899,0.017502569,agomelatine
INFLUENZA_INFECTION,-2.130721507,0.073220178,agomelatine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.118010203,0.056069505,agomelatine
EUKARYOTIC_TRANSLATION_INITIATION,-2.081502999,0.064067655,agomelatine
CELLULAR_RESPONSES_TO_MECHANICAL_STIMULI,1.84929579,0.067548977,agomelatine
NONSENSE_MEDIATED_DECAY_NMD,-2.065071071,0.061544528,agomelatine
SELENOAMINO_ACID_METABOLISM,-2.061685261,0.053760761,agomelatine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,4.119988598,0,azelastine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,4.087830239,0,azelastine
INFLUENZA_INFECTION,4.048718379,0,azelastine
CELLULAR_RESPONSE_TO_STARVATION,3.985519614,0,azelastine
EUKARYOTIC_TRANSLATION_ELONGATION,3.951098032,0,azelastine
SELENOAMINO_ACID_METABOLISM,3.814391475,0,azelastine
NONSENSE_MEDIATED_DECAY_NMD,3.688945716,0,azelastine
EUKARYOTIC_TRANSLATION_INITIATION,3.424067463,0,azelastine
TRANSLATION,3.384135335,0,azelastine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.322995492,0,azelastine
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.463308106,0.000990241,zaleplon
ESTROGEN_DEPENDENT_GENE_EXPRESSION,1.715812746,0.400121926,zaleplon
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.776961539,1,zaleplon
TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,1.263362593,1,zaleplon
RSV_HOST_INTERACTIONS,1.26030085,1,zaleplon
GOLGI_TO_ER_RETROGRADE_TRANSPORT,1.203455067,1,zaleplon
DEATH_RECEPTOR_SIGNALING,-1.687448546,1,zaleplon
MRNA_SPLICING,1.18428721,1,zaleplon
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.17142399,0.95429452,zaleplon
GPCR_LIGAND_BINDING,-1.649292766,1,zaleplon
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.324064994,0.005021142,diminazene-aceturate
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.243741033,0.007531712,diminazene-aceturate
SARS_COV_1_HOST_INTERACTIONS,-2.203396988,0.008368569,diminazene-aceturate
EUKARYOTIC_TRANSLATION_ELONGATION,-2.163093165,0.01205074,diminazene-aceturate
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.131412683,0.012854123,diminazene-aceturate
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.114645235,0.012385483,diminazene-aceturate
NONSENSE_MEDIATED_DECAY_NMD,-2.102799546,0.012194201,diminazene-aceturate
SELENOAMINO_ACID_METABOLISM,-2.080342159,0.014435782,diminazene-aceturate
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.035315658,0.018299272,diminazene-aceturate
SARS_COV_2_HOST_INTERACTIONS,-2.013379182,0.020486258,diminazene-aceturate
GPCR_LIGAND_BINDING,2.521101157,0.000959645,alpelisib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.374311726,0.001439468,alpelisib
SIGNALING_BY_GPCR,2.35025474,0.001279527,alpelisib
RESPIRATORY_ELECTRON_TRANSPORT,-2.293562862,0.033220097,alpelisib
METABOLISM_OF_RNA,-2.10793128,0.048169141,alpelisib
G_ALPHA_I_SIGNALLING_EVENTS,2.065123193,0.028549453,alpelisib
ECM_PROTEOGLYCANS,2.05956812,0.02552657,alpelisib
G_ALPHA_Q_SIGNALLING_EVENTS,2.04128268,0.024311019,alpelisib
INTEGRIN_CELL_SURFACE_INTERACTIONS,2.033887038,0.022757307,alpelisib
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-1.903889748,0.132880389,alpelisib
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.432673718,0.002846637,zosuquidar
EUKARYOTIC_TRANSLATION_ELONGATION,-2.207153013,0.033211278,zosuquidar
COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC,2.081993618,0.026568616,zosuquidar
INFLUENZA_INFECTION,-2.077723584,0.098124229,zosuquidar
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.077309529,0.06575162,zosuquidar
NONSENSE_MEDIATED_DECAY_NMD,-2.069978128,0.053339325,zosuquidar
SELENOAMINO_ACID_METABOLISM,-2.032312855,0.063000787,zosuquidar
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.009015165,0.064577484,zosuquidar
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-1.985963483,0.065128609,zosuquidar
INTEGRIN_CELL_SURFACE_INTERACTIONS,-1.969470038,0.067806359,zosuquidar
EUKARYOTIC_TRANSLATION_ELONGATION,-2.363321147,0.003018947,miconazole
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.363861218,0.014394703,miconazole
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.264755199,0.00704421,miconazole
SELENOAMINO_ACID_METABOLISM,-2.26192228,0.005031579,miconazole
NONSENSE_MEDIATED_DECAY_NMD,-2.218893394,0.006541052,miconazole
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.181323134,0.010063158,miconazole
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.172663955,0.009224561,miconazole
INFLUENZA_INFECTION,-2.171163163,0.008050526,miconazole
EUKARYOTIC_TRANSLATION_INITIATION,-2.147723837,0.009685789,miconazole
TRANSLATION,-2.139043865,0.01017497,miconazole
RESPIRATORY_ELECTRON_TRANSPORT,2.609934321,0,lurasidone
GPCR_LIGAND_BINDING,-2.667422866,0.000804452,lurasidone
NEURONAL_SYSTEM,-2.596702914,0.000804452,lurasidone
SIGNALING_BY_GPCR,-2.551068125,0.000804452,lurasidone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.461355809,0.000804452,lurasidone
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,-2.371539689,0.000965342,lurasidone
G_ALPHA_Q_SIGNALLING_EVENTS,-2.330937813,0.001340753,lurasidone
METABOLISM_OF_RNA,2.159527743,0.047578847,lurasidone
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.114785792,0.045510201,lurasidone
HOMOLOGY_DIRECTED_REPAIR,2.082484914,0.044475879,lurasidone
MHC_CLASS_II_ANTIGEN_PRESENTATION,3.057080029,0,valrubicin
GPCR_LIGAND_BINDING,-2.3911704,0,valrubicin
G_ALPHA_Q_SIGNALLING_EVENTS,-2.377662885,0,valrubicin
SIGNALING_BY_GPCR,-2.265020771,0.000227253,valrubicin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.257314004,0.00017044,valrubicin
REGULATION_OF_BETA_CELL_DEVELOPMENT,-2.153784928,0.000954463,valrubicin
DNA_REPAIR,2.400367437,0.01562214,valrubicin
SENSORY_PERCEPTION,-2.138176181,0.001363518,valrubicin
AUTOPHAGY,2.226371587,0.024735054,valrubicin
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.074267249,0.003311401,valrubicin
GPCR_LIGAND_BINDING,-2.39227698,0.010212309,etoricoxib
SIGNALING_BY_GPCR,-2.241076723,0.029105079,etoricoxib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.169209608,0.039487593,etoricoxib
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.094017411,0.051572158,etoricoxib
ECM_PROTEOGLYCANS,-2.072371844,0.047589358,etoricoxib
RESPIRATORY_ELECTRON_TRANSPORT,2.018225357,0.227242882,etoricoxib
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,-2.043257046,0.049699901,etoricoxib
NEURONAL_SYSTEM,-2.02025036,0.050186202,etoricoxib
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-1.989456202,0.055018812,etoricoxib
BIOLOGICAL_OXIDATIONS,1.933078562,0.214671999,etoricoxib
EUKARYOTIC_TRANSLATION_INITIATION,-2.50521951,0,decitabine
RRNA_PROCESSING,-2.484415777,0,decitabine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.430431829,0.000393583,decitabine
METABOLISM_OF_RNA,-2.344354286,0.001475938,decitabine
NONSENSE_MEDIATED_DECAY_NMD,-2.317423208,0.0018892,decitabine
TRANSLATION,-2.314389624,0.001771125,decitabine
PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,2.354092357,0.003858735,decitabine
SIGNALING_BY_ROBO_RECEPTORS,-2.263479372,0.002530179,decitabine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.263352654,0.002213907,decitabine
INFLUENZA_INFECTION,-2.255487624,0.002230306,decitabine
METABOLISM_OF_RNA,-4.15617706,0,erlotinib
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-3.478131288,0,erlotinib
MRNA_SPLICING,-3.19625683,0,erlotinib
COLLAGEN_FORMATION,2.433569614,0,erlotinib
CELL_CYCLE,-2.793935895,0.00069728,erlotinib
CELL_CYCLE_CHECKPOINTS,-2.750574641,0.000557824,erlotinib
RESPIRATORY_ELECTRON_TRANSPORT,-2.646256025,0.000464853,erlotinib
DEVELOPMENTAL_CELL_LINEAGES,2.335096691,0.000312835,erlotinib
GPCR_LIGAND_BINDING,2.308774944,0.000417113,erlotinib
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,2.300038891,0.000312835,erlotinib
MITOCHONDRIAL_PROTEIN_DEGRADATION,2.284628628,0.006867233,mepivacaine
NEDDYLATION,1.758171114,0.13734467,mepivacaine
SENSORY_PERCEPTION,-1.910098836,0.369370621,mepivacaine
RAC3_GTPASE_CYCLE,-1.883078142,0.242701639,mepivacaine
CHROMATIN_ORGANIZATION,-1.881068858,0.164379596,mepivacaine
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,1.474022215,0.40058862,mepivacaine
INTEGRIN_CELL_SURFACE_INTERACTIONS,-1.75059669,0.361393376,mepivacaine
TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION,1.272046365,0.769816874,mepivacaine
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1.269378348,0.623270111,mepivacaine
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,-1.654598698,0.620001158,mepivacaine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.698407285,0,allopurinol
NONSENSE_MEDIATED_DECAY_NMD,-2.519955507,0,allopurinol
SELENOAMINO_ACID_METABOLISM,-2.467163001,0,allopurinol
EXTRACELLULAR_MATRIX_ORGANIZATION,2.72138978,0.000926498,allopurinol
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.461369428,0.000252191,allopurinol
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.458247678,0.000201752,allopurinol
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.429417964,0.000168127,allopurinol
EUKARYOTIC_TRANSLATION_INITIATION,-2.401211708,0.000144109,allopurinol
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.364038152,0.000630476,allopurinol
SIGNALING_BY_ROBO_RECEPTORS,-2.357355891,0.000672508,allopurinol
DNA_REPLICATION,2.764584342,0,camptothecin
SYNTHESIS_OF_DNA,2.700924503,0,camptothecin
RRNA_PROCESSING,2.69223302,0,camptothecin
METABOLISM_OF_RNA,2.59348445,0,camptothecin
RESPIRATORY_ELECTRON_TRANSPORT,2.589858127,0,camptothecin
CELLULAR_RESPONSE_TO_STARVATION,2.534852306,0.000261288,camptothecin
GPCR_LIGAND_BINDING,-2.374066491,0.007521717,camptothecin
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.373814929,0.004031306,camptothecin
NUCLEOTIDE_EXCISION_REPAIR,2.347192365,0.003919325,camptothecin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.29660665,0.007897803,camptothecin
METABOLISM_OF_RNA,2.785452502,0,fomepizole
GPCR_LIGAND_BINDING,-2.535003615,0,fomepizole
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.476529898,0.006018369,fomepizole
SIGNALING_BY_GPCR,-2.30004127,0.002248571,fomepizole
SENSORY_PERCEPTION,-2.278613713,0.001927347,fomepizole
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,2.396724555,0.006419593,fomepizole
CELLULAR_RESPONSE_TO_STARVATION,2.389921779,0.004814695,fomepizole
RRNA_PROCESSING,2.346720715,0.004814695,fomepizole
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-2.165367331,0.00433653,fomepizole
G2_M_CHECKPOINTS,2.239342575,0.009228165,fomepizole
CELLULAR_RESPONSE_TO_STARVATION,4.210725861,0,oxiconazole
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,2.681570649,0,oxiconazole
VIRAL_INFECTION_PATHWAYS,2.722563462,0,oxiconazole
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.748252099,0,oxiconazole
SIGNALING_BY_GPCR,-2.902723979,0,oxiconazole
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,2.925956716,0,oxiconazole
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.363591405,0,oxiconazole
METABOLISM_OF_RNA,3.583207062,0,oxiconazole
INFLUENZA_INFECTION,3.628052429,0,oxiconazole
SIGNALING_BY_ROBO_RECEPTORS,3.792270137,0,oxiconazole
EUKARYOTIC_TRANSLATION_ELONGATION,-2.792701862,0,dipraglurant
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.723851704,0,dipraglurant
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.708578494,0,dipraglurant
SELENOAMINO_ACID_METABOLISM,-2.689260757,0,dipraglurant
NONSENSE_MEDIATED_DECAY_NMD,-2.659372509,0,dipraglurant
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.659068872,0,dipraglurant
EUKARYOTIC_TRANSLATION_INITIATION,-2.607410757,0,dipraglurant
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.541364053,0.000120808,dipraglurant
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.467718855,0.000193293,dipraglurant
SARS_COV_1_HOST_INTERACTIONS,-2.47717881,0.000214771,dipraglurant
CELLULAR_RESPONSE_TO_STARVATION,3.316902439,0,bicalutamide
SIGNALING_BY_ROBO_RECEPTORS,2.736852255,0,bicalutamide
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.874917883,0,bicalutamide
METABOLISM_OF_RNA,2.942212132,0,bicalutamide
NONSENSE_MEDIATED_DECAY_NMD,3.034688577,0,bicalutamide
RRNA_PROCESSING,3.101213218,0,bicalutamide
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.029915665,0,bicalutamide
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.13140598,0,bicalutamide
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.135497578,0,bicalutamide
TRANSLATION,3.212869523,0,bicalutamide
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.915322307,0.067826387,droperidol
ECM_PROTEOGLYCANS,-2.740660331,0.675271527,droperidol
COLLAGEN_FORMATION,1.402945588,1,droperidol
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.481509532,1,droperidol
DISEASES_OF_GLYCOSYLATION,1.368600307,0.940241511,droperidol
EUKARYOTIC_TRANSLATION_INITIATION,-1.833205333,1,droperidol
MITOCHONDRIAL_PROTEIN_DEGRADATION,-1.76713584,1,droperidol
EUKARYOTIC_TRANSLATION_ELONGATION,-1.751446397,0.956551543,droperidol
TP53_REGULATES_METABOLIC_GENES,-1.749149057,0.823748618,droperidol
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,-1.731173064,0.754817915,droperidol
EUKARYOTIC_TRANSLATION_ELONGATION,-2.43532924,0.001004216,amrinone
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.34943768,0.002008431,amrinone
SIGNALING_BY_ROBO_RECEPTORS,-2.276825042,0.008703201,amrinone
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.259616127,0.006527401,amrinone
NONSENSE_MEDIATED_DECAY_NMD,-2.233286219,0.006828666,amrinone
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.231879476,0.006025293,amrinone
EUKARYOTIC_TRANSLATION_INITIATION,-2.220033583,0.005881834,amrinone
SELENOAMINO_ACID_METABOLISM,-2.181992975,0.007029509,amrinone
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.160812989,0.008145304,amrinone
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.124161324,0.011548479,amrinone
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.750905367,0.002770723,sobetirome
EUKARYOTIC_TRANSLATION_ELONGATION,-2.286861662,0.010455439,sobetirome
NONSENSE_MEDIATED_DECAY_NMD,-2.085063138,0.084689055,sobetirome
INFLUENZA_INFECTION,-2.06577045,0.069354411,sobetirome
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.05325841,0.058550458,sobetirome
SELENOAMINO_ACID_METABOLISM,-2.052464966,0.047049475,sobetirome
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-1.995800349,0.0726653,sobetirome
NEURONAL_SYSTEM,1.786637825,0.165550681,sobetirome
EUKARYOTIC_TRANSLATION_INITIATION,-1.96283925,0.082000514,sobetirome
RRNA_PROCESSING,-1.957062028,0.075801932,sobetirome
GPCR_LIGAND_BINDING,-2.322859726,0.020554847,ivacaftor
NEURONAL_SYSTEM,-2.216807696,0.018499362,ivacaftor
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,-2.172814606,0.019869685,ivacaftor
RESPIRATORY_ELECTRON_TRANSPORT,2.147253699,0.066392113,ivacaftor
SIGNALING_BY_GPCR,-2.145995013,0.019527104,ivacaftor
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.006541275,0.061458991,ivacaftor
SIGNALING_BY_INTERLEUKINS,-1.943335201,0.091469067,ivacaftor
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.909058328,0.102921053,ivacaftor
COLLAGEN_FORMATION,-1.871914168,0.120888191,ivacaftor
MRNA_SPLICING,1.804139915,0.412579558,ivacaftor
EUKARYOTIC_TRANSLATION_ELONGATION,-2.558784507,0,tetracaine
EUKARYOTIC_TRANSLATION_INITIATION,-2.413449397,0,tetracaine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.381433651,0.000344748,tetracaine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.35494601,0.000775683,tetracaine
TRANSLATION,-2.353458833,0.000620546,tetracaine
NONSENSE_MEDIATED_DECAY_NMD,-2.348898126,0.000517122,tetracaine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.345979031,0.000590997,tetracaine
SELENOAMINO_ACID_METABOLISM,-2.331219294,0.000646403,tetracaine
INFLUENZA_INFECTION,-2.285173554,0.001493908,tetracaine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.275848241,0.001551366,tetracaine
EXTRACELLULAR_MATRIX_ORGANIZATION,2.019106242,0.067883174,lomitapide
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,1.813830803,0.114220819,lomitapide
MUSCLE_CONTRACTION,1.797872592,0.083820963,lomitapide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.548609989,0.247183297,lomitapide
DISEASES_OF_GLYCOSYLATION,-2.722618661,1,lomitapide
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1.497390091,0.252997639,lomitapide
SIGNALING_BY_RECEPTOR_TYROSINE_KINASES,1.480618724,0.229523834,lomitapide
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION_BY_MLL3_AND_MLL4_COMPLEXES,1.436039225,0.245560004,lomitapide
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.661649047,1,lomitapide
SELENOAMINO_ACID_METABOLISM,-2.65347137,1,lomitapide
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-3.039613067,0.150538353,suvorexant
METABOLISM_OF_STEROIDS,1.315446412,1,suvorexant
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.866953903,1,suvorexant
ION_CHANNEL_TRANSPORT,-2.837052357,1,suvorexant
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.829301765,0.976226062,suvorexant
G_ALPHA_I_SIGNALLING_EVENTS,-2.807990052,0.858775837,suvorexant
NEUTROPHIL_DEGRANULATION,-2.713024757,0.888917185,suvorexant
MRNA_SPLICING_MINOR_PATHWAY,1.188247161,1,suvorexant
SARS_COV_2_INFECTION,-2.643091711,0.820094842,suvorexant
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.570574167,0.753070635,suvorexant
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.415272528,0.048224384,idelalisib
ION_CHANNEL_TRANSPORT,-2.283388949,0.07351278,idelalisib
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.871784287,0.896267813,idelalisib
RNA_POLYMERASE_II_TRANSCRIPTION,1.677684959,1,idelalisib
TRANSPORT_OF_SMALL_MOLECULES,-1.824893921,0.859511423,idelalisib
APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1,-1.795634109,0.794173264,idelalisib
TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM,1.612197182,1,idelalisib
TNFR2_NON_CANONICAL_NF_KB_PATHWAY,-1.738326157,0.866470633,idelalisib
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1.529433312,1,idelalisib
CELL_CELL_COMMUNICATION,1.523445944,0.807784995,idelalisib
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.806049741,0,repaglinide
GPCR_LIGAND_BINDING,2.780869808,0,repaglinide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.515633537,0.000687683,repaglinide
EUKARYOTIC_TRANSLATION_ELONGATION,-2.356469626,0.002984979,repaglinide
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.353256981,0.00149249,repaglinide
SIGNALING_BY_GPCR,2.341795473,0.002836692,repaglinide
EUKARYOTIC_TRANSLATION_INITIATION,-2.259213216,0.004974965,repaglinide
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.234526053,0.004477469,repaglinide
NERVOUS_SYSTEM_DEVELOPMENT,-2.210578405,0.004145804,repaglinide
SIGNALING_BY_ROBO_RECEPTORS,-2.219937956,0.004775967,repaglinide
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.525173922,0,TTNPB
GPCR_LIGAND_BINDING,-2.311101656,0,TTNPB
MITOTIC_PROMETAPHASE,2.12854031,0.02906297,TTNPB
HIV_LIFE_CYCLE,2.062599485,0.036328712,TTNPB
SUMOYLATION,2.056972378,0.02906297,TTNPB
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.025871095,0.034632929,TTNPB
NEURONAL_SYSTEM,-2.025421388,0.023354006,TTNPB
MITOTIC_PROPHASE,1.896242024,0.069751127,TTNPB
G_ALPHA_Q_SIGNALLING_EVENTS,-1.924138291,0.054337871,TTNPB
MRNA_SPLICING,1.728695739,0.150158677,TTNPB
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.909489228,0,troglitazone
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.797897819,0,troglitazone
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.756967919,0,troglitazone
ECM_PROTEOGLYCANS,-2.749263106,0.00017316,troglitazone
COLLAGEN_FORMATION,-2.555693616,0.001939387,troglitazone
TRANSLATION,2.429831173,0.02266018,troglitazone
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,-2.547474384,0.002077915,troglitazone
NEURONAL_SYSTEM,-2.522494949,0.002275812,troglitazone
RESPIRATORY_ELECTRON_TRANSPORT,2.344214441,0.021952049,troglitazone
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.341785335,0.015578874,troglitazone
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,3.859474703,0,paroxetine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.74277851,0,paroxetine
MITOCHONDRIAL_PROTEIN_DEGRADATION,2.752831714,0,paroxetine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.805780922,0,paroxetine
INFLUENZA_INFECTION,2.811122279,0,paroxetine
SELENOAMINO_ACID_METABOLISM,2.928296587,0,paroxetine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.047198884,0,paroxetine
EUKARYOTIC_TRANSLATION_ELONGATION,2.995439115,0,paroxetine
METABOLISM_OF_RNA,3.157313783,0,paroxetine
RRNA_PROCESSING,3.17146187,0,paroxetine
CARDIAC_CONDUCTION,1.901414611,0.201421801,PX-12
PI3K_AKT_SIGNALING_IN_CANCER,1.612251573,0.4781652,PX-12
EUKARYOTIC_TRANSLATION_INITIATION,-2.851931582,1,PX-12
EUKARYOTIC_TRANSLATION_ELONGATION,-2.804294321,1,PX-12
NONSENSE_MEDIATED_DECAY_NMD,-2.777031285,0.933434373,PX-12
SELENOAMINO_ACID_METABOLISM,-2.776074775,0.700843126,PX-12
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.752325431,0.579909319,PX-12
MUSCLE_CONTRACTION,1.522028534,0.504400812,PX-12
INFLUENZA_INFECTION,-2.747246287,0.485304023,PX-12
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.702970668,0.436875934,PX-12
SIGNALING_BY_MET,1.589158305,0.58040928,VX-661
NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,1.510997827,0.435083382,VX-661
PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES,1.377048147,0.531222053,VX-661
DEVELOPMENTAL_CELL_LINEAGES,1.359247871,0.429046767,VX-661
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.138937196,1,VX-661
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,1.283589411,0.487400705,VX-661
TP53_REGULATES_METABOLIC_GENES,-1.868843393,1,VX-661
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-1.835197741,1,VX-661
MITOTIC_PROMETAPHASE,1.186451625,0.525600655,VX-661
MITOTIC_PROPHASE,1.186627524,0.612604556,VX-661
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,2.324703548,0.019697965,duloxetine
MITOCHONDRIAL_PROTEIN_DEGRADATION,2.283189762,0.013131976,duloxetine
GOLGI_TO_ER_RETROGRADE_TRANSPORT,2.279390261,0.008754651,duloxetine
MHC_CLASS_II_ANTIGEN_PRESENTATION,2.129218154,0.013131976,duloxetine
RAB_REGULATION_OF_TRAFFICKING,2.1035142,0.013131976,duloxetine
NEUTROPHIL_DEGRANULATION,2.097291802,0.010943314,duloxetine
CELLULAR_RESPONSES_TO_STIMULI,1.853640157,0.062845887,duloxetine
MEMBRANE_TRAFFICKING,1.829726622,0.061145765,duloxetine
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,1.790394136,0.066754213,duloxetine
RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS,1.764438373,0.069271175,duloxetine
TRANSLATION,3.030838507,0,rimonabant
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.991732227,0,rimonabant
EUKARYOTIC_TRANSLATION_INITIATION,2.880272794,0,rimonabant
METABOLISM_OF_RNA,2.873088466,0,rimonabant
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.796592281,0,rimonabant
NEURONAL_SYSTEM,-2.759332093,0,rimonabant
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.710243125,0,rimonabant
ECM_PROTEOGLYCANS,-2.693029844,0,rimonabant
SELENOAMINO_ACID_METABOLISM,2.692805012,0,rimonabant
CELLULAR_RESPONSE_TO_STARVATION,2.679336044,0,rimonabant
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.36053693,0.010037443,resveratrol
METABOLISM_OF_VITAMINS_AND_COFACTORS,-2.00428526,0.220823754,resveratrol
SIGNALING_BY_NOTCH,-1.849976207,0.485979548,resveratrol
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-1.836324017,0.395538002,resveratrol
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,-1.835441707,0.317434146,resveratrol
DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS,-1.804173782,0.321616414,resveratrol
TRANSCRIPTION_COUPLED_NUCLEOTIDE_EXCISION_REPAIR_TC_NER,-1.791987044,0.302557221,resveratrol
UNFOLDED_PROTEIN_RESPONSE_UPR,-1.77110856,0.305828352,resveratrol
NUCLEOTIDE_EXCISION_REPAIR,-1.761722047,0.29066763,resveratrol
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1.639486777,1,resveratrol
MITOTIC_SPINDLE_CHECKPOINT,-2.791929485,0,SB-939
CELL_CYCLE_CHECKPOINTS,-2.762371736,0,SB-939
CELL_CYCLE_MITOTIC,-2.757084873,0,SB-939
CELL_CYCLE,-2.735786666,0,SB-939
M_PHASE,-2.551422801,0,SB-939
MITOTIC_METAPHASE_AND_ANAPHASE,-2.523771982,0,SB-939
MITOTIC_PROMETAPHASE,-2.496254988,0,SB-939
RESOLUTION_OF_SISTER_CHROMATID_COHESION,-2.479893524,0,SB-939
RHO_GTPASES_ACTIVATE_FORMINS,-2.461643672,0,SB-939
G2_M_CHECKPOINTS,-2.422747129,0.000200111,SB-939
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.887960509,0.15670685,tanaproget
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.741452845,0.327795025,tanaproget
SIGNALING_BY_ALK_IN_CANCER,1.596396366,0.521853475,tanaproget
GLUCOSE_METABOLISM,1.561283883,0.320100188,tanaproget
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,1.52363609,0.259236068,tanaproget
RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_PATHWAY,1.476018942,0.248246713,tanaproget
MUSCLE_CONTRACTION,1.44071214,0.238497182,tanaproget
CARDIAC_CONDUCTION,1.359125372,0.29661866,tanaproget
EPIGENETIC_REGULATION_BY_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES,1.301127723,0.334591645,tanaproget
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,1.197482759,0.467188478,tanaproget
METABOLISM_OF_VITAMINS_AND_COFACTORS,-3.219857132,0.036654667,pranlukast
MHC_CLASS_II_ANTIGEN_PRESENTATION,1.607508798,0.424925904,pranlukast
METABOLISM_OF_NUCLEOTIDES,1.608973351,0.843449911,pranlukast
ESTROGEN_DEPENDENT_GENE_EXPRESSION,1.501735539,0.486544161,pranlukast
VISUAL_PHOTOTRANSDUCTION,-3.050412447,0.91540209,pranlukast
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,1.441970014,0.476541197,pranlukast
SENSORY_PERCEPTION,-2.981902429,0.958808933,pranlukast
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.597561307,1,pranlukast
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.45771892,0.954757628,pranlukast
SARS_COV_1_HOST_INTERACTIONS,-2.404228837,0.817817076,pranlukast
METABOLISM_OF_RNA,2.996315384,0,levamisole
MHC_CLASS_II_ANTIGEN_PRESENTATION,2.48626935,0.002016614,levamisole
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.475276118,0.00134441,levamisole
RESPIRATORY_ELECTRON_TRANSPORT,2.300494726,0.004033229,levamisole
DNA_REPAIR,2.054497197,0.025812666,levamisole
TRANSLATION,1.961119544,0.0416767,levamisole
NEUTROPHIL_DEGRANULATION,1.952190741,0.038027588,levamisole
RRNA_PROCESSING,1.882395072,0.044365519,levamisole
MITOTIC_SPINDLE_CHECKPOINT,1.863344494,0.043917382,levamisole
METABOLISM_OF_STEROIDS,1.850129448,0.042348904,levamisole
TRANSLATION,3.363325842,0,nicotinamide
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.68789135,0,nicotinamide
SELENOAMINO_ACID_METABOLISM,2.696515998,0,nicotinamide
RRNA_PROCESSING,2.701707265,0,nicotinamide
GPCR_LIGAND_BINDING,-2.804449857,0,nicotinamide
ECM_PROTEOGLYCANS,-2.829588418,0,nicotinamide
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.785225877,0,nicotinamide
METABOLISM_OF_RNA,2.918817605,0,nicotinamide
CELLULAR_RESPONSE_TO_STARVATION,2.94910814,0,nicotinamide
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.021802604,0,nicotinamide
EUKARYOTIC_TRANSLATION_ELONGATION,-2.338853986,0.455828542,dazoxiben
DISEASES_OF_METABOLISM,1.694825961,0.393190825,dazoxiben
NONSENSE_MEDIATED_DECAY_NMD,-2.251446464,0.482488238,dazoxiben
SELENOAMINO_ACID_METABOLISM,-2.223852708,0.390311901,dazoxiben
EUKARYOTIC_TRANSLATION_INITIATION,-2.217016433,0.305018296,dazoxiben
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.208003572,0.256769472,dazoxiben
NEURONAL_SYSTEM,1.605978481,0.337638483,dazoxiben
INFLUENZA_INFECTION,-2.154037913,0.302143231,dazoxiben
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.147867654,0.267642446,dazoxiben
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.578279908,0.262348982,dazoxiben
CELLULAR_RESPONSE_TO_STARVATION,2.967984758,0,lacosamide
NEUTROPHIL_DEGRANULATION,2.181885762,0.027255774,lacosamide
METABOLISM_OF_STEROIDS,2.150536072,0.021039545,lacosamide
VESICLE_MEDIATED_TRANSPORT,2.078763832,0.032276574,lacosamide
MEMBRANE_TRAFFICKING,2.01524897,0.034428346,lacosamide
FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS,1.930973926,0.048295319,lacosamide
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,1.906127705,0.047543906,lacosamide
AUTOPHAGY,1.900462761,0.043035433,lacosamide
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,1.808899991,0.059612044,lacosamide
MHC_CLASS_II_ANTIGEN_PRESENTATION,1.73834025,0.087505379,lacosamide
EUKARYOTIC_TRANSLATION_INITIATION,-2.359215305,0.088332251,amantadine
TRANSLATION,-2.267558358,0.105235336,amantadine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.262914541,0.071974427,amantadine
SELENOAMINO_ACID_METABOLISM,-2.200387669,0.091331186,amantadine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.193846681,0.077208931,amantadine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.190820579,0.065794804,amantadine
RRNA_PROCESSING,-2.185068742,0.058732379,amantadine
INFLUENZA_INFECTION,-2.182730749,0.052617668,amantadine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.170740974,0.051981531,amantadine
CELLULAR_RESPONSE_TO_STARVATION,-2.165709891,0.04841916,amantadine
CELLULAR_RESPONSE_TO_STARVATION,3.320675041,0,ibrutinib
RESPIRATORY_ELECTRON_TRANSPORT,3.17771843,0,ibrutinib
INFLUENZA_INFECTION,2.854013408,0,ibrutinib
TRANSLATION,2.814586242,0,ibrutinib
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.333130501,0.004991229,ibrutinib
RAB_REGULATION_OF_TRAFFICKING,2.0902021,0.023173561,ibrutinib
METABOLISM_OF_STEROIDS,2.069473088,0.021900289,ibrutinib
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.059535888,0.021836625,ibrutinib
DNA_REPAIR,2.038126146,0.024560014,ibrutinib
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.983129273,0.032442986,ibrutinib
TRANSLATION,3.427599355,0,levothyroxine
METABOLISM_OF_RNA,2.674058984,0,levothyroxine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.741380385,0,levothyroxine
CELLULAR_RESPONSE_TO_STARVATION,2.775256145,0,levothyroxine
ECM_PROTEOGLYCANS,-2.781015827,0,levothyroxine
SELENOAMINO_ACID_METABOLISM,2.736479268,0,levothyroxine
COLLAGEN_FORMATION,-2.835981064,0,levothyroxine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.906026534,0,levothyroxine
RRNA_PROCESSING,3.044399169,0,levothyroxine
EUKARYOTIC_TRANSLATION_INITIATION,3.052933637,0,levothyroxine
METABOLISM_OF_RNA,-3.440347827,0,nintedanib
INFLUENZA_INFECTION,-2.691140203,0.002274318,nintedanib
DNA_REPAIR,-2.353980618,0.018194542,nintedanib
CELL_CYCLE_CHECKPOINTS,-2.350395534,0.013645906,nintedanib
GPCR_LIGAND_BINDING,2.154014402,0.011854274,nintedanib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.12041846,0.009261152,nintedanib
RRNA_PROCESSING,-2.076649242,0.030930721,nintedanib
MRNA_SPLICING,-2.067529724,0.025775601,nintedanib
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.063807707,0.022093372,nintedanib
G2_M_CHECKPOINTS,-2.054338946,0.0193317,nintedanib
METABOLISM_OF_RNA,-2.770797514,0.002178977,TG-101348
KEAP1_NFE2L2_PATHWAY,-2.660268219,0.001089488,TG-101348
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,-2.255707101,0.010168558,TG-101348
GPCR_LIGAND_BINDING,2.207690839,0.013566565,TG-101348
INFLUENZA_INFECTION,-1.986503974,0.046847998,TG-101348
G_ALPHA_Q_SIGNALLING_EVENTS,2.051693416,0.050276094,TG-101348
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.988926374,0.063842659,TG-101348
HIV_INFECTION,-1.826864423,0.09979713,TG-101348
TCR_SIGNALING,-1.826731459,0.083164275,TG-101348
TRANSLATION,-1.822410797,0.071906229,TG-101348
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.69352791,0.00106985,moxisylyte
EUKARYOTIC_TRANSLATION_ELONGATION,-2.41015274,0.020800747,moxisylyte
PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,2.24717822,0.0085588,moxisylyte
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.332446873,0.030210608,moxisylyte
NONSENSE_MEDIATED_DECAY_NMD,-2.274827199,0.037309275,moxisylyte
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.265034442,0.034420283,moxisylyte
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.257922211,0.030309659,moxisylyte
SELENOAMINO_ACID_METABOLISM,-2.206598805,0.040776067,moxisylyte
EUKARYOTIC_TRANSLATION_INITIATION,-2.195067581,0.038346954,moxisylyte
REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF,1.896936987,0.06062483,moxisylyte
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,-2.916526724,0.259860296,chlorpropamide
CILIUM_ASSEMBLY,1.714869423,0.604994142,chlorpropamide
GPCR_LIGAND_BINDING,1.622827243,0.493625233,chlorpropamide
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1.430190256,0.884825373,chlorpropamide
NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,1.424510415,0.68126163,chlorpropamide
CELL_CELL_COMMUNICATION,1.417001011,0.563534033,chlorpropamide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.37757585,0.561500234,chlorpropamide
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.352384488,0.538834394,chlorpropamide
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.425989625,1,chlorpropamide
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.316838237,1,chlorpropamide
METABOLISM_OF_RNA,3.345297743,0,primaquine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.540895535,0,primaquine
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-2.567787319,0,primaquine
SIGNALING_BY_ROBO_RECEPTORS,2.655179501,0,primaquine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.658370533,0,primaquine
SENSORY_PERCEPTION,-2.806022842,0,primaquine
SIGNALING_BY_GPCR,-2.820945561,0,primaquine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.933627656,0,primaquine
TRANSLATION,2.946980418,0,primaquine
SELENOAMINO_ACID_METABOLISM,3.004052834,0,primaquine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.565494049,0.011299808,nelarabine
SELENOAMINO_ACID_METABOLISM,-2.440615983,0.014895202,nelarabine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.423680913,0.01095739,nelarabine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.41719421,0.008474856,nelarabine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.335280846,0.010478004,nelarabine
NONSENSE_MEDIATED_DECAY_NMD,-2.32041351,0.009074088,nelarabine
SIGNALING_BY_ROBO_RECEPTORS,-2.281353121,0.008805045,nelarabine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.277130535,0.007704415,nelarabine
RRNA_PROCESSING,-2.256977565,0.007989763,nelarabine
SARS_COV_1_HOST_INTERACTIONS,-2.256336397,0.007190787,nelarabine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.75997081,0,moxifloxacin
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.423827767,0,moxifloxacin
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.43602525,0,moxifloxacin
SARS_COV_1_HOST_INTERACTIONS,-2.532211958,0,moxifloxacin
INFLUENZA_INFECTION,-2.545320517,0,moxifloxacin
NONSENSE_MEDIATED_DECAY_NMD,-2.632127007,0,moxifloxacin
EUKARYOTIC_TRANSLATION_INITIATION,-2.537801613,0,moxifloxacin
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.706851239,0,moxifloxacin
EUKARYOTIC_TRANSLATION_ELONGATION,-2.713837227,0,moxifloxacin
SELENOAMINO_ACID_METABOLISM,-2.727322646,0,moxifloxacin
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,3.325599384,0,butorphanol-(+)-tartrate
RESPIRATORY_ELECTRON_TRANSPORT,3.286615337,0,butorphanol-(+)-tartrate
METABOLISM_OF_RNA,3.114649347,0,butorphanol-(+)-tartrate
TCR_SIGNALING,2.88351928,0,butorphanol-(+)-tartrate
MRNA_SPLICING,2.808657879,0,butorphanol-(+)-tartrate
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.664967579,0,butorphanol-(+)-tartrate
MITOCHONDRIAL_PROTEIN_DEGRADATION,2.594874197,0,butorphanol-(+)-tartrate
GPCR_LIGAND_BINDING,-2.507373637,0,butorphanol-(+)-tartrate
HIV_INFECTION,2.469235181,0.000953375,butorphanol-(+)-tartrate
MITOCHONDRIAL_PROTEIN_IMPORT,2.460471769,0.000847444,butorphanol-(+)-tartrate
EUKARYOTIC_TRANSLATION_ELONGATION,-2.211552439,0.06638349,trazodone
INFLUENZA_INFECTION,-2.19636833,0.040735324,trazodone
COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC,1.971124775,0.110547397,trazodone
EUKARYOTIC_TRANSLATION_INITIATION,-2.094048645,0.08717024,trazodone
NONSENSE_MEDIATED_DECAY_NMD,-2.080038793,0.075184332,trazodone
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.048992523,0.079660188,trazodone
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.02262964,0.08717024,trazodone
TRANSLATION,-1.991263732,0.098282051,trazodone
SELENOAMINO_ACID_METABOLISM,-1.986010556,0.091277299,trazodone
EXTRACELLULAR_MATRIX_ORGANIZATION,1.705024598,0.325393858,trazodone
NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,1.899638685,0.183343975,BRD-A20239487
NEURONAL_SYSTEM,1.848650735,0.121089118,BRD-A20239487
PI3K_AKT_SIGNALING_IN_CANCER,1.67361807,0.1983946,BRD-A20239487
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.62606101,0.191895467,BRD-A20239487
INTEGRATION_OF_ENERGY_METABOLISM,1.597077123,0.177597373,BRD-A20239487
SIGNALING_BY_NTRKS,1.441930947,0.31720332,BRD-A20239487
METABOLISM_OF_NUCLEOTIDES,1.401834581,0.32994097,BRD-A20239487
EUKARYOTIC_TRANSLATION_ELONGATION,-2.391909283,1,BRD-A20239487
NONSENSE_MEDIATED_DECAY_NMD,-2.318377733,1,BRD-A20239487
SELENOAMINO_ACID_METABOLISM,-2.312552787,1,BRD-A20239487
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.570507841,0.002579412,flavoxate
MITOTIC_PROMETAPHASE,2.524654458,0.002579412,flavoxate
RESOLUTION_OF_SISTER_CHROMATID_COHESION,2.215765918,0.011177454,flavoxate
MRNA_SPLICING,2.195011955,0.008383091,flavoxate
NEUTROPHIL_DEGRANULATION,2.158774589,0.008770002,flavoxate
SIGNALING_BY_NTRKS,2.148925917,0.007738237,flavoxate
MITOTIC_SPINDLE_CHECKPOINT,2.083277049,0.012528575,flavoxate
FORMATION_OF_THE_CORNIFIED_ENVELOPE,2.006207792,0.01870074,flavoxate
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.960867763,0.024647719,flavoxate
KERATINIZATION,1.894114861,0.033532362,flavoxate
RESPIRATORY_ELECTRON_TRANSPORT,3.550012209,0,ambrisentan
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,3.089552707,0,ambrisentan
COMPLEX_I_BIOGENESIS,2.625765643,0,ambrisentan
SENSORY_PERCEPTION,-2.254331046,0.029549305,ambrisentan
BIOLOGICAL_OXIDATIONS,2.134931173,0.029314922,ambrisentan
MITOCHONDRIAL_PROTEIN_DEGRADATION,2.082891765,0.031691807,ambrisentan
TRANSLATION,2.018214114,0.038294267,ambrisentan
MITOCHONDRIAL_TRANSLATION,1.982595282,0.0423312,ambrisentan
NEURONAL_SYSTEM,-2.075366552,0.093291376,ambrisentan
ION_CHANNEL_TRANSPORT,-2.041077775,0.08808507,ambrisentan
METABOLISM_OF_RNA,3.170078171,0,berberine
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.96776339,0,berberine
TRANSLATION,2.881761615,0,berberine
RRNA_PROCESSING,2.820049816,0,berberine
SELENOAMINO_ACID_METABOLISM,2.815444106,0,berberine
EUKARYOTIC_TRANSLATION_ELONGATION,2.772832889,0,berberine
EUKARYOTIC_TRANSLATION_INITIATION,2.763064083,0,berberine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.751226422,0,berberine
GPCR_LIGAND_BINDING,-2.750036468,0.000278258,berberine
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,-2.72949124,0.000185505,berberine
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,2.946712325,0,levonorgestrel
MHC_CLASS_II_ANTIGEN_PRESENTATION,2.624636341,0,levonorgestrel
GOLGI_TO_ER_RETROGRADE_TRANSPORT,2.510341573,0,levonorgestrel
MEMBRANE_TRAFFICKING,2.444926936,0.001485697,levonorgestrel
MITOTIC_PROMETAPHASE,1.888107601,0.073096293,levonorgestrel
PROTEIN_LOCALIZATION,1.816493357,0.092113215,levonorgestrel
MITF_M_DEPENDENT_GENE_EXPRESSION,1.804579862,0.084472488,levonorgestrel
VESICLE_MEDIATED_TRANSPORT,1.789598321,0.082456185,levonorgestrel
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,1.691361532,0.121166846,levonorgestrel
GPCR_LIGAND_BINDING,-1.943460106,0.349871814,levonorgestrel
GPCR_LIGAND_BINDING,-2.909132916,0,vardenafil
NEURONAL_SYSTEM,-2.763685119,0,vardenafil
SIGNALING_BY_GPCR,-2.728897255,0,vardenafil
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.728384459,0,vardenafil
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,-2.548578115,0.000233978,vardenafil
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.539043646,0.000194982,vardenafil
METABOLISM_OF_RNA,2.600339275,0.006650929,vardenafil
ECM_PROTEOGLYCANS,-2.520120964,0.000334255,vardenafil
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,-2.48906952,0.000365591,vardenafil
RESPIRATORY_ELECTRON_TRANSPORT,2.532478012,0.006650929,vardenafil
EXTRACELLULAR_MATRIX_ORGANIZATION,-3.801398958,0.012086454,NVP-TAE226
RAB_REGULATION_OF_TRAFFICKING,2.004268441,0.162067553,NVP-TAE226
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,1.996609925,0.086992142,NVP-TAE226
SELENOAMINO_ACID_METABOLISM,1.861180349,0.157102248,NVP-TAE226
INTEGRIN_CELL_SURFACE_INTERACTIONS,-3.417164167,1,NVP-TAE226
EUKARYOTIC_TRANSLATION_ELONGATION,1.759137754,0.229546047,NVP-TAE226
CELL_CYCLE_MITOTIC,-2.30440828,1,NVP-TAE226
CELL_CYCLE,-2.301751537,1,NVP-TAE226
THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT,-2.291552205,0.979271337,NVP-TAE226
DNA_REPLICATION,-2.245360192,0.822997967,NVP-TAE226
INFLUENZA_INFECTION,-2.679036243,0,pazopanib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.628229317,0,pazopanib
GPCR_LIGAND_BINDING,2.617505992,0,pazopanib
REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE,-2.565813367,0,pazopanib
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.542764629,0,pazopanib
ISG15_ANTIVIRAL_MECHANISM,-2.422861902,0.001619863,pazopanib
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.390972298,0.002429794,pazopanib
CELLULAR_RESPONSE_TO_HEAT_STRESS,-2.388368519,0.001943835,pazopanib
TRANSLATION,-2.354077572,0.002429794,pazopanib
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.287778092,0.00425214,pazopanib
TRANSLATION,3.393033785,0,ketotifen
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.694187649,0,ketotifen
RRNA_PROCESSING,2.756541269,0,ketotifen
NONSENSE_MEDIATED_DECAY_NMD,2.769097592,0,ketotifen
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.796551697,0,ketotifen
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.860679798,0,ketotifen
METABOLISM_OF_RNA,2.716320804,0,ketotifen
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.959130167,0,ketotifen
EUKARYOTIC_TRANSLATION_ELONGATION,2.96938697,0,ketotifen
CELLULAR_RESPONSE_TO_STARVATION,2.982435925,0,ketotifen
GPCR_LIGAND_BINDING,-2.685927457,0,hydroxyurea
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.393034642,0.001861312,hydroxyurea
NEURONAL_SYSTEM,-2.391775586,0.001240875,hydroxyurea
SIGNALING_BY_GPCR,-2.334444508,0.002093976,hydroxyurea
RESPIRATORY_ELECTRON_TRANSPORT,2.425982815,0.012367742,hydroxyurea
ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES,-2.202860354,0.010981743,hydroxyurea
COLLAGEN_FORMATION,-2.118225685,0.021870421,hydroxyurea
SIGNALING_BY_TGFB_FAMILY_MEMBERS,-2.049767379,0.041214775,hydroxyurea
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,-2.010208153,0.049324779,hydroxyurea
INTEGRIN_CELL_SURFACE_INTERACTIONS,-1.982994824,0.053874654,hydroxyurea
TRANSLATION,3.513620077,0,amlexanox
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,2.647509805,0,amlexanox
SIGNALING_BY_ROBO_RECEPTORS,2.633818737,0,amlexanox
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.619530345,0,amlexanox
RRNA_PROCESSING,2.897111969,0,amlexanox
METABOLISM_OF_RNA,2.906048068,0,amlexanox
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,2.690400962,0,amlexanox
NONSENSE_MEDIATED_DECAY_NMD,3.017997164,0,amlexanox
ECM_PROTEOGLYCANS,-2.937253171,0,amlexanox
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.067910913,0,amlexanox
CELLULAR_RESPONSE_TO_STARVATION,3.146471164,0,tiagabine
RRNA_PROCESSING,2.678625729,0,tiagabine
SIGNALING_BY_GPCR,-2.743950814,0,tiagabine
NONSENSE_MEDIATED_DECAY_NMD,2.753066201,0,tiagabine
INFLUENZA_INFECTION,2.845285381,0,tiagabine
EUKARYOTIC_TRANSLATION_INITIATION,2.858772355,0,tiagabine
TRANSLATION,2.9025577,0,tiagabine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.603579794,0,tiagabine
EUKARYOTIC_TRANSLATION_ELONGATION,2.985255984,0,tiagabine
SELENOAMINO_ACID_METABOLISM,2.986493108,0,tiagabine
CELLULAR_RESPONSE_TO_STARVATION,3.62059797,0,niacin
G_ALPHA_S_SIGNALLING_EVENTS,-2.52425072,0,niacin
SENSORY_PERCEPTION,-2.566504874,0,niacin
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.657621844,0,niacin
RRNA_PROCESSING,2.87009331,0,niacin
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.91716271,0,niacin
INFLUENZA_INFECTION,2.978225139,0,niacin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.99648399,0,niacin
TRANSLATION,3.025101873,0,niacin
SIGNALING_BY_GPCR,-3.061976284,0,niacin
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.607644588,0.00075457,pilaralisib
GPCR_LIGAND_BINDING,2.233138869,0.007922985,pilaralisib
SIGNALING_BY_GPCR,2.097624856,0.01961882,pilaralisib
EUKARYOTIC_TRANSLATION_ELONGATION,-2.179669355,0.12864936,pilaralisib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.0454744,0.021505245,pilaralisib
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.088950974,0.13279934,pilaralisib
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-1.998941583,0.179832439,pilaralisib
NEURONAL_SYSTEM,1.7709625,0.07047684,pilaralisib
NONSENSE_MEDIATED_DECAY_NMD,-1.960235471,0.183636587,pilaralisib
SELENOAMINO_ACID_METABOLISM,-1.958113963,0.149191758,pilaralisib
GPCR_LIGAND_BINDING,-2.707300932,0,dofequidar
CELLULAR_RESPONSE_TO_STARVATION,2.574839464,0.001322281,dofequidar
ECM_PROTEOGLYCANS,-2.521123423,0.003155308,dofequidar
NEURONAL_SYSTEM,-2.48968477,0.002366481,dofequidar
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.485059941,0.001972068,dofequidar
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.472108207,0.001840597,dofequidar
METABOLISM_OF_RNA,2.364086513,0.009917111,dofequidar
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.472624817,0.002208716,dofequidar
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.441996022,0.002141102,dofequidar
MITOCHONDRIAL_TRANSLATION,2.337862772,0.00925597,dofequidar
RESPIRATORY_ELECTRON_TRANSPORT,3.600913587,0,loxoprofen
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,3.160547466,0,loxoprofen
METABOLISM_OF_RNA,3.016560028,0,loxoprofen
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.861515299,0,loxoprofen
MRNA_SPLICING,2.764955091,0,loxoprofen
TRANSLATION,2.693432647,0,loxoprofen
MITOCHONDRIAL_PROTEIN_DEGRADATION,2.66783445,0,loxoprofen
GPCR_LIGAND_BINDING,-2.300414721,0.004142851,loxoprofen
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.27662042,0.002367343,loxoprofen
INTERLEUKIN_1_SIGNALING,2.452131379,0.003107163,loxoprofen
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,-2.262933674,0.033484969,orphenadrine
GPCR_LIGAND_BINDING,-2.248260734,0.018712189,orphenadrine
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.215896315,0.015429349,orphenadrine
NEURONAL_SYSTEM,-2.196073875,0.015265207,orphenadrine
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,-2.181712987,0.013197017,orphenadrine
RESPIRATORY_ELECTRON_TRANSPORT,2.158311971,0.067662889,orphenadrine
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.164015531,0.012474792,orphenadrine
ECM_PROTEOGLYCANS,-2.146248678,0.012099611,orphenadrine
SENSORY_PERCEPTION,-2.048655986,0.029176242,orphenadrine
COLLAGEN_FORMATION,-1.996299694,0.039394082,orphenadrine
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.168811685,0.082876712,cinnarizine
TRNA_PROCESSING,2.150222794,0.045205479,cinnarizine
KEAP1_NFE2L2_PATHWAY,2.008604496,0.100456621,cinnarizine
SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS,1.944991933,0.113013699,cinnarizine
DNA_REPLICATION,1.89755961,0.105479452,cinnarizine
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,1.889099287,0.094178082,cinnarizine
S_PHASE,1.882355671,0.082876712,cinnarizine
GLUCOSE_METABOLISM,1.880280695,0.075342466,cinnarizine
ISG15_ANTIVIRAL_MECHANISM,1.83770857,0.081202435,cinnarizine
DNA_REPLICATION_PRE_INITIATION,1.82149343,0.078356164,cinnarizine
NEURONAL_SYSTEM,-2.622260423,0.000845349,methimazole
RESPIRATORY_ELECTRON_TRANSPORT,2.430752126,0.003856137,methimazole
GPCR_LIGAND_BINDING,-2.393361153,0.003804068,methimazole
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,-2.316939747,0.00591744,methimazole
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.2995308,0.005706103,methimazole
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,-2.213377235,0.008622555,methimazole
SIGNALING_BY_GPCR,-2.172412586,0.010003291,methimazole
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.103957953,0.062340888,methimazole
ECM_PROTEOGLYCANS,-2.113456575,0.016303151,methimazole
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,-2.058958185,0.023247085,methimazole
NEUTROPHIL_DEGRANULATION,-2.358629438,0.00689179,zonisamide
REGULATION_OF_TP53_ACTIVITY,2.149152662,0.059830262,zonisamide
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.108610197,0.037136025,zonisamide
MRNA_SPLICING,2.066691371,0.029571279,zonisamide
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.988514999,0.044356918,zonisamide
TCR_SIGNALING,1.898618043,0.056529282,zonisamide
MITOTIC_PROMETAPHASE,1.783336998,0.088026133,zonisamide
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1.782294614,0.076040432,zonisamide
AUTOPHAGY,-2.041204619,0.163249284,zonisamide
METABOLISM_OF_RNA,1.707231247,0.096450509,zonisamide
EUKARYOTIC_TRANSLATION_ELONGATION,-3.095957005,0,raloxifene
SARS_COV_1_INFECTION,-2.400332182,0,raloxifene
TRANSLATION,-2.466393678,0,raloxifene
SARS_COV_1_HOST_INTERACTIONS,-2.586186118,0,raloxifene
RRNA_PROCESSING,-2.599931864,0,raloxifene
SIGNALING_BY_ROBO_RECEPTORS,-2.694514798,0,raloxifene
CELLULAR_RESPONSE_TO_STARVATION,-2.715875731,0,raloxifene
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.834514464,0,raloxifene
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.816753129,0,raloxifene
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.855863727,0,raloxifene
TRANSLATION,3.460555505,0,flutamide
SIGNALING_BY_ROBO_RECEPTORS,2.773983282,0,flutamide
INFLUENZA_INFECTION,2.89399858,0,flutamide
GPCR_LIGAND_BINDING,-2.99621721,0,flutamide
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.075809828,0,flutamide
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.148517502,0,flutamide
CELLULAR_RESPONSE_TO_STARVATION,3.181152034,0,flutamide
EUKARYOTIC_TRANSLATION_INITIATION,3.082168997,0,flutamide
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.235063323,0,flutamide
METABOLISM_OF_RNA,3.274245407,0,flutamide
MHC_CLASS_II_ANTIGEN_PRESENTATION,2.418644924,0.01658222,quetiapine
RAB_REGULATION_OF_TRAFFICKING,2.33526964,0.013818517,quetiapine
GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER,2.290522404,0.011976048,quetiapine
G_ALPHA_Q_SIGNALLING_EVENTS,-2.194875372,0.046858672,quetiapine
SUMOYLATION,1.953251137,0.065637955,quetiapine
NUCLEOTIDE_EXCISION_REPAIR,1.886266611,0.075172731,quetiapine
KEAP1_NFE2L2_PATHWAY,1.724922031,0.150621833,quetiapine
MEMBRANE_TRAFFICKING,1.690518691,0.149239982,quetiapine
SENSORY_PERCEPTION,-1.966468112,0.210069807,quetiapine
RHO_GTPASE_EFFECTORS,1.644798344,0.165822202,quetiapine
GPCR_LIGAND_BINDING,2.859741598,0,pimavanserin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.795071194,0,pimavanserin
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.69161824,0.000170864,pimavanserin
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.486535279,0.002158979,pimavanserin
EUKARYOTIC_TRANSLATION_ELONGATION,-2.447917121,0.00107949,pimavanserin
NONSENSE_MEDIATED_DECAY_NMD,-2.40357309,0.00143932,pimavanserin
SIGNALING_BY_ROBO_RECEPTORS,-2.362270388,0.002158979,pimavanserin
RRNA_PROCESSING,-2.319689283,0.002374877,pimavanserin
INFLUENZA_INFECTION,-2.313436813,0.002158979,pimavanserin
EUKARYOTIC_TRANSLATION_INITIATION,-2.29415083,0.002313192,pimavanserin
KEAP1_NFE2L2_PATHWAY,1.925508591,0.698147311,minoxidil
DNA_REPLICATION,1.874180233,0.442159964,minoxidil
DEATH_RECEPTOR_SIGNALING,1.841378884,0.336145002,minoxidil
SYNTHESIS_OF_DNA,1.833925597,0.267623136,minoxidil
METABOLISM_OF_POLYAMINES,1.829451185,0.226510017,minoxidil
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,1.797668166,0.214615655,minoxidil
S_PHASE,1.79632257,0.185064446,minoxidil
NUCLEAR_EVENTS_MEDIATED_BY_NFE2L2,1.765142879,0.19296016,minoxidil
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,1.697199419,0.26374454,minoxidil
CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6,1.645399764,0.297876186,minoxidil
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,4.253334366,0,tirofiban
MITOCHONDRIAL_PROTEIN_DEGRADATION,2.810649515,0,tirofiban
EUKARYOTIC_TRANSLATION_INITIATION,2.840811726,0,tirofiban
CELLULAR_RESPONSE_TO_STARVATION,2.918685218,0,tirofiban
COMPLEX_I_BIOGENESIS,2.735943455,0,tirofiban
METABOLISM_OF_RNA,3.113412549,0,tirofiban
TRANSLATION,3.219142255,0,tirofiban
RESPIRATORY_ELECTRON_TRANSPORT,4.001428033,0,tirofiban
RRNA_PROCESSING,3.008391496,0,tirofiban
GPCR_LIGAND_BINDING,-2.627921883,0.000636601,tirofiban
TRANSLATION,3.45173499,0,eugenol
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,2.623586169,0,eugenol
SELENOAMINO_ACID_METABOLISM,2.764604112,0,eugenol
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.795292853,0,eugenol
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.814611752,0,eugenol
COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES,-2.847407654,0,eugenol
ECM_PROTEOGLYCANS,-2.858253975,0,eugenol
COLLAGEN_FORMATION,-2.870846637,0,eugenol
NONSENSE_MEDIATED_DECAY_NMD,2.600918754,0,eugenol
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.025868816,0,eugenol
EUKARYOTIC_TRANSLATION_ELONGATION,-2.857637351,0,tacrine
NONSENSE_MEDIATED_DECAY_NMD,-2.743336648,0,tacrine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.678279722,0,tacrine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.665881824,0,tacrine
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.66509999,0,tacrine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.656124031,0,tacrine
SELENOAMINO_ACID_METABOLISM,-2.652930225,0,tacrine
EUKARYOTIC_TRANSLATION_INITIATION,-2.550521491,0,tacrine
INFLUENZA_INFECTION,-2.522457915,0,tacrine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.520291979,0,tacrine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.273890831,0.011502524,fexofenadine
SELENOAMINO_ACID_METABOLISM,-2.231637626,0.008888314,fexofenadine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.189090856,0.01045684,fexofenadine
INFLUENZA_INFECTION,-2.134115746,0.016208102,fexofenadine
EUKARYOTIC_TRANSLATION_INITIATION,-2.123171619,0.014221303,fexofenadine
NONSENSE_MEDIATED_DECAY_NMD,-2.109131037,0.013942454,fexofenadine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.101907029,0.012548208,fexofenadine
NEURONAL_SYSTEM,1.984086055,0.079231417,fexofenadine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.06533503,0.016992365,fexofenadine
CELLULAR_RESPONSE_TO_STARVATION,-2.015895612,0.025096417,fexofenadine
ESTROGEN_DEPENDENT_GENE_EXPRESSION,1.713811634,0.272938098,melatonin
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.003424846,0.373723112,melatonin
RHO_GTPASES_ACTIVATE_FORMINS,1.657447553,0.194594755,melatonin
MITOTIC_PROMETAPHASE,1.651696033,0.134784246,melatonin
SELENOAMINO_ACID_METABOLISM,-1.873054987,0.590562458,melatonin
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-1.853211606,0.461657962,melatonin
RESOLUTION_OF_SISTER_CHROMATID_COHESION,1.458791011,0.264851044,melatonin
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.837648224,0.393708305,melatonin
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-1.822366048,0.352738659,melatonin
EUKARYOTIC_TRANSLATION_INITIATION,-1.814006278,0.31260173,melatonin
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,-3.101948492,0.061811968,quercetin
AUTOPHAGY,-3.081484969,0.056192698,quercetin
MHC_CLASS_II_ANTIGEN_PRESENTATION,1.806532864,0.3948268,quercetin
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,-3.02316446,0.144540107,quercetin
FATTY_ACID_METABOLISM,1.663342623,0.353463993,quercetin
ESTROGEN_DEPENDENT_GENE_EXPRESSION,1.56664174,0.396080219,quercetin
NEUTROPHIL_DEGRANULATION,-2.971911995,0.238116559,quercetin
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,1.517752173,0.384016067,quercetin
HIV_LIFE_CYCLE,1.509849818,0.320373747,quercetin
HEMOSTASIS,-2.750195973,0.555183859,quercetin
CELL_CYCLE_CHECKPOINTS,-2.941639579,0,trametinib
G2_M_CHECKPOINTS,-2.847886013,0,trametinib
HOMOLOGY_DIRECTED_REPAIR,-2.838720792,0,trametinib
SENSORY_PERCEPTION,2.364644594,0.000776152,trametinib
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-2.618506316,0.002002837,trametinib
S_PHASE,-2.57312271,0.00160227,trametinib
DNA_DOUBLE_STRAND_BREAK_REPAIR,-2.450511908,0.002336644,trametinib
DNA_REPAIR,-2.446597493,0.002002837,trametinib
CELL_CYCLE,-2.416766098,0.002753901,trametinib
CELL_CYCLE_MITOTIC,-2.386474243,0.002447912,trametinib
GPCR_LIGAND_BINDING,2.151929761,0.02647868,linsitinib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.976796895,0.047741862,linsitinib
DRUG_ADME,1.932615418,0.038781904,linsitinib
SIGNALING_BY_GPCR,1.842903643,0.055163916,linsitinib
NEURONAL_SYSTEM,1.827272591,0.047019716,linsitinib
INTEGRATION_OF_ENERGY_METABOLISM,1.573361561,0.162215345,linsitinib
G_ALPHA_12_13_SIGNALLING_EVENTS,1.497129643,0.206671252,linsitinib
BIOLOGICAL_OXIDATIONS,1.490941254,0.186654631,linsitinib
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.461126192,0.191145754,linsitinib
EUKARYOTIC_TRANSLATION_ELONGATION,-2.455572963,1,linsitinib
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,3.530275324,0,brexpiprazole
INFLUENZA_INFECTION,3.497023666,0,brexpiprazole
MRNA_SPLICING,3.489254984,0,brexpiprazole
METABOLISM_OF_RNA,3.377555632,0,brexpiprazole
TRANSLATION,2.883649562,0,brexpiprazole
MITOCHONDRIAL_PROTEIN_DEGRADATION,2.835589265,0,brexpiprazole
RESPIRATORY_ELECTRON_TRANSPORT,2.788949567,0,brexpiprazole
HIV_INFECTION,2.310827181,0.005014588,brexpiprazole
NEUTROPHIL_DEGRANULATION,2.243369402,0.006078288,brexpiprazole
RRNA_PROCESSING,2.120300837,0.009117433,brexpiprazole
REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE,2.840496161,0,ciprofloxacin
HIV_INFECTION,1.934412818,0.244307043,ciprofloxacin
DNA_REPLICATION,1.858181592,0.260594179,ciprofloxacin
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,1.853078555,0.203589202,ciprofloxacin
CELLULAR_RESPONSE_TO_HEAT_STRESS,1.810563562,0.219876338,ciprofloxacin
SYNTHESIS_OF_DNA,1.7500497,0.247021565,ciprofloxacin
KEAP1_NFE2L2_PATHWAY,1.667791047,0.368787298,ciprofloxacin
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,1.66201831,0.32676067,ciprofloxacin
TRNA_PROCESSING,1.652857243,0.304931383,ciprofloxacin
CELL_CYCLE_MITOTIC,1.6479545,0.276881315,ciprofloxacin
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.488061611,0.001216319,rucaparib
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.263897647,0.031016136,rucaparib
SENSORY_PERCEPTION,-2.087392656,0.11433399,rucaparib
VISUAL_PHOTOTRANSDUCTION,-2.007029376,0.169372427,rucaparib
COLLAGEN_FORMATION,-1.893792397,0.312837259,rucaparib
SIGNALING_BY_NOTCH,-1.878327645,0.29394377,rucaparib
GLYCOSAMINOGLYCAN_METABOLISM,-1.872277655,0.264114993,rucaparib
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,-1.862133424,0.248129086,rucaparib
SIGNALING_BY_GPCR,1.707955608,0.794326815,rucaparib
METABOLISM_OF_VITAMINS_AND_COFACTORS,-1.838766293,0.257319052,rucaparib
CELL_CYCLE_MITOTIC,-2.464784865,0.003504673,mocetinostat
CELL_CYCLE,-2.359756924,0.009929907,mocetinostat
M_PHASE,-2.271324765,0.013629283,mocetinostat
DNA_REPLICATION,-2.217488854,0.016063084,mocetinostat
METABOLISM_OF_RNA,-2.213510941,0.013084112,mocetinostat
SYNTHESIS_OF_DNA,-2.204928577,0.011876947,mocetinostat
S_PHASE,-2.142979225,0.021528705,mocetinostat
FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS,2.009778026,0.092744173,mocetinostat
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.049067391,0.048189252,mocetinostat
SEPARATION_OF_SISTER_CHROMATIDS,-2.031656333,0.048935618,mocetinostat
CELL_CYCLE_MITOTIC,-3.861252161,0,R-547
G2_M_CHECKPOINTS,-2.573469461,0,R-547
G1_S_SPECIFIC_TRANSCRIPTION,-2.604066132,0,R-547
MITOTIC_G2_G2_M_PHASES,-2.733131879,0,R-547
CHROMOSOME_MAINTENANCE,-2.761844764,0,R-547
S_PHASE,-2.794196032,0,R-547
SYNTHESIS_OF_DNA,-2.822418648,0,R-547
DNA_REPLICATION,-2.842669699,0,R-547
RHO_GTPASES_ACTIVATE_FORMINS,-3.023002057,0,R-547
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-3.000189184,0,R-547
RESPIRATORY_ELECTRON_TRANSPORT,4.122761527,0,efaproxiral
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,3.589991219,0,efaproxiral
TRANSLATION,3.390113177,0,efaproxiral
METABOLISM_OF_RNA,3.002303463,0,efaproxiral
CELLULAR_RESPONSE_TO_STARVATION,2.984383886,0,efaproxiral
COMPLEX_I_BIOGENESIS,2.837977353,0,efaproxiral
RRNA_PROCESSING,2.753452142,0,efaproxiral
EUKARYOTIC_TRANSLATION_INITIATION,2.653524703,0,efaproxiral
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.587360088,0,efaproxiral
NEURONAL_SYSTEM,-2.60510638,0.000692263,efaproxiral
NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION,2.205069145,0.047915903,CTS-1027
NUCLEOTIDE_EXCISION_REPAIR,2.189285592,0.025954447,CTS-1027
SIGNALING_BY_NTRKS,1.918239622,0.078528841,CTS-1027
INTEGRATION_OF_ENERGY_METABOLISM,1.772367961,0.13775822,CTS-1027
CELLULAR_RESPONSES_TO_MECHANICAL_STIMULI,1.700605998,0.171299352,CTS-1027
ANTIGEN_PROCESSING_CROSS_PRESENTATION,1.665323075,0.17236415,CTS-1027
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,-1.879635035,0.624467143,CTS-1027
REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION,1.548067356,0.243572505,CTS-1027
AURKA_ACTIVATION_BY_TPX2,1.548067356,0.243572505,CTS-1027
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.481389623,0.305242047,CTS-1027
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.91915293,0,nalbuphine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.874841426,0,nalbuphine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.840246756,0,nalbuphine
NONSENSE_MEDIATED_DECAY_NMD,-2.831312494,0,nalbuphine
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.829226555,0,nalbuphine
SELENOAMINO_ACID_METABOLISM,-2.774190328,0,nalbuphine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.768949674,0,nalbuphine
INFLUENZA_INFECTION,-2.701212715,0,nalbuphine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.635430146,0,nalbuphine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.622998342,0,nalbuphine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,3.300793757,0,mepacrine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.179278457,0.015990586,mepacrine
GPCR_LIGAND_BINDING,2.135871364,0.013401634,mepacrine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.158807871,0.064709757,mepacrine
SIGNALING_BY_GPCR,1.833005557,0.060764225,mepacrine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-1.998295889,0.181996191,mepacrine
RRNA_PROCESSING,-1.995112131,0.127397333,mepacrine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-1.97513504,0.119055841,mepacrine
SELENOAMINO_ACID_METABOLISM,-1.942730911,0.136699361,mepacrine
EUKARYOTIC_TRANSLATION_INITIATION,-1.939683504,0.117791979,mepacrine
SENSORY_PERCEPTION,-2.377278238,0.003000817,nimodipine
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-2.267937037,0.00712694,nimodipine
NEURONAL_SYSTEM,-2.266021495,0.004751293,nimodipine
GPCR_LIGAND_BINDING,-2.227628954,0.005063879,nimodipine
METABOLISM_OF_RNA,2.205266061,0.120656687,nimodipine
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,-2.095381993,0.017104656,nimodipine
RRNA_PROCESSING,2.135063913,0.100251512,nimodipine
G_ALPHA_S_SIGNALLING_EVENTS,-2.081272261,0.016379459,nimodipine
CYTOSOLIC_SENSORS_OF_PATHOGEN_ASSOCIATED_DNA,2.071076139,0.100547239,nimodipine
SIGNALING_BY_GPCR,-1.998533144,0.031937265,nimodipine
NEURONAL_SYSTEM,-2.88514931,0,pomalidomide
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.707090494,0,pomalidomide
GPCR_LIGAND_BINDING,-2.639648606,0,pomalidomide
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.623038939,0,pomalidomide
ECM_PROTEOGLYCANS,-2.527693268,0.000495156,pomalidomide
SIGNALING_BY_GPCR,-2.465741303,0.001444204,pomalidomide
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,-2.434488008,0.002122096,pomalidomide
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,-2.422303293,0.002243675,pomalidomide
DEVELOPMENTAL_CELL_LINEAGES,-2.411382891,0.002338236,pomalidomide
RESPIRATORY_ELECTRON_TRANSPORT,2.300450037,0.047900891,pomalidomide
METABOLISM_OF_RNA,3.39317632,0,adapalene
TRANSLATION,2.898173152,0,adapalene
CELL_CYCLE_MITOTIC,2.873418969,0,adapalene
CELL_CYCLE,2.873132395,0,adapalene
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.803464369,0,adapalene
GPCR_LIGAND_BINDING,-2.793241561,0,adapalene
M_PHASE,2.691889206,0.000295874,adapalene
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.68775335,0.000253606,adapalene
NEURONAL_SYSTEM,-2.651556732,0.000588993,adapalene
RRNA_PROCESSING,2.670553945,0.000443811,adapalene
EUKARYOTIC_TRANSLATION_ELONGATION,-2.624659988,0,loratadine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.555678525,0,loratadine
NONSENSE_MEDIATED_DECAY_NMD,-2.552082308,0,loratadine
SELENOAMINO_ACID_METABOLISM,-2.476560464,0.000247354,loratadine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.406941683,0.001385183,loratadine
SIGNALING_BY_ROBO_RECEPTORS,-2.405266342,0.001484125,loratadine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.400871602,0.001413452,loratadine
EUKARYOTIC_TRANSLATION_INITIATION,-2.360327087,0.00210251,loratadine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.33900611,0.002088768,loratadine
INFLUENZA_INFECTION,-2.28923812,0.002869308,loratadine
TRANSLATION,3.142760302,0,rolipram
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,-2.622122921,0.005493776,rolipram
EUKARYOTIC_TRANSLATION_INITIATION,2.462415449,0.015890443,rolipram
CELLULAR_RESPONSE_TO_STARVATION,2.441699037,0.012435999,rolipram
ECM_PROTEOGLYCANS,-2.600697145,0.003924126,rolipram
SIGNALING_BY_MET,-2.586289877,0.0031393,rolipram
COLLAGEN_FORMATION,-2.579246786,0.002354475,rolipram
METABOLISM_OF_RNA,2.392318268,0.013817777,rolipram
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.551767865,0.002668405,rolipram
DEVELOPMENTAL_CELL_LINEAGES,-2.540591611,0.002485279,rolipram
METABOLISM_OF_RNA,2.879452732,0,tipiracil
RRNA_PROCESSING,2.814196183,0,tipiracil
ECM_PROTEOGLYCANS,-2.733963663,0.001171229,tipiracil
CELLULAR_RESPONSE_TO_STARVATION,2.641692779,0.000495395,tipiracil
RESPIRATORY_ELECTRON_TRANSPORT,2.622774342,0.000371546,tipiracil
GPCR_LIGAND_BINDING,-2.61495161,0.000878421,tipiracil
COLLAGEN_FORMATION,-2.59937501,0.000585614,tipiracil
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.5155156,0.000495395,tipiracil
TRANSLATION,2.520922804,0.000594473,tipiracil
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.426318357,0.000636936,tipiracil
RESPIRATORY_ELECTRON_TRANSPORT,4.38707989,0,zardaverine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,4.290667651,0,zardaverine
TRANSLATION,3.332255266,0,zardaverine
COMPLEX_I_BIOGENESIS,3.114350093,0,zardaverine
RRNA_PROCESSING,3.027175937,0,zardaverine
METABOLISM_OF_RNA,2.963974519,0,zardaverine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.957715713,0,zardaverine
CELLULAR_RESPONSE_TO_STARVATION,2.854117425,0,zardaverine
GPCR_LIGAND_BINDING,-2.639076635,0,zardaverine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.515344802,0,zardaverine
SELENOAMINO_ACID_METABOLISM,3.728606492,0,tiapride
SIGNALING_BY_GPCR,-2.67862229,0,tiapride
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.881110947,0,tiapride
GPCR_LIGAND_BINDING,-2.915443662,0,tiapride
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.23527577,0,tiapride
METABOLISM_OF_RNA,3.23806633,0,tiapride
RRNA_PROCESSING,3.238876443,0,tiapride
EUKARYOTIC_TRANSLATION_INITIATION,3.285298679,0,tiapride
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.114144071,0,tiapride
EUKARYOTIC_TRANSLATION_ELONGATION,3.372524977,0,tiapride
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.548749784,0,vilazodone
SIGNALING_BY_GPCR,-2.559055694,0,vilazodone
GPCR_LIGAND_BINDING,-2.937576023,0,vilazodone
RRNA_PROCESSING,2.997652978,0,vilazodone
SIGNALING_BY_ROBO_RECEPTORS,2.999097381,0,vilazodone
INFLUENZA_INFECTION,3.055183047,0,vilazodone
METABOLISM_OF_RNA,3.147628378,0,vilazodone
NONSENSE_MEDIATED_DECAY_NMD,3.237384921,0,vilazodone
SENSORY_PERCEPTION,-2.61174502,0,vilazodone
TRANSLATION,3.296297864,0,vilazodone
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.781706281,0,iniparib
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.07656726,0.225438456,iniparib
COLLAGEN_FORMATION,-2.035396039,0.204253636,iniparib
COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC,-2.009516898,0.19036359,iniparib
BIOLOGICAL_OXIDATIONS,1.691842105,1,iniparib
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1.63269446,0.707349944,iniparib
GPCR_LIGAND_BINDING,-1.736821905,0.887124307,iniparib
MITOTIC_G2_G2_M_PHASES,-1.726329311,0.775844048,iniparib
PTEN_REGULATION,-1.721017849,0.686593717,iniparib
DISEASES_OF_GLYCOSYLATION,-1.716335246,0.614259835,iniparib
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.037784838,0.150753769,benazepril
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.014645386,0.074616522,benazepril
MRNA_SPLICING,1.891812523,0.179648241,benazepril
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,1.793655733,0.190954774,benazepril
GPCR_LIGAND_BINDING,-1.932881141,0.095823323,benazepril
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.922581731,0.067285776,benazepril
G_ALPHA_Q_SIGNALLING_EVENTS,-1.871738183,0.090521623,benazepril
FORMATION_OF_THE_CORNIFIED_ENVELOPE,1.67008639,0.282663317,benazepril
PROTEIN_LOCALIZATION,1.605205585,0.321105528,benazepril
PHASE_II_CONJUGATION_OF_COMPOUNDS,1.578911674,0.304857621,benazepril
CELLULAR_RESPONSE_TO_STARVATION,2.611061357,0,dacomitinib
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.533121583,0,dacomitinib
EUKARYOTIC_TRANSLATION_ELONGATION,2.395107208,0.002585243,dacomitinib
SELENOAMINO_ACID_METABOLISM,2.38164092,0.002215923,dacomitinib
GPCR_LIGAND_BINDING,-2.393092294,0.02135052,dacomitinib
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.269061314,0.007534137,dacomitinib
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.322416946,0.022278803,dacomitinib
NONSENSE_MEDIATED_DECAY_NMD,2.195690009,0.013110876,dacomitinib
ION_CHANNEL_TRANSPORT,-2.242854917,0.030014499,dacomitinib
TRANSLATION,1.99589829,0.051915903,dacomitinib
EUKARYOTIC_TRANSLATION_ELONGATION,4.063846939,0,pasireotide
G_ALPHA_S_SIGNALLING_EVENTS,-2.765096796,0,pasireotide
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.806144146,0,pasireotide
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.835724063,0,pasireotide
SARS_COV_1_INFECTION,2.858573591,0,pasireotide
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.870796894,0,pasireotide
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,3.056740327,0,pasireotide
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.07213914,0,pasireotide
SARS_COV_1_HOST_INTERACTIONS,3.224855254,0,pasireotide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-3.299251776,0,pasireotide
FORMATION_OF_THE_CORNIFIED_ENVELOPE,2.51615902,0.006252571,donepezil
KERATINIZATION,2.390787774,0.003907857,donepezil
GPCR_LIGAND_BINDING,-1.863251766,0.498112224,donepezil
SIGNALING_BY_TGFB_FAMILY_MEMBERS,1.587458322,0.413190731,donepezil
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.80583198,0.426756037,donepezil
P75_NTR_RECEPTOR_MEDIATED_SIGNALLING,1.5564531,0.373200329,donepezil
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.773830765,0.378724883,donepezil
KEAP1_NFE2L2_PATHWAY,1.494422391,0.402978198,donepezil
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.464767878,0.392348828,donepezil
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.741908308,0.368059818,donepezil
GPCR_LIGAND_BINDING,-3.175629821,0,TG-100801
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-3.035705955,0,TG-100801
SIGNALING_BY_GPCR,-3.026308741,0,TG-100801
METABOLISM_OF_RNA,2.812794682,0,TG-100801
HEMOSTASIS,-2.776215601,0,TG-100801
NEURONAL_SYSTEM,-2.771582075,0,TG-100801
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.748674748,0,TG-100801
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,-2.700763391,0,TG-100801
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.653020724,0,TG-100801
TRANSLATION,2.550216785,0,TG-100801
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.45422736,0,amsacrine
DNA_REPAIR,2.670907347,0.002609688,amsacrine
GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER,2.513020932,0.001304844,amsacrine
MHC_CLASS_II_ANTIGEN_PRESENTATION,2.473633342,0.002609688,amsacrine
G2_M_CHECKPOINTS,2.367899729,0.005219377,amsacrine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.315027455,0.004697439,amsacrine
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.223890557,0.004495923,amsacrine
CELL_CYCLE_CHECKPOINTS,2.181774997,0.010003806,amsacrine
MRNA_SPLICING,2.165512963,0.010438754,amsacrine
MITF_M_DEPENDENT_GENE_EXPRESSION,2.146810758,0.009786332,amsacrine
METABOLISM_OF_RNA,2.396805489,0.004058683,carfilzomib
INTERLEUKIN_1_SIGNALING,2.367858512,0.004058683,carfilzomib
INTERLEUKIN_1_FAMILY_SIGNALING,2.256410916,0.009921226,carfilzomib
FCERI_MEDIATED_NF_KB_ACTIVATION,2.242506605,0.008117367,carfilzomib
DOWNSTREAM_TCR_SIGNALING,2.124962973,0.023540363,carfilzomib
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.117122454,0.022548241,carfilzomib
REGULATION_OF_RUNX3_EXPRESSION_AND_ACTIVITY,2.093945504,0.022419394,carfilzomib
VIF_MEDIATED_DEGRADATION_OF_APOBEC3G,2.082576088,0.022322758,carfilzomib
ACTIVATION_OF_NF_KAPPAB_IN_B_CELLS,2.080578979,0.019842452,carfilzomib
ASYMMETRIC_LOCALIZATION_OF_PCP_PROTEINS,2.067890992,0.020022838,carfilzomib
MHC_CLASS_II_ANTIGEN_PRESENTATION,1.881660638,0.268438969,safinamide
DISEASES_OF_METABOLISM,-3.210354343,0.171229169,safinamide
LEISHMANIA_INFECTION,1.774028173,0.21956557,safinamide
EPIGENETIC_REGULATION_BY_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES,1.588001513,0.336521316,safinamide
METABOLISM_OF_NUCLEOTIDES,1.566339561,0.27646296,safinamide
MITOCHONDRIAL_PROTEIN_DEGRADATION,1.448072605,0.374355649,safinamide
RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_PATHWAY,1.41478449,0.362295348,safinamide
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.645816416,1,safinamide
FATTY_ACID_METABOLISM,1.341260746,0.435379663,safinamide
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.487079344,1,safinamide
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.765783216,0,TG-100115
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.673094211,0,TG-100115
EUKARYOTIC_TRANSLATION_ELONGATION,-2.665318653,0,TG-100115
SELENOAMINO_ACID_METABOLISM,-2.634173082,0,TG-100115
NONSENSE_MEDIATED_DECAY_NMD,-2.581864794,0,TG-100115
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.575522568,0,TG-100115
EUKARYOTIC_TRANSLATION_INITIATION,-2.545286175,0,TG-100115
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.533125217,0,TG-100115
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.497792271,0,TG-100115
INFLUENZA_INFECTION,-2.414538863,0,TG-100115
EUKARYOTIC_TRANSLATION_INITIATION,-3.104969142,0,VX-745
INFLUENZA_INFECTION,-3.003290929,0,VX-745
GPCR_LIGAND_BINDING,2.553958857,0,VX-745
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.807744647,0.001217825,VX-745
SELENOAMINO_ACID_METABOLISM,-2.760818546,0.000913368,VX-745
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.69560055,0.000730695,VX-745
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.381420866,0.000492402,VX-745
EUKARYOTIC_TRANSLATION_ELONGATION,-2.575499875,0.002435649,VX-745
TRANSLATION,-2.512750206,0.004175398,VX-745
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.426294974,0.005936895,VX-745
GPCR_LIGAND_BINDING,2.451802317,0,FR-180204
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.235141898,0.004078581,FR-180204
CELL_CYCLE_CHECKPOINTS,-2.267968108,0.071907422,FR-180204
EPIGENETIC_REGULATION_BY_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES,-2.177842125,0.071907422,FR-180204
REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE,-2.16912962,0.05216813,FR-180204
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.001614772,0.087769354,FR-180204
G2_M_CHECKPOINTS,-1.955015376,0.088826816,FR-180204
DNA_DOUBLE_STRAND_BREAK_REPAIR,-1.924574791,0.088121841,FR-180204
S_PHASE,-1.917866846,0.080971383,FR-180204
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,-1.90555182,0.076137271,FR-180204
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.478012201,0.004018647,levosimendan
METABOLISM_OF_RNA,1.904273269,0.077358946,levosimendan
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.594355801,0.27125864,levosimendan
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.472308606,0.356654879,levosimendan
HIV_INFECTION,1.355237174,0.50273268,levosimendan
ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE,1.202315702,0.82583186,levosimendan
HIV_LIFE_CYCLE,1.168728358,0.812914782,levosimendan
SIGNALING_BY_VEGF,1.147883852,0.775849944,levosimendan
INTEGRIN_CELL_SURFACE_INTERACTIONS,-1.925083172,1,levosimendan
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,1.100680874,0.839897123,levosimendan
EUKARYOTIC_TRANSLATION_ELONGATION,-2.234807309,0.032317246,aminosalicylic-acid
INFLUENZA_INFECTION,-2.202995728,0.025019804,aminosalicylic-acid
NEURONAL_SYSTEM,2.014938105,0.059990411,aminosalicylic-acid
EUKARYOTIC_TRANSLATION_INITIATION,-2.121494201,0.041352175,aminosalicylic-acid
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.964229761,0.041861441,aminosalicylic-acid
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.061655653,0.060725148,aminosalicylic-acid
NONSENSE_MEDIATED_DECAY_NMD,-2.038377377,0.063800499,aminosalicylic-acid
SELENOAMINO_ACID_METABOLISM,-2.02488083,0.060812023,aminosalicylic-acid
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.019447152,0.055400994,aminosalicylic-acid
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.005278541,0.057076427,aminosalicylic-acid
GPCR_LIGAND_BINDING,2.21633953,0.035729226,torcitabine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.147932623,0.027608947,torcitabine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.942568616,0.107812882,torcitabine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.942408993,0.053906441,torcitabine
SELENOAMINO_ACID_METABOLISM,-2.94017084,0.036628736,torcitabine
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,-2.924654031,0.03757901,torcitabine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.90112985,0.047686467,torcitabine
MUSCLE_CONTRACTION,1.921348059,0.083368193,torcitabine
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.897990003,0.0728795,torcitabine
SENSORY_PERCEPTION,1.878884802,0.063987795,torcitabine
PLATELET_HOMEOSTASIS,2.146003637,0.045981658,cediranib
GPCR_LIGAND_BINDING,1.852867193,0.105429373,cediranib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.824778561,0.07970154,cediranib
FATTY_ACID_METABOLISM,1.699074061,0.116596347,cediranib
G_ALPHA_S_SIGNALLING_EVENTS,1.675268932,0.107334327,cediranib
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.655155944,0.100064846,cediranib
MUSCLE_CONTRACTION,1.650335036,0.088115871,cediranib
SIGNALING_BY_GPCR,1.589340612,0.107892676,cediranib
POTASSIUM_CHANNELS,1.493689543,0.156191663,cediranib
SARS_COV_1_HOST_INTERACTIONS,-2.58258451,1,cediranib
METABOLISM_OF_RNA,4.143482883,0,quinidine
SIGNALING_BY_GPCR,-2.680529754,0,quinidine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.763486555,0,quinidine
SARS_COV_1_HOST_INTERACTIONS,2.998265586,0,quinidine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.0018239,0,quinidine
GPCR_LIGAND_BINDING,-3.006755349,0,quinidine
MRNA_SPLICING,3.023490571,0,quinidine
TRANSLATION,3.455273527,0,quinidine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,3.536811184,0,quinidine
CELLULAR_RESPONSE_TO_STARVATION,3.46924404,0,quinidine
EXTRACELLULAR_MATRIX_ORGANIZATION,-3.51421374,0,bosutinib
INTEGRIN_CELL_SURFACE_INTERACTIONS,-3.256457944,0,bosutinib
NONSENSE_MEDIATED_DECAY_NMD,2.277098233,0.013693548,bosutinib
RNA_POLYMERASE_II_TRANSCRIPTION,2.265297754,0.009781106,bosutinib
EUKARYOTIC_TRANSLATION_ELONGATION,2.257971997,0.006520737,bosutinib
SELENOAMINO_ACID_METABOLISM,2.250621356,0.005379608,bosutinib
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.238973518,0.004694931,bosutinib
CELLULAR_RESPONSE_TO_STARVATION,2.212448979,0.005705645,bosutinib
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.119107909,0.013973008,bosutinib
INFLUENZA_INFECTION,2.088905051,0.015282978,bosutinib
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.80047277,0.131132508,thalidomide
PROTEIN_FOLDING,1.457607606,1,thalidomide
ECM_PROTEOGLYCANS,-2.6905002,0.786290692,thalidomide
NEDDYLATION,1.412464678,0.696385542,thalidomide
DISEASES_OF_METABOLISM,-2.569977802,1,thalidomide
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.445547065,1,thalidomide
GASTRULATION,1.18368061,1,thalidomide
VISUAL_PHOTOTRANSDUCTION,-1.709208799,1,thalidomide
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-1.649240622,1,thalidomide
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,-1.616767488,1,thalidomide
SENSORY_PERCEPTION,-2.198303308,0.015308062,amonafide
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,1.848113716,0.424434785,amonafide
GASTRULATION,1.811476991,0.248991526,amonafide
GPCR_LIGAND_BINDING,-1.910399855,0.166137492,amonafide
NEURONAL_SYSTEM,-1.88552896,0.14467619,amonafide
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,1.634639732,0.429542304,amonafide
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,1.619103231,0.349737328,amonafide
VISUAL_PHOTOTRANSDUCTION,-1.782054197,0.270817619,amonafide
KERATINIZATION,-1.778940944,0.222957415,amonafide
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,-1.757138219,0.223167525,amonafide
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.928022537,0.122955766,varenicline
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.147613372,0.177132428,varenicline
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.133161548,0.10040937,varenicline
EUKARYOTIC_TRANSLATION_ELONGATION,-2.108023039,0.089939334,varenicline
SARS_COV_1_HOST_INTERACTIONS,-2.067809836,0.10143921,varenicline
SIGNALING_BY_ROBO_RECEPTORS,-2.050688575,0.09392138,varenicline
SELENOAMINO_ACID_METABOLISM,-2.03055171,0.091655733,varenicline
NONSENSE_MEDIATED_DECAY_NMD,-2.025494838,0.081063096,varenicline
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-1.975074289,0.10285524,varenicline
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-1.966477968,0.099551171,varenicline
SARS_COV_1_HOST_INTERACTIONS,-2.182737509,0.009117539,EMD-1214063
ESTROGEN_DEPENDENT_GENE_EXPRESSION,2.238210695,0.022624957,EMD-1214063
EUKARYOTIC_TRANSLATION_INITIATION,-2.104253225,0.012156718,EMD-1214063
TP53_REGULATES_METABOLIC_GENES,-2.097837341,0.009792912,EMD-1214063
SELENOAMINO_ACID_METABOLISM,-2.096308083,0.007597949,EMD-1214063
NONSENSE_MEDIATED_DECAY_NMD,-2.040850649,0.015195898,EMD-1214063
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.03693212,0.013338621,EMD-1214063
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.027338281,0.013314501,EMD-1214063
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.019645036,0.012536615,EMD-1214063
EUKARYOTIC_TRANSLATION_ELONGATION,-1.998231526,0.015421022,EMD-1214063
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.973448186,0.074039157,ketoprofen
ECM_PROTEOGLYCANS,-2.84124858,0.190943088,ketoprofen
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.793546278,0.249719787,ketoprofen
ESTROGEN_DEPENDENT_GENE_EXPRESSION,1.479781658,1,ketoprofen
BACTERIAL_INFECTION_PATHWAYS,1.407601088,0.899312317,ketoprofen
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.115954907,1,ketoprofen
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,1.343525872,0.801099481,ketoprofen
PROTEIN_FOLDING,1.331332071,0.638616723,ketoprofen
DISEASES_OF_GLYCOSYLATION,1.311855914,0.557643622,ketoprofen
MUSCLE_CONTRACTION,1.276918178,0.54308666,ketoprofen
GPCR_LIGAND_BINDING,-3.034861179,0,PF-02545920
TRANSLATION,2.798935748,0,PF-02545920
METABOLISM_OF_RNA,2.59824992,0,PF-02545920
ECM_PROTEOGLYCANS,-2.887020061,0.000349333,PF-02545920
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,-2.883149671,0.000232888,PF-02545920
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.864715033,0.000174666,PF-02545920
DEVELOPMENTAL_CELL_LINEAGES,-2.798490418,0.000139733,PF-02545920
EUKARYOTIC_TRANSLATION_INITIATION,2.549524499,0.00049682,PF-02545920
SIGNALING_BY_GPCR,-2.727546602,0.000582221,PF-02545920
SIGNALING_BY_MET,-2.722786142,0.000598856,PF-02545920
EUKARYOTIC_TRANSLATION_ELONGATION,-2.350972708,0.012062971,erteberel
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.370697274,0.009615649,erteberel
SELENOAMINO_ACID_METABOLISM,-2.281201704,0.015581337,erteberel
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.243058707,0.016754126,erteberel
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.222402831,0.017843144,erteberel
NONSENSE_MEDIATED_DECAY_NMD,-2.214109748,0.015480812,erteberel
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.026989095,0.044231984,erteberel
SIGNALING_BY_ROBO_RECEPTORS,-2.140008678,0.028146931,erteberel
EUKARYOTIC_TRANSLATION_INITIATION,-2.114254608,0.032024315,erteberel
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.114104001,0.028021275,erteberel
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1.905967961,0.082118899,rupatadine
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,1.584302915,0.307078418,rupatadine
ISG15_ANTIVIRAL_MECHANISM,1.565807937,0.225923356,rupatadine
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,1.303831447,0.634975711,rupatadine
DISEASES_OF_METABOLISM,-2.664274546,1,rupatadine
RSV_HOST_INTERACTIONS,1.268800788,0.59888966,rupatadine
TRNA_PROCESSING,1.26390711,0.511411828,rupatadine
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.537484182,1,rupatadine
RAB_REGULATION_OF_TRAFFICKING,1.160026152,0.690162255,rupatadine
TP53_REGULATES_METABOLIC_GENES,-2.023973801,1,rupatadine
METABOLISM_OF_VITAMINS_AND_COFACTORS,-3.089375089,0.536747997,rosiglitazone
LEISHMANIA_INFECTION,1.596930604,0.646863315,rosiglitazone
VISUAL_PHOTOTRANSDUCTION,-3.014498347,0.730272733,rosiglitazone
SENSORY_PERCEPTION,-2.970696421,0.664451343,rosiglitazone
ADIPOGENESIS,1.360047259,1,rosiglitazone
SARS_COV_1_HOST_INTERACTIONS,-2.378057003,0.954820519,rosiglitazone
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.327718534,0.780008098,rosiglitazone
NONSENSE_MEDIATED_DECAY_NMD,-2.299696618,0.655423471,rosiglitazone
EUKARYOTIC_TRANSLATION_ELONGATION,-2.278193307,0.564886817,rosiglitazone
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.242150605,0.501169976,rosiglitazone
DNA_REPAIR,2.814064749,0,diazoxide
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,2.428321634,0.003836393,diazoxide
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.373489858,0.003836393,diazoxide
MRNA_SPLICING,2.345795734,0.002877294,diazoxide
METABOLISM_OF_RNA,2.342680328,0.002301836,diazoxide
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,2.240078582,0.006393988,diazoxide
TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION,2.031283812,0.026854748,diazoxide
NUCLEOTIDE_EXCISION_REPAIR,2.017013833,0.02589565,diazoxide
MHC_CLASS_II_ANTIGEN_PRESENTATION,1.991569418,0.028133546,diazoxide
POTASSIUM_CHANNELS,-2.081810799,0.076834121,diazoxide
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.926708814,0,dicoumarol
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.474676794,0.001040899,dicoumarol
NEURONAL_SYSTEM,2.519051097,0.003217651,dicoumarol
EUKARYOTIC_TRANSLATION_ELONGATION,-2.413865117,0.001561349,dicoumarol
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,-2.371956215,0.002081799,dicoumarol
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.340266194,0.003643147,dicoumarol
SARS_COV_1_HOST_INTERACTIONS,-2.325111238,0.003330878,dicoumarol
SELENOAMINO_ACID_METABOLISM,-2.311248169,0.003296181,dicoumarol
SIGNALING_BY_NOTCH,-2.287708611,0.004609697,dicoumarol
SIGNALING_BY_ROBO_RECEPTORS,-2.279710959,0.004553934,dicoumarol
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.548679657,0.001204456,methyldopa
POTASSIUM_CHANNELS,2.373279764,0.002710027,methyldopa
NEURONAL_SYSTEM,2.314102986,0.002408913,methyldopa
GPCR_LIGAND_BINDING,2.226382825,0.003011141,methyldopa
EUKARYOTIC_TRANSLATION_ELONGATION,-2.284708048,0.036002497,methyldopa
SARS_COV_1_HOST_INTERACTIONS,-2.256445623,0.025413527,methyldopa
SIGNALING_BY_GPCR,2.095103213,0.005420054,methyldopa
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.23960238,0.019413111,methyldopa
NONSENSE_MEDIATED_DECAY_NMD,-2.162953634,0.032296357,methyldopa
SELENOAMINO_ACID_METABOLISM,-2.146728574,0.029225556,methyldopa
EUKARYOTIC_TRANSLATION_ELONGATION,-3.200187374,0.029223906,etodolac
SELENOAMINO_ACID_METABOLISM,-3.078800705,0.028702051,etodolac
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-3.077042776,0.019134701,etodolac
NONSENSE_MEDIATED_DECAY_NMD,-3.039062522,0.018264941,etodolac
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.146306234,0.03588021,etodolac
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.078419483,0.029391236,etodolac
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.997440287,0.018786797,etodolac
CELLULAR_RESPONSE_TO_STARVATION,-2.975070376,0.0238314,etodolac
RRNA_PROCESSING,-2.953231665,0.031311328,etodolac
INFLUENZA_INFECTION,-2.949433947,0.030006689,etodolac
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.47668956,0,tolfenamic-acid
EUKARYOTIC_TRANSLATION_ELONGATION,-2.446470114,0.001034676,tolfenamic-acid
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.412593722,0.001379568,tolfenamic-acid
SARS_COV_1_HOST_INTERACTIONS,-2.324380768,0.004397374,tolfenamic-acid
SELENOAMINO_ACID_METABOLISM,-2.322890569,0.0035179,tolfenamic-acid
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.3204941,0.002931583,tolfenamic-acid
NONSENSE_MEDIATED_DECAY_NMD,-2.277755484,0.003399651,tolfenamic-acid
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.244530021,0.00426804,tolfenamic-acid
SIGNALING_BY_ROBO_RECEPTORS,-2.237271127,0.004253669,tolfenamic-acid
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.192670137,0.00610459,tolfenamic-acid
EUKARYOTIC_TRANSLATION_INITIATION,-2.857069542,0,ponatinib
INFLUENZA_INFECTION,-2.828315595,0,ponatinib
SELENOAMINO_ACID_METABOLISM,-2.769168943,0,ponatinib
GPCR_LIGAND_BINDING,2.42851735,0,ponatinib
NONSENSE_MEDIATED_DECAY_NMD,-2.747011741,0.00157373,ponatinib
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.709353522,0.00314746,ponatinib
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.674725383,0.002622883,ponatinib
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.667690151,0.002248186,ponatinib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.312374661,0.001440144,ponatinib
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.638754447,0.002754027,ponatinib
EUKARYOTIC_TRANSLATION_ELONGATION,-2.613748806,0,probenecid
SELENOAMINO_ACID_METABOLISM,-2.556303316,0,probenecid
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.531203497,0.000319279,probenecid
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.495990378,0.000239459,probenecid
NONSENSE_MEDIATED_DECAY_NMD,-2.488135449,0.000383135,probenecid
CELLULAR_RESPONSE_TO_STARVATION,-2.462791897,0.000798198,probenecid
EUKARYOTIC_TRANSLATION_INITIATION,-2.43746818,0.000957837,probenecid
RRNA_PROCESSING,-2.376264533,0.001676215,probenecid
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.356013831,0.001809248,probenecid
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.328469782,0.002490377,probenecid
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.34116448,0.009165853,glycopyrrolate
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.132727237,0.050895707,glycopyrrolate
EUKARYOTIC_TRANSLATION_ELONGATION,-2.125476356,0.058050404,glycopyrrolate
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,-2.122210641,0.04039765,glycopyrrolate
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.058147596,0.062378724,glycopyrrolate
EUKARYOTIC_TRANSLATION_INITIATION,-2.034129812,0.061920431,glycopyrrolate
NONSENSE_MEDIATED_DECAY_NMD,-2.026289878,0.055674072,glycopyrrolate
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.018137182,0.051066897,glycopyrrolate
SELENOAMINO_ACID_METABOLISM,-2.01561661,0.046465784,glycopyrrolate
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.007130272,0.044810839,glycopyrrolate
EUKARYOTIC_TRANSLATION_ELONGATION,-2.824862613,0,bupropion
SELENOAMINO_ACID_METABOLISM,-2.780166809,0,bupropion
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.769381469,0,bupropion
CELLULAR_RESPONSE_TO_STARVATION,-2.760501959,0,bupropion
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.745695236,0,bupropion
EUKARYOTIC_TRANSLATION_INITIATION,-2.642347525,0,bupropion
NONSENSE_MEDIATED_DECAY_NMD,-2.633505546,0,bupropion
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.587810881,0.000430776,bupropion
INFLUENZA_INFECTION,-2.523773899,0.001914559,bupropion
REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE,2.110024832,0.068243194,bupropion
SENSORY_PERCEPTION,-2.47530816,0.002908245,phenytoin
RRNA_PROCESSING,2.56660089,0.006862371,phenytoin
METABOLISM_OF_RNA,2.395795816,0.012866946,phenytoin
KERATINIZATION,-2.254610318,0.007997673,phenytoin
GPCR_LIGAND_BINDING,-2.242430604,0.007270612,phenytoin
FORMATION_OF_THE_CORNIFIED_ENVELOPE,-2.204232605,0.007815908,phenytoin
SELENOAMINO_ACID_METABOLISM,2.203716391,0.038886771,phenytoin
MITOCHONDRIAL_BIOGENESIS,2.14815802,0.042032024,phenytoin
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.124937423,0.038429279,phenytoin
TRANSLATION,2.085580703,0.042317957,phenytoin
EUKARYOTIC_TRANSLATION_ELONGATION,-2.77136117,0,labetalol
CELLULAR_RESPONSE_TO_STARVATION,-2.588837347,0,labetalol
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.624535831,0,labetalol
NONSENSE_MEDIATED_DECAY_NMD,-2.636342823,0,labetalol
EUKARYOTIC_TRANSLATION_INITIATION,-2.659211306,0,labetalol
SARS_COV_1_HOST_INTERACTIONS,-2.573737976,0,labetalol
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.711240205,0,labetalol
SELENOAMINO_ACID_METABOLISM,-2.736856257,0,labetalol
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.749893104,0,labetalol
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.675652468,0,labetalol
NEURONAL_SYSTEM,-2.879932932,0,fluphenazine
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,-2.583897284,0,fluphenazine
GPCR_LIGAND_BINDING,-2.526567897,0,fluphenazine
RESPIRATORY_ELECTRON_TRANSPORT,2.483790058,0.003264461,fluphenazine
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,-2.417637714,0.001189846,fluphenazine
SIGNALING_BY_GPCR,-2.33815367,0.002284504,fluphenazine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.272511699,0.013057843,fluphenazine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.242730692,0.006663136,fluphenazine
ECM_PROTEOGLYCANS,-2.157673597,0.010742607,fluphenazine
TP53_REGULATES_METABOLIC_GENES,2.089188883,0.044251578,fluphenazine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.790879495,0.314063109,celecoxib
G2_M_DNA_DAMAGE_CHECKPOINT,1.51322331,0.692520452,celecoxib
SIGNALING_BY_NTRKS,1.326364976,1,celecoxib
MRNA_SPLICING,1.313986585,0.867062719,celecoxib
METABOLISM_OF_NUCLEOTIDES,1.25494099,0.89700039,celecoxib
SIGNALING_BY_ROBO_RECEPTORS,1.229142464,0.828087261,celecoxib
CHROMATIN_ORGANIZATION,-1.771290045,1,celecoxib
PROCESSING_OF_DNA_DOUBLE_STRAND_BREAK_ENDS,1.18494195,0.868918693,celecoxib
CELL_JUNCTION_ORGANIZATION,-1.727613168,1,celecoxib
HOMOLOGY_DIRECTED_REPAIR,1.159019502,0.852658746,celecoxib
EUKARYOTIC_TRANSLATION_ELONGATION,-2.451882195,0.00916587,riociguat
NONSENSE_MEDIATED_DECAY_NMD,-2.246320218,0.074345386,riociguat
EUKARYOTIC_TRANSLATION_INITIATION,-2.22496462,0.061105797,riociguat
SELENOAMINO_ACID_METABOLISM,-2.224830465,0.045829348,riociguat
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.184126347,0.057235763,riociguat
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.178109788,0.051091236,riociguat
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.147608081,0.059796387,riociguat
INFLUENZA_INFECTION,-2.065350836,0.102861424,riociguat
CELLULAR_RESPONSE_TO_STARVATION,-2.060182568,0.095506097,riociguat
SIGNALING_BY_ROBO_RECEPTORS,-2.002629404,0.126488999,riociguat
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.700353637,0,epinephrine
SELENOAMINO_ACID_METABOLISM,-2.691295064,0,epinephrine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.673789702,0,epinephrine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.599647307,0,epinephrine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.564240293,0,epinephrine
NONSENSE_MEDIATED_DECAY_NMD,-2.513092608,0,epinephrine
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.511501228,0,epinephrine
EUKARYOTIC_TRANSLATION_INITIATION,-2.484631254,0.000238508,epinephrine
INFLUENZA_INFECTION,-2.475350923,0.000212007,epinephrine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.321926308,0.000477016,epinephrine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.333971256,0.005979028,radezolid
NONSENSE_MEDIATED_DECAY_NMD,-2.155964005,0.04833048,radezolid
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.131557418,0.042185367,radezolid
EUKARYOTIC_TRANSLATION_INITIATION,-2.122892268,0.035375918,radezolid
SELENOAMINO_ACID_METABOLISM,-2.08629303,0.0420525,radezolid
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.077721347,0.037701096,radezolid
INFLUENZA_INFECTION,-2.063865272,0.038009538,radezolid
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.054286587,0.037742617,radezolid
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.032922955,0.041521031,radezolid
RRNA_PROCESSING,-2.008235823,0.046736072,radezolid
GPCR_LIGAND_BINDING,-2.953162337,0,benzylpenicillin
NEURONAL_SYSTEM,-2.753471964,0.00043914,benzylpenicillin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.724346009,0.00029276,benzylpenicillin
SIGNALING_BY_GPCR,-2.712198067,0.00021957,benzylpenicillin
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,-2.459106018,0.001229592,benzylpenicillin
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,-2.279293545,0.003220361,benzylpenicillin
RESPIRATORY_ELECTRON_TRANSPORT,2.174128089,0.064857124,benzylpenicillin
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.119682998,0.016059982,benzylpenicillin
G_ALPHA_I_SIGNALLING_EVENTS,-2.109768028,0.015150335,benzylpenicillin
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.036845998,0.097285686,benzylpenicillin
MRNA_SPLICING,2.566896887,0.004264632,diacerein
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.331279802,0.006396947,diacerein
NEUTROPHIL_DEGRANULATION,-2.321952078,0.013919409,diacerein
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.256859969,0.014789372,diacerein
METABOLISM_OF_RNA,2.069475163,0.024877018,diacerein
RAB_REGULATION_OF_TRAFFICKING,1.991354367,0.0303855,diacerein
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,1.817033723,0.072498737,diacerein
SENSORY_PERCEPTION,-2.065902376,0.065247231,diacerein
DNA_REPAIR,1.732319772,0.099508071,diacerein
MHC_CLASS_II_ANTIGEN_PRESENTATION,1.667461971,0.118495836,diacerein
METABOLISM_OF_RNA,-3.275859431,0,linifanib
HOST_INTERACTIONS_OF_HIV_FACTORS,-2.444495322,0.004151592,linifanib
PROTEIN_LOCALIZATION,-2.434750837,0.002767728,linifanib
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,-2.41401862,0.002075796,linifanib
CELL_CYCLE_CHECKPOINTS,-2.393379693,0.002490955,linifanib
M_PHASE,-2.331992002,0.002075796,linifanib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.255892398,0.004169083,linifanib
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.255368077,0.004151592,linifanib
TRANSLATION,-2.187257779,0.007784236,linifanib
GPCR_LIGAND_BINDING,2.16766747,0.006253625,linifanib
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.940053226,0,avanafil
RRNA_PROCESSING,-2.44055305,0,avanafil
TRANSLATION,-2.499500053,0,avanafil
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.544827399,0,avanafil
CELLULAR_RESPONSE_TO_STARVATION,-2.55118524,0,avanafil
INFLUENZA_INFECTION,-2.663977542,0,avanafil
EUKARYOTIC_TRANSLATION_INITIATION,-2.723971188,0,avanafil
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.588449692,0,avanafil
NONSENSE_MEDIATED_DECAY_NMD,-2.841891285,0,avanafil
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.86549691,0,avanafil
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.484472695,0,moclobemide
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.468531718,0.00029938,moclobemide
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.45787602,0.000199586,moclobemide
SELENOAMINO_ACID_METABOLISM,-2.44382218,0.00014969,moclobemide
EUKARYOTIC_TRANSLATION_ELONGATION,-2.439601636,0.000119752,moclobemide
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.41332874,9.98E-05,moclobemide
MITOTIC_METAPHASE_AND_ANAPHASE,2.500453727,0.016995963,moclobemide
M_PHASE,2.381311304,0.021244954,moclobemide
CELLULAR_RESPONSE_TO_STARVATION,-2.382900912,0.000256611,moclobemide
SARS_COV_1_HOST_INTERACTIONS,-2.358641116,0.00029938,moclobemide
RESPIRATORY_ELECTRON_TRANSPORT,2.638331123,0,lisinopril
DOWNSTREAM_TCR_SIGNALING,2.602729127,0,lisinopril
TRANSLATION,2.441277003,0.000847612,lisinopril
MITOCHONDRIAL_PROTEIN_DEGRADATION,2.16830229,0.013985604,lisinopril
DNA_REPAIR,2.113777122,0.015257022,lisinopril
TCR_SIGNALING,1.9280234,0.054670996,lisinopril
NEDDYLATION,1.890433679,0.062481138,lisinopril
UB_SPECIFIC_PROCESSING_PROTEASES,1.717294995,0.143670292,lisinopril
MHC_CLASS_II_ANTIGEN_PRESENTATION,1.680521658,0.154830521,lisinopril
G2_M_CHECKPOINTS,1.667603648,0.149773101,lisinopril
LATE_SARS_COV_2_INFECTION_EVENTS,-3.000666642,1,BRD-K63750851
SARS_COV_2_INFECTION,-2.989298671,1,BRD-K63750851
ION_CHANNEL_TRANSPORT,-2.987728041,1,BRD-K63750851
SARS_COV_INFECTIONS,-2.840375257,1,BRD-K63750851
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.8343937,0.834925132,BRD-K63750851
EUKARYOTIC_TRANSLATION_ELONGATION,-2.671349187,0.762531822,BRD-K63750851
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.65986159,0.65729055,BRD-K63750851
SELENOAMINO_ACID_METABOLISM,-2.641781828,0.581341472,BRD-K63750851
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.636050762,0.518294133,BRD-K63750851
SARS_COV_1_HOST_INTERACTIONS,-2.601597949,0.474316992,BRD-K63750851
GPCR_LIGAND_BINDING,3.03465446,0,vicriviroc
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.839045277,0.000307357,vicriviroc
EUKARYOTIC_TRANSLATION_ELONGATION,-2.501396247,0.001050103,vicriviroc
SELENOAMINO_ACID_METABOLISM,-2.34225333,0.002625258,vicriviroc
NONSENSE_MEDIATED_DECAY_NMD,-2.325446599,0.001750172,vicriviroc
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.284177281,0.002362733,vicriviroc
CELLULAR_RESPONSE_TO_STARVATION,-2.260873846,0.002940289,vicriviroc
EUKARYOTIC_TRANSLATION_INITIATION,-2.25777808,0.002625258,vicriviroc
SIGNALING_BY_GPCR,2.401302619,0.002458856,vicriviroc
NEURONAL_SYSTEM,2.329444616,0.003841963,vicriviroc
EUKARYOTIC_TRANSLATION_ELONGATION,-2.815634998,0,orlistat
SARS_COV_1_HOST_INTERACTIONS,-2.347360373,0,orlistat
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.431444787,0,orlistat
RRNA_PROCESSING,-2.477879548,0,orlistat
EUKARYOTIC_TRANSLATION_INITIATION,-2.490413152,0,orlistat
INFLUENZA_INFECTION,-2.586455872,0,orlistat
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.487024284,0,orlistat
NONSENSE_MEDIATED_DECAY_NMD,-2.644096261,0,orlistat
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.656208914,0,orlistat
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.663519849,0,orlistat
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.437448543,0,amiloride
ECM_PROTEOGLYCANS,-1.980269159,0.16399933,amiloride
EUKARYOTIC_TRANSLATION_INITIATION,-1.971371123,0.120097971,amiloride
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-1.935458987,0.130190237,amiloride
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-1.868088684,0.192560444,amiloride
NONSENSE_MEDIATED_DECAY_NMD,-1.867461625,0.16097165,amiloride
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-1.854999766,0.154555852,amiloride
EUKARYOTIC_TRANSLATION_ELONGATION,-1.847429582,0.144193257,amiloride
SELENOAMINO_ACID_METABOLISM,-1.840413574,0.135348507,amiloride
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.825095914,0.138970509,amiloride
NEURONAL_SYSTEM,2.025894627,0.084951516,VX-809
EUKARYOTIC_TRANSLATION_ELONGATION,-2.053245243,0.248800475,VX-809
RRNA_PROCESSING,-1.989224089,0.235091062,VX-809
EXTRACELLULAR_MATRIX_ORGANIZATION,1.756075984,0.247172761,VX-809
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-1.977451239,0.173652577,VX-809
CELLULAR_RESPONSE_TO_STARVATION,-1.929979921,0.198278746,VX-809
DRUG_ADME,1.65546963,0.283472965,VX-809
SELENOAMINO_ACID_METABOLISM,-1.914643998,0.182589084,VX-809
EUKARYOTIC_TRANSLATION_INITIATION,-1.86856491,0.231029013,VX-809
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-1.855312239,0.217174526,VX-809
MRNA_SPLICING,3.034410712,0,lofexidine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.922112283,0,lofexidine
METABOLISM_OF_RNA,2.475599073,0.002532996,lofexidine
INFLUENZA_INFECTION,2.131226134,0.029446074,lofexidine
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,2.090152066,0.027356352,lofexidine
FORMATION_OF_THE_CORNIFIED_ENVELOPE,1.908696984,0.053192908,lofexidine
REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION,1.843322058,0.07056202,lofexidine
HIV_LIFE_CYCLE,1.809390544,0.073615185,lofexidine
KERATINIZATION,1.796615726,0.071346043,lofexidine
HIV_INFECTION,1.787691784,0.066491135,lofexidine
NEURONAL_SYSTEM,2.250349109,0.026130097,terbinafine
MUSCLE_CONTRACTION,2.138905224,0.023517087,terbinafine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.227867772,0.245994599,terbinafine
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.839946573,0.085607174,terbinafine
SELENOAMINO_ACID_METABOLISM,-2.077690128,0.402868274,terbinafine
NONSENSE_MEDIATED_DECAY_NMD,-2.045118917,0.342585699,terbinafine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.014130304,0.321043799,terbinafine
RRNA_PROCESSING,-1.986665086,0.308744069,terbinafine
EUKARYOTIC_TRANSLATION_INITIATION,-1.963880202,0.301065424,terbinafine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-1.949370948,0.286348435,terbinafine
INFLUENZA_INFECTION,-2.855155438,0,sorafenib
METABOLISM_OF_RNA,-2.783072736,0,sorafenib
PROTEIN_LOCALIZATION,-2.573772781,0.000835708,sorafenib
TRANSLATION,-1.750371672,0.14980057,sorafenib
G_ALPHA_Q_SIGNALLING_EVENTS,1.952557692,0.203037306,sorafenib
GPCR_LIGAND_BINDING,1.930736653,0.122152526,sorafenib
SIGNALING_BY_GPCR,1.910442969,0.098217233,sorafenib
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,-1.672065148,0.192045584,sorafenib
NEURONAL_SYSTEM,1.901991773,0.078202377,sorafenib
EXTRA_NUCLEAR_ESTROGEN_SIGNALING,1.896827389,0.06569825,sorafenib
EUKARYOTIC_TRANSLATION_ELONGATION,-2.356561315,0,fluticasone-propionate
SELENOAMINO_ACID_METABOLISM,-2.344161094,0.000466444,fluticasone-propionate
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.336784231,0.000310963,fluticasone-propionate
NONSENSE_MEDIATED_DECAY_NMD,-2.30147245,0.000466444,fluticasone-propionate
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.278198618,0.00074631,fluticasone-propionate
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.253687536,0.000621925,fluticasone-propionate
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.237825622,0.001199427,fluticasone-propionate
EUKARYOTIC_TRANSLATION_INITIATION,-2.21997714,0.001049499,fluticasone-propionate
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.180240058,0.001762121,fluticasone-propionate
SIGNALING_BY_ROBO_RECEPTORS,-2.122411467,0.003171818,fluticasone-propionate
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.471912276,0.000806868,amoxapine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.904107551,0.262058488,amoxapine
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.105498064,0.054463565,amoxapine
METABOLISM_OF_RNA,1.839749342,0.175180403,amoxapine
MITOTIC_PROMETAPHASE,1.819798891,0.130079757,amoxapine
MITOTIC_METAPHASE_AND_ANAPHASE,1.776457262,0.131029244,amoxapine
SUMOYLATION,1.738166609,0.128180782,amoxapine
RHO_GTPASES_ACTIVATE_FORMINS,1.574990115,0.257785796,amoxapine
SEPARATION_OF_SISTER_CHROMATIDS,1.549729605,0.24659541,amoxapine
GPCR_LIGAND_BINDING,-1.906529194,0.205213335,amoxapine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.435854598,0.001006928,reserpine
NONSENSE_MEDIATED_DECAY_NMD,-2.419868465,0.000503464,reserpine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.389888237,0.000335643,reserpine
SARS_COV_1_HOST_INTERACTIONS,-2.378726492,0.000251732,reserpine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.339903066,0.000402771,reserpine
SELENOAMINO_ACID_METABOLISM,-2.322805779,0.000335643,reserpine
EUKARYOTIC_TRANSLATION_INITIATION,-2.316225878,0.00043154,reserpine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.298313109,0.000377598,reserpine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.29318227,0.000447523,reserpine
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.260442664,0.000587375,reserpine
GPCR_LIGAND_BINDING,2.353269302,0.00569471,A-443654
SIGNALING_BY_GPCR,2.338877535,0.003660885,A-443654
HIV_INFECTION,-2.344535302,0.028107584,A-443654
PROTEIN_LOCALIZATION,-2.315124751,0.016688878,A-443654
G_ALPHA_Q_SIGNALLING_EVENTS,2.183912501,0.00894883,A-443654
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.182497325,0.006915005,A-443654
METABOLISM_OF_RNA,-2.091517529,0.042746951,A-443654
SENSORY_PERCEPTION,2.08804321,0.01301648,A-443654
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,-1.985068557,0.063681245,A-443654
AMINE_LIGAND_BINDING_RECEPTORS,1.986792273,0.032405611,A-443654
EUKARYOTIC_TRANSLATION_ELONGATION,-2.416837134,0.07263413,tolbutamide
NONSENSE_MEDIATED_DECAY_NMD,-2.296771184,0.066408347,tolbutamide
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.266899838,0.051189768,tolbutamide
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.242038468,0.043839886,tolbutamide
EUKARYOTIC_TRANSLATION_INITIATION,-2.185893634,0.048561104,tolbutamide
LEISHMANIA_INFECTION,1.984199639,0.087528467,tolbutamide
SELENOAMINO_ACID_METABOLISM,-2.166735288,0.046693369,tolbutamide
INFLUENZA_INFECTION,-2.157470114,0.042542848,tolbutamide
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.092355789,0.063684568,tolbutamide
SARS_COV_1_HOST_INTERACTIONS,-2.087086969,0.05995198,tolbutamide
INNATE_IMMUNE_SYSTEM,1.818594936,0.169635284,minaprine
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.025893552,0.174183667,minaprine
INTEGRIN_CELL_SURFACE_INTERACTIONS,-1.940950225,0.186833877,minaprine
CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,-1.909790541,0.168669473,minaprine
SLC_TRANSPORTER_DISORDERS,1.543729353,0.401252691,minaprine
SIGNALING_BY_NOTCH,-1.750902526,0.455894123,minaprine
CLATHRIN_MEDIATED_ENDOCYTOSIS,-1.746813696,0.378143983,minaprine
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,1.284090453,0.906896327,minaprine
EPH_EPHRIN_SIGNALING,-1.707493887,0.420700589,minaprine
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,-1.68668295,0.411896413,minaprine
NEUTROPHIL_DEGRANULATION,1.903380587,0.14435364,pimozide
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.744833551,0.202526003,pimozide
EXTRACELLULAR_MATRIX_ORGANIZATION,-3.109786019,0.230988667,pimozide
CELLULAR_RESPONSE_TO_STARVATION,1.582774593,0.31312531,pimozide
INTEGRIN_CELL_SURFACE_INTERACTIONS,-3.023180419,0.416588511,pimozide
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.513174581,0.340954681,pimozide
ECM_PROTEOGLYCANS,-3.008206784,0.305887717,pimozide
MRNA_SPLICING,1.438367618,0.386953938,pimozide
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,1.402006479,0.386379396,pimozide
FORMATION_OF_THE_CORNIFIED_ENVELOPE,1.356970316,0.401974103,pimozide
PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,2.400513368,0.015312836,aripiprazole
EUKARYOTIC_TRANSLATION_ELONGATION,-2.347386218,0.017163586,aripiprazole
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.337729397,0.011006101,aripiprazole
NEURONAL_SYSTEM,2.299972231,0.009570523,aripiprazole
NONSENSE_MEDIATED_DECAY_NMD,-2.289249135,0.019182831,aripiprazole
SIGNALING_BY_GPCR,2.144970572,0.017705467,aripiprazole
GPCR_LIGAND_BINDING,2.134642567,0.014930016,aripiprazole
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.23258291,0.021538617,aripiprazole
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.217854321,0.019435237,aripiprazole
INFLUENZA_INFECTION,-2.204855905,0.018173208,aripiprazole
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.494830329,0.002006074,cabergoline
EUKARYOTIC_TRANSLATION_ELONGATION,-2.272963086,0.066231987,cabergoline
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.13898828,0.142078296,cabergoline
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.135725441,0.095431036,cabergoline
NONSENSE_MEDIATED_DECAY_NMD,-2.123885149,0.079051082,cabergoline
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.065188549,0.105543877,cabergoline
SIGNALING_BY_ROBO_RECEPTORS,-2.036660123,0.110742732,cabergoline
SELENOAMINO_ACID_METABOLISM,-2.030338414,0.099500589,cabergoline
NEURONAL_SYSTEM,1.70194796,0.171519322,cabergoline
EUKARYOTIC_TRANSLATION_INITIATION,-1.986718823,0.122849654,cabergoline
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.377215743,0,ifosfamide
EUKARYOTIC_TRANSLATION_ELONGATION,-2.375430933,0,ifosfamide
SELENOAMINO_ACID_METABOLISM,-2.333215956,0.000314338,ifosfamide
HCMV_INFECTION,2.264448889,0.008979103,ifosfamide
NONSENSE_MEDIATED_DECAY_NMD,-2.18521152,0.003300549,ifosfamide
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.168429804,0.003772056,ifosfamide
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.108151148,0.007386942,ifosfamide
INFLUENZA_INFECTION,-2.080211233,0.009295423,ifosfamide
MITOTIC_PROMETAPHASE,1.828887377,0.116728341,ifosfamide
RRNA_PROCESSING,-2.004151608,0.02168932,ifosfamide
SENSORY_PERCEPTION,-2.462008527,0,rasagiline
GPCR_LIGAND_BINDING,-2.2602597,0.003409888,rasagiline
KERATINIZATION,-2.122663815,0.016481123,rasagiline
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-2.041885456,0.031328342,rasagiline
FORMATION_OF_THE_CORNIFIED_ENVELOPE,-2.03019953,0.027620089,rasagiline
SIGNALING_BY_GPCR,-2.011843869,0.027705336,rasagiline
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.996169905,0.284455177,rasagiline
METABOLISM_OF_RNA,1.98731536,0.151403562,rasagiline
TRANSPORT_OF_SMALL_MOLECULES,-1.992069545,0.029105826,rasagiline
NEURONAL_SYSTEM,-1.955850457,0.038467794,rasagiline
MRNA_SPLICING,3.136594499,0,zofenopril-calcium
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,3.033208919,0,zofenopril-calcium
PROTEIN_LOCALIZATION,2.295049546,0.004548892,zofenopril-calcium
INFLUENZA_INFECTION,2.153255275,0.013159294,zofenopril-calcium
TCR_SIGNALING,2.082704898,0.019885155,zofenopril-calcium
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,-2.015025591,0.149823516,zofenopril-calcium
METABOLISM_OF_RNA,1.803485338,0.084479418,zofenopril-calcium
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.752356381,0.098311762,zofenopril-calcium
FATTY_ACID_METABOLISM,1.708351636,0.11648412,zofenopril-calcium
GPCR_LIGAND_BINDING,-1.861615395,0.306722032,zofenopril-calcium
REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION,1.989233896,0.133658197,ketanserin
AURKA_ACTIVATION_BY_TPX2,1.784967336,0.247824574,ketanserin
NUCLEOTIDE_EXCISION_REPAIR,1.73942413,0.217813358,ketanserin
RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES,1.696312337,0.212553661,ketanserin
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.455537747,0.622995707,ketanserin
CELLULAR_RESPONSES_TO_MECHANICAL_STIMULI,1.436279899,0.564025216,ketanserin
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,1.380966211,0.62798137,ketanserin
RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES,1.370218092,0.576400975,ketanserin
HIGH_LAMINAR_FLOW_SHEAR_STRESS_ACTIVATES_SIGNALING_BY_PIEZO1_AND_PECAM1_CDH5_KDR_IN_ENDOTHELIAL_CELLS,1.291673838,0.739451599,ketanserin
G_ALPHA_Q_SIGNALLING_EVENTS,-1.705931003,1,ketanserin
GPCR_LIGAND_BINDING,-2.838294961,0,lorcaserin
SIGNALING_BY_GPCR,-2.727724212,0,lorcaserin
RESPIRATORY_ELECTRON_TRANSPORT,2.720362243,0,lorcaserin
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.646000748,0,lorcaserin
NEURONAL_SYSTEM,-2.620351998,0,lorcaserin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.606175009,0,lorcaserin
METABOLISM_OF_RNA,2.538507152,0.001294305,lorcaserin
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.528249422,0.000970729,lorcaserin
MRNA_SPLICING,2.241386437,0.009577857,lorcaserin
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.224715015,0.007567099,lorcaserin
RESPIRATORY_ELECTRON_TRANSPORT,3.494331685,0,acetazolamide
TRANSLATION,3.290382119,0,acetazolamide
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,3.156949533,0,acetazolamide
CELLULAR_RESPONSE_TO_STARVATION,3.118113758,0,acetazolamide
METABOLISM_OF_RNA,2.866099979,0,acetazolamide
MITOCHONDRIAL_PROTEIN_IMPORT,2.75228712,0.000387225,acetazolamide
MITOCHONDRIAL_TRANSLATION,2.665217789,0.000331907,acetazolamide
RRNA_PROCESSING,2.53326878,0.000871256,acetazolamide
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,-2.489698142,0.00207744,acetazolamide
GPCR_LIGAND_BINDING,-2.442199617,0.00103872,acetazolamide
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-3.003752648,0.217226053,eflornithine
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.978737371,0.165848937,eflornithine
MHC_CLASS_II_ANTIGEN_PRESENTATION,1.631171918,1,eflornithine
ESTROGEN_DEPENDENT_GENE_EXPRESSION,1.561580084,0.759622539,eflornithine
DISEASES_OF_METABOLISM,-2.9298367,0.267401365,eflornithine
RNA_POLYMERASE_II_TRANSCRIBES_SNRNA_GENES,1.510900911,0.64574173,eflornithine
HCMV_EARLY_EVENTS,1.352251699,1,eflornithine
COPI_MEDIATED_ANTEROGRADE_TRANSPORT,1.345491485,0.850476899,eflornithine
METABOLISM_OF_STEROIDS,1.324566054,0.766714018,eflornithine
HIV_LIFE_CYCLE,1.278760552,0.796629333,eflornithine
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.823725335,0.115503879,diosmin
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,1.595002259,0.41966098,diosmin
UNFOLDED_PROTEIN_RESPONSE_UPR,1.47704776,0.420895277,diosmin
DISEASES_OF_METABOLISM,-2.672960419,1,diosmin
MITF_M_DEPENDENT_GENE_EXPRESSION,1.378791785,0.463821384,diosmin
NEUTROPHIL_DEGRANULATION,1.367663942,0.364117615,diosmin
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.532312852,1,diosmin
SELENOAMINO_ACID_METABOLISM,-1.935311762,1,diosmin
EUKARYOTIC_TRANSLATION_INITIATION,-1.896745145,1,diosmin
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-1.858825325,1,diosmin
GPCR_LIGAND_BINDING,2.632559814,0.000976007,phenazone
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.426496472,0.001952013,phenazone
SIGNALING_BY_GPCR,2.298981478,0.003578691,phenazone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.291462383,0.00292802,phenazone
G_ALPHA_S_SIGNALLING_EVENTS,2.100087293,0.008784059,phenazone
EUKARYOTIC_TRANSLATION_ELONGATION,-2.141911748,0.103336223,phenazone
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.11623592,0.069726869,phenazone
SIGNALING_BY_ROBO_RECEPTORS,-2.048033987,0.092969158,phenazone
SELENOAMINO_ACID_METABOLISM,-1.999363983,0.112365601,phenazone
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-1.982877259,0.10313557,phenazone
EUKARYOTIC_TRANSLATION_ELONGATION,-2.87397015,0,pramipexole
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.815720506,0,pramipexole
SELENOAMINO_ACID_METABOLISM,-2.810308196,0,pramipexole
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.806055992,0,pramipexole
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.799863049,0,pramipexole
NONSENSE_MEDIATED_DECAY_NMD,-2.683857898,0,pramipexole
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.667245242,0,pramipexole
EUKARYOTIC_TRANSLATION_INITIATION,-2.636031511,0,pramipexole
CELLULAR_RESPONSE_TO_STARVATION,-2.626511268,0,pramipexole
SARS_COV_1_HOST_INTERACTIONS,-2.598159542,0,pramipexole
NUCLEAR_ENVELOPE_NE_REASSEMBLY,2.083502943,0.148826329,dronedarone
HCMV_INFECTION,2.06054304,0.099217553,dronedarone
SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS,2.038653059,0.069452287,dronedarone
SUMOYLATION_OF_DNA_REPLICATION_PROTEINS,2.023433202,0.054569654,dronedarone
HCMV_EARLY_EVENTS,1.976856233,0.065483585,dronedarone
GLUCOSE_METABOLISM,1.862080577,0.117407437,dronedarone
RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES,1.857593807,0.106304521,dronedarone
COPI_MEDIATED_ANTEROGRADE_TRANSPORT,1.855970625,0.095496894,dronedarone
MITOTIC_PROMETAPHASE,1.775202971,0.12016348,dronedarone
HIV_INFECTION,1.730263932,0.143865451,dronedarone
EXTRACELLULAR_MATRIX_ORGANIZATION,-3.217367389,0,vandetanib
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.890350195,0.001258286,vandetanib
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.306443291,0.013063347,vandetanib
COLLAGEN_FORMATION,-2.547739902,0.011324574,vandetanib
NONSENSE_MEDIATED_DECAY_NMD,2.250144012,0.012294914,vandetanib
CELLULAR_RESPONSE_TO_STARVATION,2.182838745,0.017930084,vandetanib
ECM_PROTEOGLYCANS,-2.463233434,0.020761719,vandetanib
SELENOAMINO_ACID_METABOLISM,2.153413894,0.018058156,vandetanib
EUKARYOTIC_TRANSLATION_ELONGATION,2.148666043,0.01506127,vandetanib
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.071838872,0.023949469,vandetanib
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.103467744,0.136228033,tamsulosin
GASTRULATION,-1.990362675,0.207900244,tamsulosin
MAPK_FAMILY_SIGNALING_CASCADES,-1.959497179,0.189092643,tamsulosin
SIGNALING_BY_ROBO_RECEPTORS,-1.954866756,0.147919245,tamsulosin
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,1.67331673,0.414403916,tamsulosin
HCMV_EARLY_EVENTS,1.657906211,0.221069805,tamsulosin
FORMATION_OF_PARAXIAL_MESODERM,-1.934592951,0.144767701,tamsulosin
NONSENSE_MEDIATED_DECAY_NMD,-1.918978969,0.136736347,tamsulosin
MAPK1_MAPK3_SIGNALING,-1.905197313,0.135647103,tamsulosin
TRANSCRIPTIONAL_REGULATION_BY_RUNX3,-1.903419972,0.12072447,tamsulosin
REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE,2.238946842,0.049321101,nafamostat
SYNTHESIS_OF_DNA,2.144019442,0.057541284,nafamostat
NUCLEAR_EVENTS_MEDIATED_BY_NFE2L2,2.092628172,0.060281346,nafamostat
KEAP1_NFE2L2_PATHWAY,2.021764465,0.080146789,nafamostat
CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6,1.914323356,0.082201835,nafamostat
DEFECTIVE_CFTR_CAUSES_CYSTIC_FIBROSIS,1.92077787,0.109602446,nafamostat
S_PHASE,1.924740431,0.129878899,nafamostat
APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1,1.914323356,0.082201835,nafamostat
APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS,1.883630312,0.080557798,nafamostat
ACTIVATION_OF_APC_C_AND_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS,1.883630312,0.080557798,nafamostat
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.209113984,0.047599062,oxandrolone
GPCR_LIGAND_BINDING,-2.096736522,0.087264947,oxandrolone
SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,1.767169849,0.269380088,oxandrolone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.035126918,0.112056125,oxandrolone
RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_PATHWAY,1.700480873,0.183719474,oxandrolone
MITOCHONDRIAL_BIOGENESIS,1.418263325,0.465122104,oxandrolone
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.818242278,0.513673209,oxandrolone
RRNA_PROCESSING,-1.772514528,0.545009258,oxandrolone
OPIOID_SIGNALLING,1.291357093,0.631747026,oxandrolone
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-1.755709693,0.501938718,oxandrolone
RESPIRATORY_ELECTRON_TRANSPORT,2.885328347,0,curcumin
GPCR_LIGAND_BINDING,-2.7915178,0,curcumin
NEURONAL_SYSTEM,-2.663444272,0,curcumin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.564282305,0,curcumin
SIGNALING_BY_GPCR,-2.522255316,0,curcumin
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,-2.416060372,0.000173983,curcumin
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.35558389,0.005639952,curcumin
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.232940838,0.003106842,curcumin
NERVOUS_SYSTEM_DEVELOPMENT,-2.235154723,0.003624649,curcumin
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.195563163,0.004784537,curcumin
GPCR_LIGAND_BINDING,-2.5532025,0.001728061,venlafaxine
RESPIRATORY_ELECTRON_TRANSPORT,2.401266044,0.002531076,venlafaxine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.371137896,0.003163845,venlafaxine
MRNA_SPLICING,2.364617807,0.002531076,venlafaxine
NEURONAL_SYSTEM,-2.312688066,0.014256502,venlafaxine
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-2.214971434,0.023040811,venlafaxine
SIGNALING_BY_GPCR,-2.167263738,0.027216958,venlafaxine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.165742094,0.021946373,venlafaxine
METABOLISM_OF_RNA,2.05371616,0.039231678,venlafaxine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.016039877,0.044800045,venlafaxine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-1.956809816,1,phentermine
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,1.438438495,0.814991014,phentermine
INTEGRIN_CELL_SURFACE_INTERACTIONS,-1.85225123,1,phentermine
COMPLEX_I_BIOGENESIS,1.345238373,0.648694365,phentermine
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-1.788123197,1,phentermine
ESR_MEDIATED_SIGNALING,1.309566858,0.516527469,phentermine
ABC_TRANSPORTER_DISORDERS,-1.755128947,0.984509081,phentermine
RHO_GTPASE_EFFECTORS,1.259243418,0.495282271,phentermine
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-1.734629761,0.863972617,phentermine
GPCR_LIGAND_BINDING,-1.724675149,0.754440544,phentermine
NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY,2.279420775,0.020045939,fluspirilene
NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,2.091883015,0.037586135,fluspirilene
EUKARYOTIC_TRANSLATION_ELONGATION,-2.101704609,0.054029313,fluspirilene
HCMV_EARLY_EVENTS,1.967066256,0.055683163,fluspirilene
SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS,1.931562974,0.051367718,fluspirilene
NUCLEAR_ENVELOPE_BREAKDOWN,1.804960616,0.080183754,fluspirilene
SELENOAMINO_ACID_METABOLISM,-1.977718638,0.108058626,fluspirilene
NONSENSE_MEDIATED_DECAY_NMD,-1.977631278,0.072039084,fluspirilene
RHO_GTPASES_ACTIVATE_FORMINS,1.79457282,0.070717617,fluspirilene
HCMV_INFECTION,1.756492228,0.075410912,fluspirilene
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,4.846176114,0,D-serine
MRNA_SPLICING,2.630327688,0,D-serine
NEUTROPHIL_DEGRANULATION,2.660787977,0,D-serine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.864676208,0,D-serine
SIGNALING_BY_ROBO_RECEPTORS,2.908421393,0,D-serine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.944668275,0,D-serine
INFECTIOUS_DISEASE,2.96457608,0,D-serine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.330142535,0,D-serine
RESPIRATORY_ELECTRON_TRANSPORT,3.378511201,0,D-serine
VIRAL_INFECTION_PATHWAYS,3.411695166,0,D-serine
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.810628565,0.308876609,RAF-265
ECM_PROTEOGLYCANS,-2.761436699,0.4021413,RAF-265
PROTEIN_FOLDING,1.422733581,1,RAF-265
DISEASES_OF_METABOLISM,-2.664600576,0.967412237,RAF-265
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.585011927,1,RAF-265
SIGNALING_BY_VEGF,1.187659025,1,RAF-265
SIGNALING_BY_INSULIN_RECEPTOR,1.161524758,1,RAF-265
CELLULAR_RESPONSES_TO_MECHANICAL_STIMULI,1.126095766,1,RAF-265
ISG15_ANTIVIRAL_MECHANISM,1.119998265,0.959821479,RAF-265
SIGNALING_BY_FGFR,1.117095997,0.808975011,RAF-265
EUKARYOTIC_TRANSLATION_ELONGATION,-2.396922688,0.00307722,piribedil
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.342578774,0.00359009,piribedil
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.260903262,0.008889746,piribedil
SELENOAMINO_ACID_METABOLISM,-2.250621599,0.007693049,piribedil
SARS_COV_1_INFECTION,-2.147198709,0.017642726,piribedil
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.143775399,0.014873229,piribedil
RRNA_PROCESSING,-2.133618374,0.01406729,piribedil
EUKARYOTIC_TRANSLATION_INITIATION,-2.121398168,0.014745011,piribedil
SIGNALING_BY_ROBO_RECEPTORS,-2.121392624,0.013106677,piribedil
SARS_COV_1_HOST_INTERACTIONS,-2.110399135,0.011749384,piribedil
REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE,2.845631603,0,raclopride
NUCLEAR_ENVELOPE_NE_REASSEMBLY,2.330361033,0.006851312,raclopride
TRNA_PROCESSING,2.272480278,0.013702624,raclopride
HCMV_INFECTION,2.236145663,0.013702624,raclopride
SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS,2.171636559,0.030145773,raclopride
HCMV_EARLY_EVENTS,2.126633579,0.028547133,raclopride
MRNA_SPLICING,2.037046316,0.036214077,raclopride
CELLULAR_RESPONSE_TO_HEAT_STRESS,2.007903913,0.036825802,raclopride
DNA_REPLICATION,1.908521727,0.060139294,raclopride
GLUCOSE_METABOLISM,1.822128294,0.094548105,raclopride
EUKARYOTIC_TRANSLATION_ELONGATION,-2.510993013,0.00101825,otamixaban
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.405974906,0.001527374,otamixaban
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.371782005,0.001357666,otamixaban
SELENOAMINO_ACID_METABOLISM,-2.345288752,0.00101825,otamixaban
EUKARYOTIC_TRANSLATION_INITIATION,-2.339224181,0.0008146,otamixaban
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.284951902,0.002375916,otamixaban
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.282294954,0.002036499,otamixaban
INFLUENZA_INFECTION,-2.271716905,0.001781937,otamixaban
SIGNALING_BY_ROBO_RECEPTORS,-2.260590728,0.002036499,otamixaban
NONSENSE_MEDIATED_DECAY_NMD,-2.235232336,0.003156574,otamixaban
SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS,2.571459549,0.003461743,doxapram
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.127550321,0.130407868,doxapram
SUMOYLATION,1.909356566,0.116833836,doxapram
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.903935165,0.080197053,doxapram
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.7117303,0.163134653,doxapram
REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION,1.618621913,0.210127818,doxapram
RAB_REGULATION_OF_TRAFFICKING,1.586088008,0.213762649,doxapram
TRNA_PROCESSING,1.543277145,0.226249651,doxapram
GPCR_LIGAND_BINDING,-1.87451951,0.577779306,doxapram
RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS,1.437136711,0.339467202,doxapram
METABOLISM_OF_RNA,2.755576458,0,valdecoxib
GPCR_LIGAND_BINDING,-2.754551167,0,valdecoxib
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.718463464,0,valdecoxib
TRANSLATION,2.651780167,0,valdecoxib
NEURONAL_SYSTEM,-2.612972386,0,valdecoxib
ECM_PROTEOGLYCANS,-2.60683776,0,valdecoxib
RESPIRATORY_ELECTRON_TRANSPORT,2.551807405,0,valdecoxib
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.452672933,0.001753215,valdecoxib
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.329054021,0.003443282,valdecoxib
RRNA_PROCESSING,2.337270928,0.004304102,valdecoxib
MITOCHONDRIAL_PROTEIN_DEGRADATION,2.314385666,0.037398712,rilpivirine
S_PHASE,1.991293115,0.112196135,rilpivirine
NUCLEAR_ENVELOPE_NE_REASSEMBLY,1.892043924,0.159567837,rilpivirine
MITOTIC_METAPHASE_AND_ANAPHASE,1.794338206,0.216912529,rilpivirine
NEUTROPHIL_DEGRANULATION,1.7869407,0.182505714,rilpivirine
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,1.7308685,0.228132142,rilpivirine
MITOTIC_PROMETAPHASE,1.713171556,0.228666409,rilpivirine
MITOTIC_SPINDLE_CHECKPOINT,1.643709554,0.319758986,rilpivirine
REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE,1.610218566,0.349054644,rilpivirine
DNA_REPLICATION,1.606617796,0.31788905,rilpivirine
RESPIRATORY_ELECTRON_TRANSPORT,3.609235279,0,clonazepam
TRANSLATION,3.027806968,0,clonazepam
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.874414013,0,clonazepam
ECM_PROTEOGLYCANS,-2.525535707,0,clonazepam
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.411307523,0.001243983,clonazepam
NEURONAL_SYSTEM,-2.398047236,0.001105763,clonazepam
MITOCHONDRIAL_TRANSLATION,2.455160876,0.001631952,clonazepam
GPCR_LIGAND_BINDING,-2.335814633,0.001658644,clonazepam
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.314304468,0.001326915,clonazepam
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,-2.313573519,0.001105763,clonazepam
ION_CHANNEL_TRANSPORT,-2.941053049,1,mycophenolate-mofetil
SARS_COV_2_INFECTION,-2.86631322,1,mycophenolate-mofetil
SARS_COV_INFECTIONS,-2.609126191,1,mycophenolate-mofetil
TRANSPORT_OF_SMALL_MOLECULES,-2.500431156,0.847013177,mycophenolate-mofetil
TRANS_GOLGI_NETWORK_VESICLE_BUDDING,1.373266437,1,mycophenolate-mofetil
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-1.965875128,0.878544864,mycophenolate-mofetil
VIRAL_INFECTION_PATHWAYS,-1.911914916,0.772583919,mycophenolate-mofetil
LEISHMANIA_INFECTION,1.301998436,1,mycophenolate-mofetil
G_PROTEIN_MEDIATED_EVENTS,1.274941509,1,mycophenolate-mofetil
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-1.813621075,0.749626576,mycophenolate-mofetil
OPIOID_SIGNALLING,1.993622196,0.077165976,relcovaptan
METABOLISM_OF_NUCLEOTIDES,1.962994377,0.04614828,relcovaptan
METABOLISM_OF_VITAMINS_AND_COFACTORS,-3.187750618,0.258478095,relcovaptan
SENSORY_PERCEPTION,-3.090814723,0.549508881,relcovaptan
VISUAL_PHOTOTRANSDUCTION,-3.089421671,0.370226143,relcovaptan
ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION,1.437024127,0.540161831,relcovaptan
LEISHMANIA_INFECTION,1.43404,0.410795342,relcovaptan
METABOLISM_OF_STEROIDS,1.419896836,0.355871324,relcovaptan
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,1.381484791,0.350525185,relcovaptan
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.282796322,1,relcovaptan
SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS,1.916335703,0.275573123,BRD-A04553218
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-3.030866245,0.074891905,BRD-A04553218
SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS,1.86549219,0.209960474,BRD-A04553218
SUMOYLATION_OF_DNA_REPLICATION_PROTEINS,1.848040349,0.157470356,BRD-A04553218
REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE,1.846535858,0.119743083,BRD-A04553218
NUCLEAR_ENVELOPE_NE_REASSEMBLY,1.842005581,0.099731225,BRD-A04553218
HCMV_INFECTION,1.761199763,0.133412385,BRD-A04553218
NUCLEAR_ENVELOPE_BREAKDOWN,1.744898161,0.124664032,BRD-A04553218
INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS,1.731528971,0.113181818,BRD-A04553218
VIRAL_MESSENGER_RNA_SYNTHESIS,1.684140179,0.149451032,BRD-A04553218
CELLULAR_RESPONSE_TO_STARVATION,3.112740873,0,BVD-523
DEVELOPMENTAL_CELL_LINEAGES,-2.767417413,0,BVD-523
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.79605966,0,BVD-523
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.805529928,0,BVD-523
NONSENSE_MEDIATED_DECAY_NMD,2.815143368,0,BVD-523
SELENOAMINO_ACID_METABOLISM,2.618428585,0,BVD-523
EUKARYOTIC_TRANSLATION_ELONGATION,2.829994713,0,BVD-523
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.90230169,0,BVD-523
TRANSLATION,2.912366568,0,BVD-523
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.926537434,0,BVD-523
EUKARYOTIC_TRANSLATION_ELONGATION,-2.357872272,0.003051926,itopride
NONSENSE_MEDIATED_DECAY_NMD,-2.305933845,0.002543272,itopride
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.305697314,0.001695514,itopride
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.282724144,0.003051926,itopride
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.262920626,0.003255388,itopride
RRNA_PROCESSING,-2.261147027,0.003051926,itopride
CELLULAR_RESPONSE_TO_STARVATION,-2.220691168,0.004214564,itopride
SELENOAMINO_ACID_METABOLISM,-2.206829775,0.004196398,itopride
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.128793455,0.009720949,itopride
EUKARYOTIC_TRANSLATION_INITIATION,-2.10626439,0.012105973,itopride
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.893519607,0,E-2012
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.354650239,0.008014393,E-2012
MRNA_SPLICING,2.264877422,0.010017991,E-2012
GPCR_LIGAND_BINDING,-2.123939492,0.060721701,E-2012
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.097556981,0.03934082,E-2012
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,-2.066003548,0.037060193,E-2012
METABOLISM_OF_RNA,1.745926799,0.15277437,E-2012
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.961552178,0.077826405,E-2012
RRNA_PROCESSING,1.72506318,0.139049722,E-2012
INTEGRIN_CELL_SURFACE_INTERACTIONS,-1.945811016,0.074918605,E-2012
CHROMOSOME_MAINTENANCE,-2.547928109,0,pitavastatin
ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS,-2.301448187,0.000109023,pitavastatin
S_PHASE,-2.361751157,0.000140172,pitavastatin
CELL_CYCLE_CHECKPOINTS,-2.364252344,0.000163534,pitavastatin
SYNTHESIS_OF_DNA,-2.377211608,0.000196241,pitavastatin
DNA_STRAND_ELONGATION,-2.318992705,0.000122651,pitavastatin
DNA_REPLICATION,-2.459814682,0.000327069,pitavastatin
CELL_CYCLE,-2.534224575,0.000490603,pitavastatin
CELL_CYCLE_MITOTIC,-2.403603789,0.000245302,pitavastatin
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.459948633,0.003407155,pitavastatin
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.744691588,0,dexloxiglumide
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.704995072,0,dexloxiglumide
EUKARYOTIC_TRANSLATION_ELONGATION,-2.665202686,0,dexloxiglumide
SARS_COV_1_HOST_INTERACTIONS,-2.631761826,0,dexloxiglumide
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.602910481,0.000136703,dexloxiglumide
SELENOAMINO_ACID_METABOLISM,-2.57092055,0.000113919,dexloxiglumide
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.563804278,9.76E-05,dexloxiglumide
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.558442239,8.54E-05,dexloxiglumide
CELLULAR_RESPONSE_TO_STARVATION,-2.515434616,7.59E-05,dexloxiglumide
NONSENSE_MEDIATED_DECAY_NMD,-2.495840218,6.84E-05,dexloxiglumide
EUKARYOTIC_TRANSLATION_ELONGATION,-2.436065051,0.001069326,gliquidone
SELENOAMINO_ACID_METABOLISM,-2.376759598,0.002673315,gliquidone
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.335664483,0.002851536,gliquidone
NONSENSE_MEDIATED_DECAY_NMD,-2.274730101,0.002940647,gliquidone
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.171723813,0.008768474,gliquidone
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.16875073,0.007307061,gliquidone
EUKARYOTIC_TRANSLATION_INITIATION,-2.168133901,0.006415956,gliquidone
RRNA_PROCESSING,-2.166747771,0.005613962,gliquidone
INFLUENZA_INFECTION,-2.147848245,0.006415956,gliquidone
SIGNALING_BY_ROBO_RECEPTORS,-2.147332567,0.005881293,gliquidone
MITOCHONDRIAL_PROTEIN_DEGRADATION,2.939508631,0,nicotine
KEAP1_NFE2L2_PATHWAY,2.165375623,0.032029742,nicotine
DISEASES_OF_METABOLISM,-3.053777384,0.01670923,nicotine
DNA_REPLICATION,1.939941729,0.158623484,nicotine
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,1.869378601,0.196754129,nicotine
S_PHASE,1.852419083,0.1702152,nicotine
SYNTHESIS_OF_DNA,1.825876252,0.141192332,nicotine
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,1.827208315,0.163199161,nicotine
MITOTIC_METAPHASE_AND_ANAPHASE,1.807830252,0.144133839,nicotine
M_PHASE,1.738286675,0.187094365,nicotine
GPCR_LIGAND_BINDING,-2.774029924,0,dabigatran-etexilate
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.635025194,0,dabigatran-etexilate
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.322851679,0.001211349,dabigatran-etexilate
METABOLISM_OF_RNA,2.341594036,0.029551875,dabigatran-etexilate
SENSORY_PERCEPTION,-2.264711411,0.002422699,dabigatran-etexilate
SIGNALING_BY_GPCR,-2.258994009,0.001938159,dabigatran-etexilate
G_ALPHA_S_SIGNALLING_EVENTS,-2.203349304,0.002422699,dabigatran-etexilate
TRANSLATION,2.25801545,0.034098317,dabigatran-etexilate
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-2.131242788,0.005797172,dabigatran-etexilate
RRNA_PROCESSING,2.141879751,0.062134711,dabigatran-etexilate
EUKARYOTIC_TRANSLATION_ELONGATION,-2.768312449,0,metformin
TRANSLATION,-2.347875926,0,metformin
EUKARYOTIC_TRANSLATION_INITIATION,-2.489561476,0,metformin
INFLUENZA_INFECTION,-2.495994522,0,metformin
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.509994291,0,metformin
SIGNALING_BY_ROBO_RECEPTORS,-2.39565156,0,metformin
CELLULAR_RESPONSE_TO_STARVATION,-2.656610163,0,metformin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.669893217,0,metformin
NONSENSE_MEDIATED_DECAY_NMD,-2.693449879,0,metformin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.733407526,0,metformin
GPCR_LIGAND_BINDING,2.289125614,0.021958736,pindolol
CARDIAC_CONDUCTION,2.247470213,0.012199298,pindolol
MUSCLE_CONTRACTION,2.203083532,0.011386011,pindolol
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.881270271,0.065062923,pindolol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.758501249,0.107841794,pindolol
DISEASES_OF_METABOLISM,-2.815217277,0.722844659,pindolol
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1.685192263,0.140969666,pindolol
C_TYPE_LECTIN_RECEPTORS_CLRS,-2.781558236,0.659582788,pindolol
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION_BY_MLL3_AND_MLL4_COMPLEXES,1.493196518,0.320202527,pindolol
SIGNALING_BY_GPCR,1.464696674,0.324806309,pindolol
CELLULAR_RESPONSE_TO_STARVATION,3.604689426,0,mazindol
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.507709581,0,mazindol
EUKARYOTIC_TRANSLATION_INITIATION,3.488995707,0,mazindol
SELENOAMINO_ACID_METABOLISM,3.289279824,0,mazindol
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.276498121,0,mazindol
TRANSLATION,3.016729355,0,mazindol
EUKARYOTIC_TRANSLATION_ELONGATION,2.929977827,0,mazindol
NONSENSE_MEDIATED_DECAY_NMD,2.85741071,0,mazindol
INFLUENZA_INFECTION,2.755278767,0.000402492,mazindol
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.386926191,0.003622425,mazindol
EUKARYOTIC_TRANSLATION_ELONGATION,-2.49600153,0,levetiracetam
RRNA_PROCESSING,-2.349372147,0.001500777,levetiracetam
SELENOAMINO_ACID_METABOLISM,-2.348712909,0.001000518,levetiracetam
SARS_COV_1_HOST_INTERACTIONS,-2.327740603,0.001250648,levetiracetam
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.324161429,0.001200622,levetiracetam
NEURONAL_SYSTEM,2.342646523,0.00697489,levetiracetam
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.312450772,0.001500777,levetiracetam
SARS_COV_1_INFECTION,-2.307271995,0.001286381,levetiracetam
NONSENSE_MEDIATED_DECAY_NMD,-2.305272441,0.001125583,levetiracetam
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.317524044,0.005480271,levetiracetam
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION_BY_MLL3_AND_MLL4_COMPLEXES,-2.132486934,0.074940132,mCPP
EUKARYOTIC_TRANSLATION_INITIATION,-2.086800477,0.056698126,mCPP
EUKARYOTIC_TRANSLATION_ELONGATION,-2.063416083,0.049302719,mCPP
EPIGENETIC_REGULATION_BY_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES,-2.040434486,0.04733061,mCPP
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.853177496,0.298557159,mCPP
TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION,-1.995883334,0.057191154,mCPP
NEURONAL_SYSTEM,1.807377326,0.19700333,mCPP
CONSTITUTIVE_SIGNALING_BY_ABERRANT_PI3K_IN_CANCER,1.791909469,0.142804292,mCPP
PI3K_AKT_SIGNALING_IN_CANCER,1.770248629,0.12208657,mCPP
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-1.958981896,0.069516833,mCPP
MRNA_SPLICING,2.367999405,0.007377109,metoprolol
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.153737795,0.029508436,metoprolol
CELL_CYCLE_MITOTIC,2.132648598,0.031967473,metoprolol
M_PHASE,2.009281795,0.086681031,metoprolol
SYNTHESIS_OF_DNA,1.938638292,0.097377839,metoprolol
DNA_REPLICATION,1.932802288,0.082377718,metoprolol
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,1.790485089,0.146488308,metoprolol
MITOTIC_METAPHASE_AND_ANAPHASE,1.784441275,0.13463224,metoprolol
S_PHASE,1.748255906,0.123935432,metoprolol
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,1.748799662,0.137706036,metoprolol
EUKARYOTIC_TRANSLATION_ELONGATION,-3.782426276,0,nepafenac
NERVOUS_SYSTEM_DEVELOPMENT,-2.82079893,0,nepafenac
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-3.065778531,0,nepafenac
SARS_COV_1_INFECTION,-3.097197592,0,nepafenac
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-3.197918442,0,nepafenac
SARS_COV_1_HOST_INTERACTIONS,-3.23343693,0,nepafenac
TRANSLATION,-3.266917931,0,nepafenac
SIGNALING_BY_ROBO_RECEPTORS,-3.287441426,0,nepafenac
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-3.302905476,0,nepafenac
SARS_COV_2_HOST_INTERACTIONS,-2.56964192,0,nepafenac
TCR_SIGNALING,2.344510897,0.010437052,histamine
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1.747040866,0.153294194,histamine
GASTRULATION,-1.844454866,0.789429265,histamine
SIGNALING_BY_NTRKS,1.441812475,0.477495108,histamine
SIGNALING_BY_NOTCH,-1.796964719,0.591341897,histamine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.295280103,0.73320287,histamine
G_ALPHA_12_13_SIGNALLING_EVENTS,-1.685051347,0.964641679,histamine
SPHINGOLIPID_METABOLISM,-1.674341813,0.776775035,histamine
EPH_EPHRIN_SIGNALING,-1.632375068,0.84627596,histamine
G_ALPHA_S_SIGNALLING_EVENTS,1.144753675,1,histamine
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,1.643881329,0.456283042,ranolazine
METABOLISM_OF_NUCLEOTIDES,1.365234935,0.966856446,ranolazine
BACTERIAL_INFECTION_PATHWAYS,1.340198622,0.729971533,ranolazine
DISEASES_OF_METABOLISM,-2.652571571,1,ranolazine
SIGNALING_BY_NTRKS,1.265385825,0.785685238,ranolazine
SIGNALING_BY_VEGF,1.200672658,0.839609597,ranolazine
EPIGENETIC_REGULATION_BY_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES,1.17617934,0.786498577,ranolazine
NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,1.1691959,0.692616046,ranolazine
RHOA_GTPASE_CYCLE,1.165920773,0.614731598,ranolazine
RAC2_GTPASE_CYCLE,1.130516516,0.637250915,ranolazine
NEURONAL_SYSTEM,1.947238867,0.112733669,BRD-K76022557
NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,1.676680138,0.252055467,BRD-K76022557
SIGNALING_BY_ERBB2,1.601178047,0.246028824,BRD-K76022557
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.59073713,0.195422751,BRD-K76022557
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.612578455,1,BRD-K76022557
NONSENSE_MEDIATED_DECAY_NMD,-2.316264966,1,BRD-K76022557
EUKARYOTIC_TRANSLATION_ELONGATION,-2.308636963,1,BRD-K76022557
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.234250924,1,BRD-K76022557
INFLUENZA_INFECTION,-2.194404715,1,BRD-K76022557
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.178087065,0.860376592,BRD-K76022557
EUKARYOTIC_TRANSLATION_ELONGATION,-2.598331075,0,apixaban
SELENOAMINO_ACID_METABOLISM,-2.533387638,0,apixaban
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.529453837,0,apixaban
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.517839888,0,apixaban
NONSENSE_MEDIATED_DECAY_NMD,-2.447980851,0,apixaban
SARS_COV_1_HOST_INTERACTIONS,-2.42495974,0,apixaban
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.419630439,0,apixaban
EUKARYOTIC_TRANSLATION_INITIATION,-2.376457662,0.000119812,apixaban
INFLUENZA_INFECTION,-2.372898471,0.000212999,apixaban
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.340474531,0.000287549,apixaban
MUSCLE_CONTRACTION,2.629825143,0.004918444,MEK-162
CELL_CYCLE_MITOTIC,-2.328973572,0.007299296,MEK-162
CELL_CYCLE,-2.26233007,0.013034458,MEK-162
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,2.065411825,0.040050188,MEK-162
PI3K_AKT_SIGNALING_IN_CANCER,2.028693074,0.033258051,MEK-162
CELL_CYCLE_CHECKPOINTS,-2.083345843,0.06082747,MEK-162
DNA_STRAND_ELONGATION,-2.023051932,0.07742468,MEK-162
CHROMOSOME_MAINTENANCE,-2.016189144,0.067153527,MEK-162
M_PHASE,-2.014575761,0.056482651,MEK-162
EXTRACELLULAR_MATRIX_ORGANIZATION,1.838811609,0.062885822,MEK-162
RESPIRATORY_ELECTRON_TRANSPORT,3.67939093,0,AMD-11070
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.73598325,0.001174819,AMD-11070
SENSORY_PERCEPTION,-2.353978056,0.000734044,AMD-11070
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.510864489,0.002349638,AMD-11070
MRNA_SPLICING,2.503056432,0.001762228,AMD-11070
NEURONAL_SYSTEM,-2.288677875,0.002569155,AMD-11070
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,-2.228572141,0.005138311,AMD-11070
MITOCHONDRIAL_PROTEIN_DEGRADATION,2.187964826,0.016447463,AMD-11070
METABOLISM_OF_RNA,2.162147561,0.014881038,AMD-11070
BIOLOGICAL_OXIDATIONS,1.989183265,0.039608175,AMD-11070
VESICLE_MEDIATED_TRANSPORT,2.572334586,0,atorvastatin
METABOLISM_OF_STEROIDS,2.569249479,0,atorvastatin
MEMBRANE_TRAFFICKING,2.523546838,0,atorvastatin
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,2.383932644,0.000511883,atorvastatin
COPI_MEDIATED_ANTEROGRADE_TRANSPORT,2.368103139,0.000409506,atorvastatin
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,2.363327268,0.000341255,atorvastatin
ASPARAGINE_N_LINKED_GLYCOSYLATION,2.308639528,0.002047532,atorvastatin
GOLGI_TO_ER_RETROGRADE_TRANSPORT,2.295356524,0.002303473,atorvastatin
AUTOPHAGY,2.216184713,0.004777575,atorvastatin
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,2.087452345,0.01023766,atorvastatin
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.973259625,0.01623901,istaroxime
ECM_PROTEOGLYCANS,-2.800777792,0.484632951,istaroxime
ESTROGEN_DEPENDENT_GENE_EXPRESSION,1.536703126,0.486264887,istaroxime
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.685256411,0.778457536,istaroxime
NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION,1.391424175,0.529834221,istaroxime
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.176376556,1,istaroxime
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.032154446,0.938817758,istaroxime
SARS_COV_1_HOST_INTERACTIONS,-1.943946629,0.830726849,istaroxime
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-1.92898764,0.71901116,istaroxime
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-1.924249824,0.630530305,istaroxime
ECM_PROTEOGLYCANS,-2.785493236,0,midostaurin
NEURONAL_SYSTEM,-2.491797196,0.008005752,midostaurin
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.47982797,0.006404602,midostaurin
DEVELOPMENTAL_CELL_LINEAGES,-2.451349623,0.00580417,midostaurin
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.431962192,0.004803451,midostaurin
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,-2.37378162,0.007338606,midostaurin
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,-2.348326303,0.008234488,midostaurin
RESPIRATORY_ELECTRON_TRANSPORT,2.201240868,0.146949961,midostaurin
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,-2.29932696,0.011107981,midostaurin
COLLAGEN_FORMATION,-2.260358453,0.01334292,midostaurin
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,1.846447259,0.280042592,piclamilast
MHC_CLASS_II_ANTIGEN_PRESENTATION,1.627777157,0.458929115,piclamilast
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,1.614361914,0.329023426,piclamilast
METABOLISM_OF_VITAMINS_AND_COFACTORS,1.570770552,0.311454214,piclamilast
ECM_PROTEOGLYCANS,-1.828150444,1,piclamilast
FATTY_ACID_METABOLISM,1.402071871,0.608001217,piclamilast
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,-1.723681712,1,piclamilast
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.721487771,1,piclamilast
PROTEIN_LOCALIZATION,1.361868842,0.615099888,piclamilast
NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,1.355064095,0.541375114,piclamilast
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.405693191,0.009051434,caffeine
HIV_INFECTION,2.165222504,0.023760015,caffeine
INFLUENZA_INFECTION,1.944202816,0.056571464,caffeine
INNATE_IMMUNE_SYSTEM,1.852265661,0.068451471,caffeine
NEUTROPHIL_DEGRANULATION,1.759506676,0.084178338,caffeine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.746977794,0.075051475,caffeine
PEPTIDE_HORMONE_METABOLISM,1.439488476,0.344277764,caffeine
CELLULAR_RESPONSE_TO_STARVATION,1.392784161,0.381574521,caffeine
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1.309001532,0.503360311,caffeine
FORMATION_OF_THE_CORNIFIED_ENVELOPE,1.218090853,0.69152957,caffeine
SELENOAMINO_ACID_METABOLISM,2.803900606,0,BMS-927711
METABOLISM_OF_RNA,2.718268439,0.001322134,BMS-927711
TRANSLATION,2.676438939,0.000881423,BMS-927711
RRNA_PROCESSING,2.65780953,0.000661067,BMS-927711
GPCR_LIGAND_BINDING,-2.486522391,0.000581931,BMS-927711
SENSORY_PERCEPTION,-2.425672455,0.000581931,BMS-927711
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.613992503,0.001586561,BMS-927711
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.551065643,0.001762845,BMS-927711
MRNA_SPLICING,2.529086123,0.002266516,BMS-927711
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.526464913,0.001983201,BMS-927711
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.733959284,0,BRD-K55591206
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.292165702,0.009118458,BRD-K55591206
GLYCOSAMINOGLYCAN_METABOLISM,-2.134380908,0.036879098,BRD-K55591206
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.049827742,0.065045003,BRD-K55591206
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,1.976637984,0.160332637,BRD-K55591206
GPCR_LIGAND_BINDING,-1.991839798,0.092400377,BRD-K55591206
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.98794152,0.079634536,BRD-K55591206
COLLAGEN_FORMATION,-1.914797961,0.131479484,BRD-K55591206
INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS,-1.912804882,0.117476138,BRD-K55591206
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-1.907583773,0.108205705,BRD-K55591206
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.562482333,0,semaxanib
INFLUENZA_INFECTION,-2.308449382,0,semaxanib
SARS_COV_1_INFECTION,-2.354294598,0,semaxanib
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.371851774,0,semaxanib
EUKARYOTIC_TRANSLATION_INITIATION,-2.445942827,0,semaxanib
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.479260722,0,semaxanib
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.385619163,0,semaxanib
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.500317794,0,semaxanib
EUKARYOTIC_TRANSLATION_ELONGATION,-2.506354034,0,semaxanib
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.514645571,0,semaxanib
EUKARYOTIC_TRANSLATION_ELONGATION,-2.330679825,0.142189933,talazoparib
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.27304603,0.117997895,talazoparib
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.223526182,0.116845894,talazoparib
SELENOAMINO_ACID_METABOLISM,-2.211020646,0.096768149,talazoparib
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.181525067,0.095583232,talazoparib
NONSENSE_MEDIATED_DECAY_NMD,-2.181243289,0.079981837,talazoparib
CELLULAR_RESPONSE_TO_STARVATION,-2.165615552,0.075608932,talazoparib
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.122247473,0.092571571,talazoparib
RRNA_PROCESSING,-2.118700705,0.084809273,talazoparib
EUKARYOTIC_TRANSLATION_INITIATION,-2.079281996,0.102199014,talazoparib
FATTY_ACID_METABOLISM,1.545639752,0.62077791,rizatriptan
NEURONAL_SYSTEM,1.506264103,0.380555856,rizatriptan
EUKARYOTIC_TRANSLATION_ELONGATION,-2.07338933,1,rizatriptan
NONSENSE_MEDIATED_DECAY_NMD,-2.05070124,1,rizatriptan
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-1.978028476,1,rizatriptan
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-1.951196222,1,rizatriptan
SELENOAMINO_ACID_METABOLISM,-1.924361902,1,rizatriptan
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-1.914286298,1,rizatriptan
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-1.903914937,0.91482587,rizatriptan
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,-1.885349939,0.818997897,rizatriptan
EUKARYOTIC_TRANSLATION_ELONGATION,-2.675597037,0,BRD-K82225283
SELENOAMINO_ACID_METABOLISM,-2.569134907,0,BRD-K82225283
NONSENSE_MEDIATED_DECAY_NMD,-2.560344505,0,BRD-K82225283
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.499291477,0,BRD-K82225283
EUKARYOTIC_TRANSLATION_INITIATION,-2.493107998,0,BRD-K82225283
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.453729649,0,BRD-K82225283
INFLUENZA_INFECTION,-2.444515067,0,BRD-K82225283
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.401229806,0.000254321,BRD-K82225283
CELLULAR_RESPONSE_TO_STARVATION,-2.275380879,0.002034565,BRD-K82225283
SIGNALING_BY_ROBO_RECEPTORS,-2.24514112,0.00233975,BRD-K82225283
BACTERIAL_INFECTION_PATHWAYS,1.897253235,0.105542901,trapidil
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.943943963,0.116183609,trapidil
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.834662035,0.470339785,trapidil
SELENOAMINO_ACID_METABOLISM,-1.83373595,1,trapidil
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-1.818333729,1,trapidil
EUKARYOTIC_TRANSLATION_ELONGATION,-1.816155523,1,trapidil
EUKARYOTIC_TRANSLATION_INITIATION,-1.802332521,0.858297918,trapidil
INTERLEUKIN_17_SIGNALING,1.253117892,0.786889395,trapidil
IRON_UPTAKE_AND_TRANSPORT,1.253502667,1,trapidil
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-1.745806129,0.835997848,trapidil
EXTRACELLULAR_MATRIX_ORGANIZATION,-3.873791798,0.005364297,AZD-9291
CELLULAR_RESPONSE_TO_STARVATION,1.87952242,0.450832273,AZD-9291
TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM,1.871398658,0.240250389,AZD-9291
INTEGRIN_CELL_SURFACE_INTERACTIONS,-3.489462641,0.853593739,AZD-9291
RNA_POLYMERASE_II_TRANSCRIPTION_TERMINATION,1.830133508,0.210689379,AZD-9291
SELENOAMINO_ACID_METABOLISM,1.748903338,0.272498763,AZD-9291
NONSENSE_MEDIATED_DECAY_NMD,1.709110761,0.280560857,AZD-9291
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.176210154,1,AZD-9291
ION_CHANNEL_TRANSPORT,-2.075334919,1,AZD-9291
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,1.666338643,0.305714589,AZD-9291
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.401837707,0.008821903,navitoclax
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.32345677,0.017477633,navitoclax
SELENOAMINO_ACID_METABOLISM,-2.299722788,0.014907393,navitoclax
EUKARYOTIC_TRANSLATION_ELONGATION,-2.288376244,0.012679851,navitoclax
NONSENSE_MEDIATED_DECAY_NMD,-2.243823812,0.017991681,navitoclax
GPCR_LIGAND_BINDING,2.001822994,0.047317478,navitoclax
RRNA_PROCESSING,-2.164970978,0.035366504,navitoclax
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.138311488,0.038382253,navitoclax
SIGNALING_BY_ROBO_RECEPTORS,-2.128893421,0.036570846,navitoclax
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.103995786,0.039581698,navitoclax
GPCR_LIGAND_BINDING,-2.55844703,0.001042984,equol
NEURONAL_SYSTEM,-2.378650002,0.003650445,equol
RESPIRATORY_ELECTRON_TRANSPORT,2.255214247,0.019226577,equol
SENSORY_PERCEPTION,-2.234495896,0.011125166,equol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.159910952,0.018773717,equol
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,-2.134907573,0.019399507,equol
SIGNALING_BY_GPCR,-2.101123275,0.022771823,equol
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.085056918,0.022498661,equol
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.038788214,0.03050729,equol
NERVOUS_SYSTEM_DEVELOPMENT,-2.022599295,0.032100738,equol
GPCR_LIGAND_BINDING,-3.090989338,0,lorazepam
EUKARYOTIC_TRANSLATION_INITIATION,2.50660922,0,lorazepam
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.525302888,0,lorazepam
EUKARYOTIC_TRANSLATION_ELONGATION,2.537625417,0,lorazepam
RRNA_PROCESSING,2.54319279,0,lorazepam
METABOLISM_OF_RNA,2.641600267,0,lorazepam
RESPIRATORY_ELECTRON_TRANSPORT,2.46349207,0,lorazepam
CELLULAR_RESPONSE_TO_STARVATION,2.679505308,0,lorazepam
TRANSLATION,2.734426068,0,lorazepam
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.694013833,0.000212848,lorazepam
CILIUM_ASSEMBLY,1.699949391,0.531289641,clofazimine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.754806021,1,clofazimine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.697375537,1,clofazimine
SELENOAMINO_ACID_METABOLISM,-2.691831147,0.899784215,clofazimine
TRANSLATION,-2.686658062,0.676657833,clofazimine
EUKARYOTIC_TRANSLATION_INITIATION,-2.676977696,0.547149215,clofazimine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.675441665,0.456650887,clofazimine
NEUTROPHIL_DEGRANULATION,-2.645927973,0.404932606,clofazimine
NONSENSE_MEDIATED_DECAY_NMD,-2.598922596,0.374852322,clofazimine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.595241415,0.334704015,clofazimine
EUKARYOTIC_TRANSLATION_ELONGATION,-3.225156605,0,oxybuprocaine
SARS_COV_2_HOST_INTERACTIONS,-2.404249526,0,oxybuprocaine
NERVOUS_SYSTEM_DEVELOPMENT,-2.42017566,0,oxybuprocaine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.498794054,0,oxybuprocaine
SIGNALING_BY_ROBO_RECEPTORS,-2.686814327,0,oxybuprocaine
MRNA_SPLICING,2.727525338,0,oxybuprocaine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.776823663,0,oxybuprocaine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.784674614,0,oxybuprocaine
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.835130364,0,oxybuprocaine
TRANSLATION,-2.83822355,0,oxybuprocaine
NEURONAL_SYSTEM,3.776646131,0,sildenafil
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,2.815189476,0,sildenafil
EUKARYOTIC_TRANSLATION_ELONGATION,-2.619802805,0,sildenafil
SELENOAMINO_ACID_METABOLISM,-2.553353772,0,sildenafil
NONSENSE_MEDIATED_DECAY_NMD,-2.550605458,0.00031525,sildenafil
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.459629837,0.000945751,sildenafil
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.450153122,0.000756601,sildenafil
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.42378668,0.001261001,sildenafil
G_ALPHA_S_SIGNALLING_EVENTS,2.355503912,0.004229526,sildenafil
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,2.332810975,0.003568662,sildenafil
HIV_INFECTION,2.654277027,0,alizapride
INFLUENZA_INFECTION,2.554500575,0,alizapride
METABOLISM_OF_RNA,2.206855158,0.012612329,alizapride
HIV_LIFE_CYCLE,2.206686772,0.009459246,alizapride
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.038343097,0.01418887,alizapride
RESPIRATORY_ELECTRON_TRANSPORT,2.018082869,0.013006464,alizapride
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,1.670912294,0.093916804,alizapride
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.660396017,0.084837616,alizapride
GPCR_LIGAND_BINDING,-1.971418886,0.320023574,alizapride
TRNA_PROCESSING,1.633009018,0.086709759,alizapride
HIV_INFECTION,1.709038076,0.368393511,bupivacaine
CELLULAR_SENESCENCE,-1.911671361,0.552996707,bupivacaine
CIRCADIAN_CLOCK,1.483583486,0.589594079,bupivacaine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.379720164,0.6512671,bupivacaine
SIGNALING_BY_NOTCH,-1.80971895,0.629092835,bupivacaine
BETA_CATENIN_INDEPENDENT_WNT_SIGNALING,-1.78917479,0.489662042,bupivacaine
GPCR_LIGAND_BINDING,-1.764066262,0.436725605,bupivacaine
SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,1.27498967,0.775024295,bupivacaine
REGULATION_OF_INSULIN_SECRETION,-1.701024794,0.542031303,bupivacaine
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-1.668790463,0.551736316,bupivacaine
RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES,1.87572921,0.306663675,resorcinol
COPI_MEDIATED_ANTEROGRADE_TRANSPORT,1.69807689,0.346331613,resorcinol
AURKA_ACTIVATION_BY_TPX2,1.695830401,0.232413432,resorcinol
RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES,1.665984313,0.201772493,resorcinol
RHO_GTPASES_ACTIVATE_FORMINS,1.637844795,0.178505721,resorcinol
RHO_GTPASE_EFFECTORS,1.615316245,0.16452023,resorcinol
NONSENSE_MEDIATED_DECAY_NMD,-1.897952726,0.708664303,resorcinol
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-1.88540121,0.399944014,resorcinol
HCMV_EARLY_EVENTS,1.547229579,0.193980576,resorcinol
EUKARYOTIC_TRANSLATION_ELONGATION,-1.870374702,0.311120913,resorcinol
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.437068047,0.443803862,melperone
NONSENSE_MEDIATED_DECAY_NMD,-2.393884947,0.35384362,melperone
EUKARYOTIC_TRANSLATION_ELONGATION,-2.379875966,0.269880727,melperone
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.330900591,0.301616701,melperone
SELENOAMINO_ACID_METABOLISM,-2.322385827,0.258685674,melperone
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.281268051,0.272213029,melperone
ION_CHANNEL_TRANSPORT,-2.258559392,0.254887353,melperone
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.25619066,0.224150937,melperone
EUKARYOTIC_TRANSLATION_INITIATION,-2.245033072,0.205908999,melperone
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.201215255,0.209207541,melperone
MITOCHONDRIAL_PROTEIN_DEGRADATION,1.887598937,0.190741209,tadalafil
DISEASES_OF_METABOLISM,-3.105208302,0.41444183,tadalafil
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,1.590605537,0.439033645,tadalafil
MHC_CLASS_II_ANTIGEN_PRESENTATION,1.481966068,0.498229193,tadalafil
COPI_MEDIATED_ANTEROGRADE_TRANSPORT,1.453371925,0.432867442,tadalafil
RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES,1.430562382,0.379180369,tadalafil
RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES,1.352520917,0.449173623,tadalafil
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,1.336785155,0.413194319,tadalafil
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.664169515,1,tadalafil
SARS_COV_1_HOST_INTERACTIONS,-2.641032528,1,tadalafil
MRNA_SPLICING,1.954328372,0.16626347,umeclidinium
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.953036014,0.084121399,umeclidinium
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1.856428948,0.110182538,umeclidinium
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,1.732375509,0.161809985,umeclidinium
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.665087287,0.201099626,umeclidinium
MITOCHONDRIAL_PROTEIN_DEGRADATION,1.573412248,0.266549373,umeclidinium
MEMBRANE_TRAFFICKING,1.538274731,0.270602281,umeclidinium
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-1.878434034,1,umeclidinium
NEUTROPHIL_DEGRANULATION,-1.862778591,0.580513441,umeclidinium
HCMV_EARLY_EVENTS,1.492636973,0.296404223,umeclidinium
ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS,1.966514157,0.043730221,nicergoline
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-1.960971717,0.566576252,nicergoline
EUKARYOTIC_TRANSLATION_ELONGATION,-1.958011345,0.29364601,nicergoline
NONSENSE_MEDIATED_DECAY_NMD,-1.923335204,0.274483924,nicergoline
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION_BY_MLL3_AND_MLL4_COMPLEXES,-1.906259621,0.240820802,nicergoline
EUKARYOTIC_TRANSLATION_INITIATION,-1.881023407,0.241131538,nicergoline
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-1.872134652,0.217342931,nicergoline
SELENOAMINO_ACID_METABOLISM,-1.871390474,0.188217548,nicergoline
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-1.84723427,0.198741898,nicergoline
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-1.831871858,0.200252423,nicergoline
EUKARYOTIC_TRANSLATION_ELONGATION,-3.137402722,0.001025424,cariprazine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-3.047439343,0.034351717,cariprazine
SELENOAMINO_ACID_METABOLISM,-3.036895937,0.028711883,cariprazine
NONSENSE_MEDIATED_DECAY_NMD,-3.029711139,0.027430102,cariprazine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.996632943,0.055167832,cariprazine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.986436194,0.055885629,cariprazine
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.975790824,0.061085995,cariprazine
RRNA_PROCESSING,-2.975768361,0.053450246,cariprazine
EUKARYOTIC_TRANSLATION_INITIATION,-2.971829594,0.051385155,cariprazine
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.947264952,0.073215301,cariprazine
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,2.527994355,0.011666244,adenosine
AURKA_ACTIVATION_BY_TPX2,1.789193577,0.17369741,adenosine
RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES,1.789193577,0.17369741,adenosine
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,1.706058058,0.190548652,adenosine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.666934255,0.185882154,adenosine
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,1.65003056,0.167864288,adenosine
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,1.595933011,0.190548652,adenosine
KERATINIZATION,1.50814318,0.264920957,adenosine
REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION,1.385823236,0.453687266,adenosine
TRANSLATION,1.349627875,0.482982501,adenosine
EUKARYOTIC_TRANSLATION_ELONGATION,4.286693686,0,lomerizine
SIGNALING_BY_GPCR,-2.698881586,0,lomerizine
SARS_COV_1_INFECTION,2.83181815,0,lomerizine
GPCR_LIGAND_BINDING,-2.891149769,0,lomerizine
MRNA_SPLICING,2.926120027,0,lomerizine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,3.012064986,0,lomerizine
SARS_COV_1_HOST_INTERACTIONS,3.072099843,0,lomerizine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,3.179727793,0,lomerizine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.62063179,0,lomerizine
RRNA_PROCESSING,3.798823287,0,lomerizine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.96251867,0,meclizine
GPCR_LIGAND_BINDING,-2.556283029,0,meclizine
SIGNALING_BY_GPCR,-2.606881032,0,meclizine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.767834912,0,meclizine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.840055098,0,meclizine
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,3.022047942,0,meclizine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,3.133125556,0,meclizine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,3.181711091,0,meclizine
SIGNALING_BY_ROBO_RECEPTORS,3.286862847,0,meclizine
RRNA_PROCESSING,3.430204291,0,meclizine
METABOLISM_OF_RNA,2.689081855,0,FK-866
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.472445605,0.005551203,FK-866
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.325729166,0.013726191,FK-866
MRNA_SPLICING,2.352631605,0.008635204,FK-866
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.212874173,0.026079763,FK-866
ECM_PROTEOGLYCANS,-2.119127516,0.046058997,FK-866
MITOTIC_METAPHASE_AND_ANAPHASE,2.086800965,0.053661627,FK-866
SEPARATION_OF_SISTER_CHROMATIDS,2.064870462,0.051317786,FK-866
RRNA_PROCESSING,2.010296607,0.061680031,FK-866
DNA_REPLICATION,1.982791632,0.064323461,FK-866
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,4.277426651,0,levomequitazine
GPCR_LIGAND_BINDING,-2.629892073,0,levomequitazine
VIRAL_INFECTION_PATHWAYS,2.696820646,0,levomequitazine
MRNA_SPLICING,2.762507779,0,levomequitazine
SARS_COV_1_HOST_INTERACTIONS,2.836272385,0,levomequitazine
SARS_COV_1_INFECTION,2.852187732,0,levomequitazine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.872943538,0,levomequitazine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.076762647,0,levomequitazine
RESPIRATORY_ELECTRON_TRANSPORT,3.192020969,0,levomequitazine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,3.338675206,0,levomequitazine
METABOLISM_OF_RNA,3.701676843,0,acrivastine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.142462047,0,acrivastine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.732998856,0,acrivastine
CELLULAR_RESPONSE_TO_STARVATION,3.474416564,0,acrivastine
NONSENSE_MEDIATED_DECAY_NMD,3.491700242,0,acrivastine
RRNA_PROCESSING,3.49294651,0,acrivastine
INFLUENZA_INFECTION,3.430219448,0,acrivastine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.562359144,0,acrivastine
EUKARYOTIC_TRANSLATION_ELONGATION,3.578540391,0,acrivastine
EUKARYOTIC_TRANSLATION_INITIATION,3.595578151,0,acrivastine
EPIGENETIC_REGULATION_BY_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES,1.803879801,0.245630609,tandutinib
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION_BY_MLL3_AND_MLL4_COMPLEXES,1.663786387,0.280585735,tandutinib
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,1.611371069,0.241851677,tandutinib
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-2.596723293,0.541130675,tandutinib
SIGNALING_BY_TGFB_FAMILY_MEMBERS,1.498716316,0.291922532,tandutinib
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1.408811064,0.361265942,tandutinib
SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX,1.372323719,0.364666982,tandutinib
INTERLEUKIN_12_FAMILY_SIGNALING,1.316582812,0.407314934,tandutinib
GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER,1.302033349,0.380727444,tandutinib
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.533266324,0.793784022,tandutinib
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,2.164499813,0.119511277,andarine
METABOLISM_OF_RNA,2.156697193,0.064067901,andarine
NEDDYLATION,2.026120174,0.096923235,andarine
RRNA_PROCESSING,1.945038248,0.125055614,andarine
MITOTIC_SPINDLE_CHECKPOINT,1.842400634,0.196639173,andarine
MRNA_SPLICING,1.767125824,0.246209658,andarine
SEPARATION_OF_SISTER_CHROMATIDS,1.731480585,0.251871336,andarine
GASTRULATION,1.725646781,0.228241897,andarine
MITOTIC_G2_G2_M_PHASES,1.689186069,0.243403265,andarine
MITOTIC_PROMETAPHASE,1.683239375,0.226332181,andarine
PROTEIN_FOLDING,2.074901016,0.065149537,acenocoumarol
ECM_PROTEOGLYCANS,1.783677854,0.150956245,acenocoumarol
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.727430625,0.196992994,acenocoumarol
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,-2.719112148,0.104712296,acenocoumarol
CELLULAR_RESPONSE_TO_STARVATION,1.485795988,0.479352288,acenocoumarol
RRNA_PROCESSING,1.439315495,0.459224789,acenocoumarol
RHO_GTPASES_ACTIVATE_FORMINS,1.393864624,0.452868736,acenocoumarol
DNA_DOUBLE_STRAND_BREAK_REPAIR,1.371325959,0.425590678,acenocoumarol
TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER,1.36806816,0.37092106,acenocoumarol
CILIUM_ASSEMBLY,1.337453142,0.37699336,acenocoumarol
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,4.684746283,0,etacrynic-acid
SARS_COV_1_INFECTION,2.718789902,0,etacrynic-acid
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.367436584,0,etacrynic-acid
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,3.38628446,0,etacrynic-acid
METABOLISM_OF_RNA,3.536291678,0,etacrynic-acid
RRNA_PROCESSING,3.885368541,0,etacrynic-acid
TRANSLATION,3.908383283,0,etacrynic-acid
SIGNALING_BY_ROBO_RECEPTORS,3.939965286,0,etacrynic-acid
SARS_COV_1_HOST_INTERACTIONS,2.943396433,0,etacrynic-acid
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,4.251596063,0,etacrynic-acid
METABOLISM_OF_RNA,2.327595888,0.036613502,armodafinil
G2_M_CHECKPOINTS,2.323301243,0.019771291,armodafinil
MRNA_SPLICING,2.250747162,0.022944461,armodafinil
ECM_PROTEOGLYCANS,-2.218479834,0.09987038,armodafinil
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.185270905,0.072128608,armodafinil
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.183963917,0.049508394,armodafinil
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,2.054740657,0.061876818,armodafinil
NEDDYLATION,2.021999167,0.057995787,armodafinil
DNA_REPLICATION_PRE_INITIATION,2.00447917,0.053699803,armodafinil
CELL_CYCLE_CHECKPOINTS,1.956529205,0.059627703,armodafinil
PROTEIN_FOLDING,2.365378266,0.007800422,ARN-509
DISEASES_OF_GLYCOSYLATION,2.289075942,0.009100492,ARN-509
DNA_REPLICATION,1.61486295,0.325017569,ARN-509
DISEASES_OF_METABOLISM,-2.589856409,1,ARN-509
CILIUM_ASSEMBLY,1.35970017,0.695797611,ARN-509
CELLULAR_RESPONSES_TO_MECHANICAL_STIMULI,1.359783487,0.869747013,ARN-509
EPIGENETIC_REGULATION_BY_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES,1.356699346,0.590231904,ARN-509
P75_NTR_RECEPTOR_MEDIATED_SIGNALLING,1.331645101,0.577974099,ARN-509
SYNTHESIS_OF_DNA,1.291116154,0.603882642,ARN-509
UNFOLDED_PROTEIN_RESPONSE_UPR,1.208585857,0.784086828,ARN-509
METABOLISM_OF_RNA,3.267671975,0,amodiaquine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.905120629,0,amodiaquine
RESPIRATORY_ELECTRON_TRANSPORT,2.883505203,0,amodiaquine
MRNA_SPLICING,2.587908771,0,amodiaquine
RRNA_PROCESSING,2.351900487,0.003577961,amodiaquine
CELLULAR_RESPONSE_TO_HEAT_STRESS,2.317307312,0.004174288,amodiaquine
ECM_PROTEOGLYCANS,-2.224223854,0.02733597,amodiaquine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.133347823,0.016867532,amodiaquine
GASTRULATION,2.100074127,0.018784297,amodiaquine
G2_M_CHECKPOINTS,2.098164191,0.017094704,amodiaquine
TRANSLATION,3.050423672,0,prazosin
EUKARYOTIC_TRANSLATION_ELONGATION,2.914577265,0,prazosin
EUKARYOTIC_TRANSLATION_INITIATION,2.903628633,0,prazosin
NONSENSE_MEDIATED_DECAY_NMD,2.792434668,0,prazosin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.765657326,0,prazosin
SELENOAMINO_ACID_METABOLISM,2.724358212,0,prazosin
CELLULAR_RESPONSE_TO_STARVATION,2.558655684,0.000160067,prazosin
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.585963245,0.000177852,prazosin
RRNA_PROCESSING,2.525261725,0.000145516,prazosin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.656891183,0.000228667,prazosin
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.941644955,0.001839195,clinofibrate
INFLUENZA_INFECTION,1.934431931,0.140903329,clinofibrate
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.748695749,0.058854253,clinofibrate
PROTEIN_FOLDING,1.804084309,0.1365001,clinofibrate
CELLULAR_RESPONSE_TO_STARVATION,1.688045083,0.173193675,clinofibrate
ECM_PROTEOGLYCANS,-2.573924577,0.205070287,clinofibrate
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.571255607,0.162079094,clinofibrate
DISEASES_OF_GLYCOSYLATION,1.533812941,0.320885316,clinofibrate
CELLULAR_RESPONSES_TO_MECHANICAL_STIMULI,1.481014319,0.338608313,clinofibrate
COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES,-2.521312802,0.302363723,clinofibrate
METABOLISM_OF_RNA,2.966599744,0,felbamate
HOST_INTERACTIONS_OF_HIV_FACTORS,2.217065874,0.044607604,felbamate
RRNA_PROCESSING,2.212840881,0.030746484,felbamate
DNA_REPLICATION,2.191674693,0.025328047,felbamate
REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE,2.165871301,0.023286682,felbamate
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.305460723,0.153760475,felbamate
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.29961884,0.083047101,felbamate
CELLULAR_RESPONSE_TO_HEAT_STRESS,2.040489698,0.049648012,felbamate
ECM_PROTEOGLYCANS,-2.236694801,0.092091835,felbamate
GASTRULATION,1.99648333,0.056596573,felbamate
METABOLISM_OF_RNA,2.777187837,0,phenprocoumon
RESPIRATORY_ELECTRON_TRANSPORT,2.564188902,0.001891832,phenprocoumon
ECM_PROTEOGLYCANS,-2.534554002,0.001523175,phenprocoumon
MRNA_SPLICING,2.401260173,0.006306106,phenprocoumon
NEURONAL_SYSTEM,-2.3774904,0.004188731,phenprocoumon
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,-2.24746282,0.014977886,phenprocoumon
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.175311118,0.032634097,phenprocoumon
TRANSLATION,2.085467677,0.048809259,phenprocoumon
RRNA_PROCESSING,2.049589388,0.053917205,phenprocoumon
GASTRULATION,2.020444574,0.053782074,phenprocoumon
EXTRACELLULAR_MATRIX_ORGANIZATION,2.4848254,0.00292721,naftifine
MUSCLE_CONTRACTION,2.472946253,0.001463605,naftifine
CARDIAC_CONDUCTION,2.377199718,0.001626228,naftifine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.46528841,0.008022757,naftifine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.395595573,0.007521334,naftifine
NEURONAL_SYSTEM,2.223913937,0.003171144,naftifine
EUKARYOTIC_TRANSLATION_INITIATION,-2.34245675,0.008022757,naftifine
G_ALPHA_S_SIGNALLING_EVENTS,2.135279198,0.006244715,naftifine
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,2.11724063,0.006179666,naftifine
NONSENSE_MEDIATED_DECAY_NMD,-2.273722387,0.016296224,naftifine
METABOLISM_OF_RNA,3.28656263,0,moxonidine
MRNA_SPLICING,2.727721235,0.000968143,moxonidine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.724532053,0.000645428,moxonidine
TRANSLATION,2.333276847,0.006292927,moxonidine
RESPIRATORY_ELECTRON_TRANSPORT,2.280824381,0.007357884,moxonidine
REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS,2.233334715,0.010972283,moxonidine
HIV_INFECTION,2.192633295,0.013553997,moxonidine
GASTRULATION,2.147138072,0.016216389,moxonidine
RRNA_PROCESSING,2.135327947,0.016565996,moxonidine
SEPARATION_OF_SISTER_CHROMATIDS,1.986907693,0.038532077,moxonidine
GPCR_LIGAND_BINDING,-2.730151959,0,tipifarnib-P2
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.72097025,0,tipifarnib-P2
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.598643676,0.00055473,tipifarnib-P2
SENSORY_PERCEPTION,-2.581025614,0.000624072,tipifarnib-P2
SIGNALING_BY_GPCR,-2.376543648,0.005824668,tipifarnib-P2
SELENOAMINO_ACID_METABOLISM,2.183642,0.09788936,tipifarnib-P2
CELLULAR_RESPONSE_TO_STARVATION,2.167979239,0.054382978,tipifarnib-P2
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.154253999,0.03988085,tipifarnib-P2
TRANSLATION,2.145371528,0.031270212,tipifarnib-P2
RAB_REGULATION_OF_TRAFFICKING,2.056351048,0.048672765,tipifarnib-P2
METABOLISM_OF_RNA,3.133287328,0,irbesartan
MRNA_SPLICING,2.909308019,0,irbesartan
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.73415804,0,irbesartan
RESPIRATORY_ELECTRON_TRANSPORT,2.708122176,0,irbesartan
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.434638023,0.019771237,irbesartan
G2_M_CHECKPOINTS,2.304385345,0.007471094,irbesartan
RRNA_PROCESSING,2.288005283,0.006522384,irbesartan
TRANSLATION,2.221366287,0.008640041,irbesartan
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,2.220736967,0.00778239,irbesartan
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.342590244,0.024516334,irbesartan
METABOLISM_OF_RNA,2.606980218,0.001671432,nefazodone
DNA_REPLICATION_PRE_INITIATION,2.317344047,0.016714317,nefazodone
DNA_REPLICATION,2.275286803,0.013928598,nefazodone
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.241301505,0.013371454,nefazodone
MRNA_SPLICING,2.202797004,0.015377172,nefazodone
SYNTHESIS_OF_DNA,2.128957075,0.02145004,nefazodone
ECM_PROTEOGLYCANS,-2.304155375,0.064049086,nefazodone
G2_M_CHECKPOINTS,2.085145402,0.025549028,nefazodone
NEDDYLATION,2.066497502,0.026951836,nefazodone
DOWNSTREAM_TCR_SIGNALING,2.045773181,0.027671481,nefazodone
METABOLISM_OF_RNA,2.495061347,0.010914928,isoniazid
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,2.260941575,0.026605136,isoniazid
ECM_PROTEOGLYCANS,-2.281892101,0.134693149,isoniazid
RRNA_PROCESSING,2.102846373,0.069127876,isoniazid
GASTRULATION,2.010577561,0.093459069,isoniazid
MRNA_SPLICING,1.995105612,0.081861958,isoniazid
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.92910805,0.102554842,isoniazid
DNA_REPLICATION,1.825799033,0.154758083,isoniazid
NEDDYLATION,1.809089235,0.145987159,isoniazid
RESPIRATORY_ELECTRON_TRANSPORT,1.802278961,0.13552702,isoniazid
METABOLISM_OF_RNA,2.181089628,0.084913939,lesinurad
GASTRULATION,1.943774812,0.226628417,lesinurad
MRNA_SPLICING,1.858189345,0.247856902,lesinurad
G2_M_CHECKPOINTS,1.641135215,0.588660142,lesinurad
RRNA_PROCESSING,1.607166781,0.552399595,lesinurad
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,1.602160906,0.473529081,lesinurad
SUMOYLATION,1.597825929,0.414734102,lesinurad
NEDDYLATION,1.561692679,0.430450557,lesinurad
RESPIRATORY_ELECTRON_TRANSPORT,1.554947753,0.396137548,lesinurad
MITOTIC_SPINDLE_CHECKPOINT,1.549060288,0.36558893,lesinurad
EUKARYOTIC_TRANSLATION_INITIATION,3.437723752,0,aminocaproic-acid
SELENOAMINO_ACID_METABOLISM,3.370983791,0,aminocaproic-acid
NONSENSE_MEDIATED_DECAY_NMD,3.33239732,0,aminocaproic-acid
EUKARYOTIC_TRANSLATION_ELONGATION,3.328582977,0,aminocaproic-acid
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.319015427,0,aminocaproic-acid
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.315098988,0,aminocaproic-acid
INFLUENZA_INFECTION,3.295572077,0,aminocaproic-acid
CELLULAR_RESPONSE_TO_STARVATION,3.189005388,0,aminocaproic-acid
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.18115761,0,aminocaproic-acid
METABOLISM_OF_RNA,3.072321688,0,aminocaproic-acid
PROTEIN_FOLDING,2.011710699,0.050864563,chlormezanone
RRNA_PROCESSING,1.780971987,0.136244365,chlormezanone
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,-2.666688377,0.818088009,chlormezanone
INFLUENZA_INFECTION,1.497593312,0.440826213,chlormezanone
SIGNALING_BY_VEGF,1.459702981,0.4078248,chlormezanone
DISEASES_OF_METABOLISM,-2.609715028,1,chlormezanone
UNFOLDED_PROTEIN_RESPONSE_UPR,1.310718442,0.653972953,chlormezanone
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-2.593053931,0.861492909,chlormezanone
TRNA_PROCESSING,1.273987138,0.652459127,chlormezanone
REGULATION_OF_TP53_ACTIVITY,1.23744255,0.581990513,chlormezanone
COLLAGEN_FORMATION,-2.634222403,0.361659195,carbimazole
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.60483145,0.249535302,carbimazole
COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES,-2.578349768,0.254465573,carbimazole
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,-2.57497956,0.201584446,carbimazole
COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC,1.410056135,1,carbimazole
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.521986781,0.379599018,carbimazole
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-2.512268288,0.364840015,carbimazole
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,-2.478004703,0.479576724,carbimazole
CILIUM_ASSEMBLY,1.222140362,1,carbimazole
PROTEIN_FOLDING,1.21808295,1,carbimazole
CELLULAR_RESPONSE_TO_STARVATION,4.137658305,0,ARRY-334543
SARS_COV_2_HOST_INTERACTIONS,2.742523085,0,ARRY-334543
SARS_COV_1_INFECTION,2.819046657,0,ARRY-334543
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.985938952,0,ARRY-334543
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,3.209425486,0,ARRY-334543
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,3.319442608,0,ARRY-334543
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,3.320033995,0,ARRY-334543
TRANSLATION,3.538519048,0,ARRY-334543
INFLUENZA_INFECTION,3.574920574,0,ARRY-334543
SIGNALING_BY_ROBO_RECEPTORS,3.674997058,0,ARRY-334543
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.56358375,0,furosemide
EUKARYOTIC_TRANSLATION_ELONGATION,-2.517090352,0,furosemide
NONSENSE_MEDIATED_DECAY_NMD,-2.430935338,0,furosemide
SIGNALING_BY_ROBO_RECEPTORS,-2.402000127,0,furosemide
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.387343307,0.000200639,furosemide
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.345764123,0.000835997,furosemide
SELENOAMINO_ACID_METABOLISM,-2.336141624,0.000716569,furosemide
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.301837601,0.001128596,furosemide
EUKARYOTIC_TRANSLATION_INITIATION,-2.292043776,0.001337595,furosemide
INFLUENZA_INFECTION,-2.286645326,0.001203836,furosemide
EPIGENETIC_REGULATION_BY_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES,2.250054959,0.008345861,doxorubicin
TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION,2.100297038,0.011922658,doxorubicin
UNFOLDED_PROTEIN_RESPONSE_UPR,2.097021862,0.007948439,doxorubicin
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1.870774556,0.035767975,doxorubicin
GLUCOSE_METABOLISM,1.852553058,0.032191177,doxorubicin
PROTEIN_FOLDING,1.832990989,0.029607935,doxorubicin
RAB_REGULATION_OF_TRAFFICKING,1.61367621,0.086865081,doxorubicin
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.628968044,0.746695938,doxorubicin
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.616641706,0.477274646,doxorubicin
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,1.455969928,0.171388212,doxorubicin
SIGNALING_BY_MET,1.823333516,0.325292338,flumazenil
DISEASES_OF_GLYCOSYLATION,1.815757317,0.172377136,flumazenil
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,1.514913367,0.529179273,flumazenil
ECM_PROTEOGLYCANS,1.476223769,0.4858533,flumazenil
SARS_COV_2_HOST_INTERACTIONS,1.462533227,0.421489901,flumazenil
CELLULAR_RESPONSES_TO_MECHANICAL_STIMULI,1.379387564,0.506010303,flumazenil
RESOLUTION_OF_SISTER_CHROMATID_COHESION,1.350079667,0.498463839,flumazenil
PKR_MEDIATED_SIGNALING,1.294262974,0.568218988,flumazenil
S_PHASE,1.285952873,0.527943595,flumazenil
RAB_REGULATION_OF_TRAFFICKING,1.270462625,0.511014801,flumazenil
PROTEIN_FOLDING,2.469900835,0.006906818,aniracetam
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.748218607,0.140480007,aniracetam
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.610616076,0.512087592,aniracetam
UNFOLDED_PROTEIN_RESPONSE_UPR,1.392701422,1,aniracetam
EPIGENETIC_REGULATION_BY_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES,1.314520391,1,aniracetam
SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX,1.28782215,0.975587973,aniracetam
CELLULAR_RESPONSE_TO_STARVATION,1.279743206,0.810860375,aniracetam
SIGNALING_BY_TGFB_FAMILY_MEMBERS,1.264059363,0.726942542,aniracetam
SIGNALING_BY_VEGF,1.224700292,0.753336452,aniracetam
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-2.537362931,1,aniracetam
METABOLISM_OF_RNA,3.305882206,0,urea
MRNA_SPLICING,2.812627309,0.001685313,urea
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.715909919,0.001123542,urea
MITOCHONDRIAL_PROTEIN_IMPORT,2.302680113,0.009690552,urea
RRNA_PROCESSING,2.22613765,0.014493695,urea
ECM_PROTEOGLYCANS,-2.309817924,0.08284794,urea
HIV_INFECTION,2.071478901,0.035110696,urea
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.131116397,0.178691635,urea
CELLULAR_RESPONSE_TO_HEAT_STRESS,1.925949273,0.070301645,urea
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.906359463,0.070361835,urea
CELLULAR_RESPONSE_TO_STARVATION,3.770501333,0,diethylcarbamazine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.668999003,0,diethylcarbamazine
RESPIRATORY_ELECTRON_TRANSPORT,2.721077662,0,diethylcarbamazine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.734415942,0,diethylcarbamazine
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,2.75079077,0,diethylcarbamazine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.877668856,0,diethylcarbamazine
INFLUENZA_INFECTION,2.961610248,0,diethylcarbamazine
SIGNALING_BY_ROBO_RECEPTORS,2.979638973,0,diethylcarbamazine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,3.077604137,0,diethylcarbamazine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.183236536,0,diethylcarbamazine
GASTRULATION,2.14252543,0.157436042,asymmetrical-dimethylarginine
METABOLISM_OF_RNA,1.983958222,0.201168275,asymmetrical-dimethylarginine
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,1.896325546,0.226991118,asymmetrical-dimethylarginine
NEDDYLATION,1.804918434,0.286133758,asymmetrical-dimethylarginine
RRNA_PROCESSING,1.804201379,0.230406397,asymmetrical-dimethylarginine
DNA_REPLICATION_PRE_INITIATION,1.804175184,0.192005331,asymmetrical-dimethylarginine
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,1.702802867,0.28256378,asymmetrical-dimethylarginine
RRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL,1.665834126,0.300502921,asymmetrical-dimethylarginine
TCR_SIGNALING,1.663351809,0.270723352,asymmetrical-dimethylarginine
DNA_REPLICATION,1.644374192,0.268640865,asymmetrical-dimethylarginine
METABOLISM_OF_RNA,3.006384042,0,fingolimod
MRNA_SPLICING,2.851672767,0,fingolimod
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.732502643,0.000488294,fingolimod
RESPIRATORY_ELECTRON_TRANSPORT,2.437308213,0.003662202,fingolimod
RRNA_PROCESSING,2.348007828,0.006445476,fingolimod
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.277501384,0.035447472,fingolimod
NEDDYLATION,2.217472516,0.013183928,fingolimod
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.228950311,0.030692323,fingolimod
MITOCHONDRIAL_PROTEIN_IMPORT,2.175749209,0.015276615,fingolimod
REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS,2.045025347,0.034058481,fingolimod
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,-2.734570525,0.335905968,KD-025
SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS,1.521831737,1,KD-025
MITOTIC_PROMETAPHASE,1.516340702,0.630004292,KD-025
RESOLUTION_OF_SISTER_CHROMATID_COHESION,1.475738472,0.516134306,KD-025
MHC_CLASS_II_ANTIGEN_PRESENTATION,1.473169981,0.390533995,KD-025
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1.434712984,0.379375881,KD-025
TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM,1.431527038,0.321296467,KD-025
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-2.633866285,0.837392704,KD-025
RHO_GTPASES_ACTIVATE_FORMINS,1.386880018,0.34038379,KD-025
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,1.384332605,0.301483661,KD-025
METABOLISM_OF_RNA,2.903282779,0,miglustat
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.741672466,0.000695596,miglustat
MRNA_SPLICING,2.606603954,0.000463731,miglustat
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.429195058,0.010546993,miglustat
RESPIRATORY_ELECTRON_TRANSPORT,2.297743141,0.006260362,miglustat
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.337103785,0.021972901,miglustat
RRNA_PROCESSING,2.192445475,0.016416062,miglustat
DNA_REPLICATION,2.054535635,0.037098444,miglustat
GASTRULATION,2.021010494,0.038754625,miglustat
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,2.020706083,0.033910297,miglustat
RHO_GTPASE_EFFECTORS,2.255729422,0.021117693,mercaptopurine
GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER,1.50575001,0.898821787,mercaptopurine
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.500587128,0.939080323,mercaptopurine
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,1.439514162,0.88342347,mercaptopurine
TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER,1.422130424,0.714701906,mercaptopurine
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,1.395780138,0.651480814,mercaptopurine
RHO_GTPASES_ACTIVATE_FORMINS,1.384332297,0.572817409,mercaptopurine
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-2.465946517,0.834394511,mercaptopurine
PROTEIN_FOLDING,1.310984679,0.695375446,mercaptopurine
SUMOYLATION,1.294336613,0.65233872,mercaptopurine
EUKARYOTIC_TRANSLATION_INITIATION,4.18879672,0,pioglitazone
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,3.169552916,0,pioglitazone
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,3.218460572,0,pioglitazone
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.398522897,0,pioglitazone
SIGNALING_BY_ROBO_RECEPTORS,3.698712631,0,pioglitazone
RESPIRATORY_ELECTRON_TRANSPORT,2.675164317,0,pioglitazone
SELENOAMINO_ACID_METABOLISM,3.766845574,0,pioglitazone
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.884870273,0,pioglitazone
METABOLISM_OF_RNA,3.707365997,0,pioglitazone
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.97335794,0,pioglitazone
RRNA_PROCESSING,1.839491637,0.134636119,nortriptyline
CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,1.591235012,0.271698113,nortriptyline
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-2.611882651,0.618420545,nortriptyline
MUSCLE_CONTRACTION,1.557014052,0.217924528,nortriptyline
ADIPOGENESIS,1.555193777,0.165869272,nortriptyline
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,-2.563424454,0.700646843,nortriptyline
PROTEIN_FOLDING,1.388886068,0.300080863,nortriptyline
REGULATION_OF_TP53_ACTIVITY,1.208380941,0.576549865,nortriptyline
METABOLISM_OF_VITAMINS_AND_COFACTORS,1.156298748,0.619811321,nortriptyline
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,1.137408195,0.585545822,nortriptyline
METABOLISM_OF_RNA,2.119409057,0.153770511,perindopril
GASTRULATION,2.020506827,0.139453946,perindopril
RRNA_PROCESSING,1.968587777,0.126904858,perindopril
ECM_PROTEOGLYCANS,-2.170994617,0.680762977,perindopril
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,1.853065715,0.181873397,perindopril
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.131507123,0.45547451,perindopril
NEURONAL_SYSTEM,-2.117806974,0.337279691,perindopril
RRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL,1.780420699,0.217399688,perindopril
MRNA_SPLICING,1.759869377,0.200608655,perindopril
NEDDYLATION,1.643896977,0.298905633,perindopril
SELENOAMINO_ACID_METABOLISM,-3.199077267,0,bumetanide
SARS_COV_1_INFECTION,-2.590524097,0,bumetanide
SARS_COV_1_HOST_INTERACTIONS,-2.672867728,0,bumetanide
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.683725789,0,bumetanide
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.694407958,0,bumetanide
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.757327058,0,bumetanide
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.850749839,0,bumetanide
TRANSLATION,-2.934824799,0,bumetanide
RRNA_PROCESSING,-2.982669959,0,bumetanide
CELLULAR_RESPONSE_TO_STARVATION,-2.942223853,0,bumetanide
METABOLISM_OF_RNA,3.001157534,0,piretanide
RRNA_PROCESSING,2.793102482,0,piretanide
NEURONAL_SYSTEM,-2.588373423,0,piretanide
MRNA_SPLICING,2.53505929,0.001791045,piretanide
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.349096039,0.007164179,piretanide
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,-2.314714085,0.007267974,piretanide
ECM_PROTEOGLYCANS,-2.272152177,0.009690632,piretanide
RESPIRATORY_ELECTRON_TRANSPORT,2.20045252,0.016835821,piretanide
POTASSIUM_CHANNELS,-2.203476829,0.013324619,piretanide
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,-2.1814252,0.013082353,piretanide
PROTEIN_FOLDING,1.590969511,0.679990049,retigabine
MUSCLE_CONTRACTION,1.353571687,1,retigabine
COMPLEX_I_BIOGENESIS,1.343697847,0.711501783,retigabine
EPIGENETIC_REGULATION_BY_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES,1.293025721,0.669209719,retigabine
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,-2.518106525,1,retigabine
SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX,1.281224255,0.567874616,retigabine
RRNA_PROCESSING,1.111614188,0.976310916,retigabine
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-2.427822679,1,retigabine
RHO_GTPASES_ACTIVATE_FORMINS,1.053426766,1,retigabine
CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,1.052554512,0.915913426,retigabine
SELENOAMINO_ACID_METABOLISM,3.140515643,0,ORE-1001
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.089850518,0,ORE-1001
NONSENSE_MEDIATED_DECAY_NMD,2.988301887,0,ORE-1001
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.916274939,0,ORE-1001
EUKARYOTIC_TRANSLATION_INITIATION,2.916226207,0,ORE-1001
TRANSLATION,2.849782482,0,ORE-1001
EUKARYOTIC_TRANSLATION_ELONGATION,2.848378047,0,ORE-1001
METABOLISM_OF_RNA,2.834263045,0,ORE-1001
RESPIRATORY_ELECTRON_TRANSPORT,2.781586934,0,ORE-1001
CELLULAR_RESPONSE_TO_STARVATION,2.780278985,0,ORE-1001
CELLULAR_RESPONSE_TO_STARVATION,3.392149565,0,oxybutynin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.303432767,0,oxybutynin
RRNA_PROCESSING,3.277333078,0,oxybutynin
SELENOAMINO_ACID_METABOLISM,3.271242466,0,oxybutynin
INFLUENZA_INFECTION,2.857603376,0,oxybutynin
EUKARYOTIC_TRANSLATION_INITIATION,3.195436589,0,oxybutynin
EUKARYOTIC_TRANSLATION_ELONGATION,3.160977354,0,oxybutynin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.129219732,0,oxybutynin
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.87002859,0,oxybutynin
TRANSLATION,2.903246684,0,oxybutynin
EUKARYOTIC_TRANSLATION_INITIATION,3.618290996,0,milrinone
EUKARYOTIC_TRANSLATION_ELONGATION,3.614281832,0,milrinone
SELENOAMINO_ACID_METABOLISM,3.607548306,0,milrinone
NONSENSE_MEDIATED_DECAY_NMD,3.573290456,0,milrinone
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.544468034,0,milrinone
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.475287273,0,milrinone
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.440771471,0,milrinone
METABOLISM_OF_RNA,3.402418699,0,milrinone
RRNA_PROCESSING,3.36311391,0,milrinone
CELLULAR_RESPONSE_TO_STARVATION,3.350914249,0,milrinone
EUKARYOTIC_TRANSLATION_INITIATION,3.388183709,0,molindone
NONSENSE_MEDIATED_DECAY_NMD,2.820583278,0,molindone
SIGNALING_BY_ROBO_RECEPTORS,2.833715674,0,molindone
SELENOAMINO_ACID_METABOLISM,3.072759741,0,molindone
CELLULAR_RESPONSE_TO_STARVATION,3.080287214,0,molindone
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.128577233,0,molindone
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.06989477,0,molindone
TRANSLATION,3.143585515,0,molindone
METABOLISM_OF_RNA,3.180915989,0,molindone
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.188561131,0,molindone
PROTEIN_FOLDING,2.085115717,0.067492013,ramipril
COLLAGEN_FORMATION,-2.632955389,0.644015569,ramipril
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,1.566515432,0.674920128,ramipril
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.578048305,0.868796627,ramipril
TRNA_PROCESSING,1.317182159,1,ramipril
SIGNALING_BY_TGFB_FAMILY_MEMBERS,1.306857879,1,ramipril
TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,1.297573589,1,ramipril
RRNA_PROCESSING,1.293826073,0.892971246,ramipril
S_PHASE,1.275189092,0.822512551,ramipril
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,1.25923406,0.778753994,ramipril
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.26064941,0.027525274,clofibrate
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.199192215,0.010259037,clofibrate
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.197716896,0.005524097,clofibrate
GPCR_LIGAND_BINDING,-2.143270564,0.007365463,clofibrate
MRNA_SPLICING,1.986220696,0.0928978,clofibrate
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,1.858233728,0.130745051,clofibrate
GOLGI_TO_ER_RETROGRADE_TRANSPORT,1.833829056,0.112968312,clofibrate
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.760304918,0.140837652,clofibrate
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1.692222569,0.165533939,clofibrate
MEMBRANE_TRAFFICKING,1.688751811,0.144507688,clofibrate
EUKARYOTIC_TRANSLATION_ELONGATION,-2.559359169,0,losartan
SELENOAMINO_ACID_METABOLISM,-2.535999132,0.000527718,losartan
EUKARYOTIC_TRANSLATION_INITIATION,-2.517456967,0.000351812,losartan
NONSENSE_MEDIATED_DECAY_NMD,-2.484788409,0.000527718,losartan
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.46223306,0.000633262,losartan
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.419944767,0.00087953,losartan
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.373591943,0.001055437,losartan
SIGNALING_BY_ROBO_RECEPTORS,-2.344681777,0.001187366,losartan
NERVOUS_SYSTEM_DEVELOPMENT,-2.324345262,0.001407249,losartan
INFLUENZA_INFECTION,-2.262276716,0.004116203,losartan
CELLULAR_RESPONSE_TO_STARVATION,-2.277517697,0.005948427,carbachol
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.275473594,0.002974213,carbachol
EUKARYOTIC_TRANSLATION_ELONGATION,-2.274365061,0.001982809,carbachol
TRANSLATION,-2.251474472,0.00223066,carbachol
NONSENSE_MEDIATED_DECAY_NMD,-2.232856307,0.001784528,carbachol
SELENOAMINO_ACID_METABOLISM,-2.226232879,0.001487107,carbachol
SIGNALING_BY_ROBO_RECEPTORS,-2.201177767,0.00184118,carbachol
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.174547998,0.002850288,carbachol
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.173956033,0.002533589,carbachol
EUKARYOTIC_TRANSLATION_INITIATION,-2.167509416,0.002577652,carbachol
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-3.053534552,0,anagrelide
TRANSLATION,-2.332372529,0,anagrelide
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.450474919,0,anagrelide
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.465664063,0,anagrelide
SIGNALING_BY_ROBO_RECEPTORS,-2.469667544,0,anagrelide
SARS_COV_1_INFECTION,-2.525621617,0,anagrelide
CELLULAR_RESPONSE_TO_STARVATION,-2.60839707,0,anagrelide
RRNA_PROCESSING,-2.689596648,0,anagrelide
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.689819758,0,anagrelide
SARS_COV_2_HOST_INTERACTIONS,-2.389880231,0,anagrelide
EUKARYOTIC_TRANSLATION_ELONGATION,-2.254085598,0.125886067,indoramin
NONSENSE_MEDIATED_DECAY_NMD,-2.23189705,0.079694002,indoramin
OPIOID_SIGNALLING,1.947148081,0.086600719,indoramin
INTEGRATION_OF_ENERGY_METABOLISM,1.879922586,0.062320144,indoramin
SELENOAMINO_ACID_METABOLISM,-2.126265634,0.130623715,indoramin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.093632831,0.126393672,indoramin
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.07356798,0.116140049,indoramin
EUKARYOTIC_TRANSLATION_INITIATION,-2.046854095,0.121486823,indoramin
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.003583411,0.143434701,indoramin
CELLULAR_RESPONSE_TO_STARVATION,-1.999266596,0.130073809,indoramin
METABOLISM_OF_RNA,3.664306498,0,gabapentin
INFLUENZA_INFECTION,2.708217686,0,gabapentin
MRNA_SPLICING,2.735695402,0,gabapentin
CELLULAR_RESPONSE_TO_STARVATION,2.841171884,0,gabapentin
EUKARYOTIC_TRANSLATION_ELONGATION,2.919234075,0,gabapentin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.001583386,0,gabapentin
TRANSLATION,2.875054226,0,gabapentin
EUKARYOTIC_TRANSLATION_INITIATION,3.051414579,0,gabapentin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.063586923,0,gabapentin
NONSENSE_MEDIATED_DECAY_NMD,3.153133965,0,gabapentin
METABOLISM_OF_RNA,3.430023979,0,hydroflumethiazide
MRNA_SPLICING,3.314233899,0,hydroflumethiazide
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.827605503,0,hydroflumethiazide
RRNA_PROCESSING,2.696593555,0,hydroflumethiazide
RESPIRATORY_ELECTRON_TRANSPORT,2.596216902,0,hydroflumethiazide
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,2.256300448,0.009435196,hydroflumethiazide
TRANSLATION,2.256113346,0.008087311,hydroflumethiazide
RRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL,2.194285701,0.009906956,hydroflumethiazide
HIV_INFECTION,2.016998247,0.033757035,hydroflumethiazide
DNA_REPLICATION,2.005307718,0.032268371,hydroflumethiazide
CILIUM_ASSEMBLY,2.178083153,0.029189604,desvenlafaxine
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-2.861652378,0.041350319,desvenlafaxine
CELLULAR_RESPONSE_TO_STARVATION,1.890554734,0.072974011,desvenlafaxine
GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER,1.701405671,0.135193957,desvenlafaxine
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.652028798,0.173575177,desvenlafaxine
MITOTIC_PROMETAPHASE,1.600569656,0.176289848,desvenlafaxine
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,-2.603418387,0.212521408,desvenlafaxine
RRNA_PROCESSING,1.511641561,0.222455511,desvenlafaxine
RHO_GTPASES_ACTIVATE_FORMINS,1.426943456,0.279861733,desvenlafaxine
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.569752326,0.291135096,desvenlafaxine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.834293025,0,dapsone
RESPIRATORY_ELECTRON_TRANSPORT,2.611036441,0,dapsone
SIGNALING_BY_GPCR,-2.709639612,0,dapsone
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,2.746649498,0,dapsone
GPCR_LIGAND_BINDING,-2.847184399,0,dapsone
MRNA_SPLICING,2.888499712,0,dapsone
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.975644765,0,dapsone
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,3.031782573,0,dapsone
SIGNALING_BY_ROBO_RECEPTORS,3.140379141,0,dapsone
RRNA_PROCESSING,3.300216815,0,dapsone
METABOLISM_OF_RNA,4.203573855,0,mestinon
MRNA_SPLICING,3.446355215,0,mestinon
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,3.376453017,0,mestinon
TRANSLATION,3.37495979,0,mestinon
RRNA_PROCESSING,3.285274169,0,mestinon
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.963484968,0,mestinon
EUKARYOTIC_TRANSLATION_INITIATION,2.887443369,0,mestinon
CELLULAR_RESPONSE_TO_STARVATION,2.849613648,0,mestinon
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.730483587,0,mestinon
NEURONAL_SYSTEM,-2.596143249,0,mestinon
DNA_REPLICATION,2.826515029,0,SN-38
SYNTHESIS_OF_DNA,2.823170584,0,SN-38
DNA_STRAND_ELONGATION,2.693240207,0,SN-38
ORC1_REMOVAL_FROM_CHROMATIN,2.503184367,0.000753994,SN-38
NEURONAL_SYSTEM,-2.433908894,0.007418894,SN-38
G2_M_CHECKPOINTS,2.448960285,0.00271438,SN-38
DNA_REPAIR,2.396444271,0.00351864,SN-38
BASE_EXCISION_REPAIR,2.31553813,0.004523966,SN-38
S_PHASE,2.292117008,0.004146969,SN-38
RESPIRATORY_ELECTRON_TRANSPORT,2.285704747,0.003686195,SN-38
MHC_CLASS_II_ANTIGEN_PRESENTATION,2.112703632,0.054459766,chloroquine
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,1.781736747,0.185721766,chloroquine
S_PHASE,1.782936477,0.276488043,chloroquine
DNA_REPLICATION,1.643989083,0.288008378,chloroquine
EPIGENETIC_REGULATION_BY_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES,1.548042259,0.365299354,chloroquine
ESTROGEN_DEPENDENT_GENE_EXPRESSION,1.536097349,0.326060394,chloroquine
SYNTHESIS_OF_DNA,1.506241716,0.317183253,chloroquine
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,-2.215741213,1,chloroquine
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.158919267,0.849402142,chloroquine
TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,1.339734256,0.66556118,chloroquine
SELENOAMINO_ACID_METABOLISM,-2.614109243,0.001033857,nimesulide
EUKARYOTIC_TRANSLATION_ELONGATION,-2.613948805,0.000516929,nimesulide
NONSENSE_MEDIATED_DECAY_NMD,-2.533086979,0.000344619,nimesulide
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.515562302,0.000258464,nimesulide
INFLUENZA_INFECTION,-2.505386595,0.000206771,nimesulide
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.471313616,0.000689238,nimesulide
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.432950379,0.000886163,nimesulide
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.385961639,0.000904625,nimesulide
SIGNALING_BY_ROBO_RECEPTORS,-2.379428985,0.000804111,nimesulide
EUKARYOTIC_TRANSLATION_INITIATION,-2.363444052,0.0007237,nimesulide
METABOLISM_OF_RNA,2.818801044,0,enprofylline
TRANSLATION,2.627411156,0,enprofylline
ECM_PROTEOGLYCANS,-2.602855456,0.000728635,enprofylline
RESPIRATORY_ELECTRON_TRANSPORT,2.531081118,0.001893017,enprofylline
MRNA_SPLICING,2.378751723,0.005205798,enprofylline
RRNA_PROCESSING,2.3075064,0.007193466,enprofylline
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.243654628,0.009149584,enprofylline
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.244092663,0.02368065,enprofylline
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.190654965,0.028173901,enprofylline
HIV_INFECTION,2.024147913,0.046243712,enprofylline
EUKARYOTIC_TRANSLATION_INITIATION,-2.898428148,0,BRD-K41170226
SARS_COV_1_HOST_INTERACTIONS,-2.392589416,0,BRD-K41170226
NERVOUS_SYSTEM_DEVELOPMENT,-2.424029946,0,BRD-K41170226
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.454317144,0,BRD-K41170226
SIGNALING_BY_ROBO_RECEPTORS,-2.554316852,0,BRD-K41170226
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.566538752,0,BRD-K41170226
INFLUENZA_INFECTION,-2.631052114,0,BRD-K41170226
RRNA_PROCESSING,-2.643294171,0,BRD-K41170226
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.647497122,0,BRD-K41170226
CELLULAR_RESPONSE_TO_STARVATION,-2.65867161,0,BRD-K41170226
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1.946234317,0.085106383,indacaterol
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-2.583333852,0.324499435,indacaterol
TRNA_PROCESSING,1.550133233,0.39198036,indacaterol
RHOA_GTPASE_CYCLE,1.549164696,0.262411348,indacaterol
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,1.488996846,0.25695581,indacaterol
INTEGRATION_OF_ENERGY_METABOLISM,1.415136929,0.290016367,indacaterol
CELLULAR_RESPONSE_TO_STARVATION,1.364674895,0.307146754,indacaterol
REGULATION_OF_TP53_ACTIVITY,1.363241437,0.264905307,indacaterol
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,-2.476907379,0.753645138,indacaterol
EPIGENETIC_REGULATION_BY_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES,1.27960093,0.347176759,indacaterol
TRANSLATION,3.458659114,0,sumatriptan
EUKARYOTIC_TRANSLATION_ELONGATION,3.355710503,0,sumatriptan
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.315732405,0,sumatriptan
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.251030054,0,sumatriptan
CELLULAR_RESPONSE_TO_STARVATION,3.24175522,0,sumatriptan
METABOLISM_OF_RNA,3.189989404,0,sumatriptan
SELENOAMINO_ACID_METABOLISM,3.187212379,0,sumatriptan
RRNA_PROCESSING,3.178831196,0,sumatriptan
NONSENSE_MEDIATED_DECAY_NMD,3.067772618,0,sumatriptan
EUKARYOTIC_TRANSLATION_INITIATION,3.05862814,0,sumatriptan
RESPIRATORY_ELECTRON_TRANSPORT,2.594284398,0.015549544,glibenclamide
METABOLISM_OF_RNA,2.585456922,0.007774772,glibenclamide
NEDDYLATION,2.297102922,0.01943693,glibenclamide
SENSORY_PERCEPTION,-2.246169657,0.051793561,glibenclamide
RRNA_PROCESSING,2.064821476,0.074346258,glibenclamide
MRNA_SPLICING,2.054168787,0.065308085,glibenclamide
GASTRULATION,2.01569928,0.071916642,glibenclamide
NEURONAL_SYSTEM,-2.085939123,0.121824291,glibenclamide
MITOTIC_G2_G2_M_PHASES,1.93702453,0.101905048,glibenclamide
ECM_PROTEOGLYCANS,-2.054546394,0.106748231,glibenclamide
RESOLUTION_OF_SISTER_CHROMATID_COHESION,1.988310177,0.102345416,bazedoxifene
MITOTIC_PROMETAPHASE,1.902933692,0.07767286,bazedoxifene
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.647039564,0.229090737,bazedoxifene
COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC,1.690886623,0.151081328,bazedoxifene
RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS,1.613980166,0.17225099,bazedoxifene
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.534572981,0.256902164,bazedoxifene
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-2.521102563,0.1888663,bazedoxifene
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.49416675,0.187609286,bazedoxifene
RHO_GTPASES_ACTIVATE_FORMINS,1.472134918,0.286201645,bazedoxifene
CILIUM_ASSEMBLY,1.315713205,0.484922327,bazedoxifene
METABOLISM_OF_RNA,2.469704019,0.008186849,fenoldopam
RRNA_PROCESSING,2.377007651,0.005847749,fenoldopam
GASTRULATION,2.148196171,0.030408295,fenoldopam
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.116264269,0.027484421,fenoldopam
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.075188959,0.028770925,fenoldopam
MRNA_SPLICING,2.035720794,0.033916945,fenoldopam
CELLULAR_RESPONSE_TO_STARVATION,1.84989709,0.106094876,fenoldopam
TRANSLATION,1.814031364,0.115493044,fenoldopam
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.436302698,1,fenoldopam
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.168275873,1,fenoldopam
NEURONAL_SYSTEM,2.761822429,0,pralatrexate
MUSCLE_CONTRACTION,2.391754953,0.001104268,pralatrexate
SELENOAMINO_ACID_METABOLISM,-2.496659642,0.006936693,pralatrexate
EUKARYOTIC_TRANSLATION_ELONGATION,-2.495413236,0.003468347,pralatrexate
NONSENSE_MEDIATED_DECAY_NMD,-2.374892836,0.009579243,pralatrexate
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.361406514,0.008670866,pralatrexate
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.309189519,0.0112969,pralatrexate
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.91916922,0.048587811,pralatrexate
INFLUENZA_INFECTION,-2.255978179,0.018332689,pralatrexate
EUKARYOTIC_TRANSLATION_INITIATION,-2.251871844,0.016279994,pralatrexate
NONSENSE_MEDIATED_DECAY_NMD,3.961396785,0,cilostazol
G_ALPHA_I_SIGNALLING_EVENTS,-2.653098523,0,cilostazol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.695655854,0,cilostazol
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.792204401,0,cilostazol
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,2.861003719,0,cilostazol
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.904530479,0,cilostazol
GPCR_LIGAND_BINDING,-3.009626019,0,cilostazol
SIGNALING_BY_GPCR,-3.093958947,0,cilostazol
INFLUENZA_INFECTION,3.395655854,0,cilostazol
TRANSLATION,3.447508484,0,cilostazol
UNFOLDED_PROTEIN_RESPONSE_UPR,1.729058881,0.490537755,carisoprodol
TRNA_PROCESSING,1.629884806,0.444881644,carisoprodol
RRNA_PROCESSING,1.612053993,0.323485937,carisoprodol
DNA_REPAIR,1.570048734,0.303666229,carisoprodol
DUAL_INCISION_IN_TC_NER,1.555379072,0.256098932,carisoprodol
RHO_GTPASE_EFFECTORS,1.516857237,0.230859141,carisoprodol
PROTEIN_FOLDING,1.517261793,0.268273895,carisoprodol
RAC1_GTPASE_CYCLE,1.442957696,0.285616139,carisoprodol
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1.429381748,0.269925537,carisoprodol
TRANSCRIPTION_COUPLED_NUCLEOTIDE_EXCISION_REPAIR_TC_NER,1.393194072,0.285828493,carisoprodol
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.767862162,0,triflupromazine
CELLULAR_RESPONSE_TO_STARVATION,2.715317371,0,triflupromazine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.668944864,0.000506462,triflupromazine
EUKARYOTIC_TRANSLATION_INITIATION,2.584172593,0.000759693,triflupromazine
EUKARYOTIC_TRANSLATION_ELONGATION,2.549242376,0.001215509,triflupromazine
SELENOAMINO_ACID_METABOLISM,2.512207939,0.001266155,triflupromazine
TRANSLATION,2.432355494,0.002089155,triflupromazine
SIGNALING_BY_ROBO_RECEPTORS,2.463246456,0.002387606,triflupromazine
RRNA_PROCESSING,2.420947528,0.001823263,triflupromazine
METABOLISM_OF_RNA,2.426792949,0.002025848,triflupromazine
METABOLISM_OF_RNA,2.945147197,0,letrozole
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.404836427,0.008990822,letrozole
HOST_INTERACTIONS_OF_HIV_FACTORS,2.342712161,0.007377085,letrozole
RRNA_PROCESSING,2.329307206,0.006224415,letrozole
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.315864469,0.005532814,letrozole
MRNA_SPLICING,2.118878432,0.024436594,letrozole
HIV_INFECTION,2.118076822,0.020945652,letrozole
REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE,2.039058695,0.03215948,letrozole
NEURONAL_SYSTEM,-2.123736784,0.194500335,letrozole
MITOTIC_METAPHASE_AND_ANAPHASE,2.019304695,0.032428436,letrozole
CILIUM_ASSEMBLY,1.651890772,0.63130362,triamterene
UNFOLDED_PROTEIN_RESPONSE_UPR,1.565899441,0.478970496,triamterene
RAB_REGULATION_OF_TRAFFICKING,1.552964274,0.341773035,triamterene
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.633850629,1,triamterene
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,1.397307675,0.562460766,triamterene
PROTEIN_FOLDING,1.394419269,0.455534631,triamterene
EPIGENETIC_REGULATION_BY_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES,1.343693758,0.479458743,triamterene
MHC_CLASS_II_ANTIGEN_PRESENTATION,1.32281438,0.458464114,triamterene
GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER,1.32235072,0.401339192,triamterene
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-2.580689532,1,triamterene
EUKARYOTIC_TRANSLATION_ELONGATION,-2.546031456,0,lonidamine
NONSENSE_MEDIATED_DECAY_NMD,-2.465312089,0.000486961,lonidamine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.456980267,0.000324641,lonidamine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.456147026,0.00024348,lonidamine
SELENOAMINO_ACID_METABOLISM,-2.439005629,0.000194784,lonidamine
INFLUENZA_INFECTION,-2.427625065,0.00016232,lonidamine
CELLULAR_RESPONSE_TO_STARVATION,-2.403887278,0.000278263,lonidamine
TRANSLATION,-2.370496094,0.00024348,lonidamine
EUKARYOTIC_TRANSLATION_INITIATION,-2.358270081,0.000216427,lonidamine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.324402374,0.000194784,lonidamine
GASTRULATION,2.293420762,0.030977649,elacridar
NEURONAL_SYSTEM,-2.316510365,0.035848054,elacridar
METABOLISM_OF_RNA,2.089963278,0.091524871,elacridar
TRANSLATION,2.035812762,0.096218454,elacridar
MRNA_SPLICING,2.022994276,0.079556234,elacridar
NEDDYLATION,2.0054777,0.071248592,elacridar
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.115965265,0.135472295,elacridar
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.051290304,0.155063673,elacridar
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,-1.990162779,0.188827538,elacridar
ECM_PROTEOGLYCANS,-1.934215498,0.223758548,elacridar
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,4.226957277,0,vismodegib
SIGNALING_BY_GPCR,-2.854177873,0,vismodegib
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.854663479,0,vismodegib
GPCR_LIGAND_BINDING,-2.862915668,0,vismodegib
VIRAL_INFECTION_PATHWAYS,2.943578827,0,vismodegib
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.097579173,0,vismodegib
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,3.130174026,0,vismodegib
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,3.365523768,0,vismodegib
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,3.433530142,0,vismodegib
TRANSLATION,3.521682129,0,vismodegib
EUKARYOTIC_TRANSLATION_ELONGATION,-2.561720216,0,leflunomide
SELENOAMINO_ACID_METABOLISM,-2.498756521,0,leflunomide
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.459409643,0,leflunomide
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.444822457,0,leflunomide
NONSENSE_MEDIATED_DECAY_NMD,-2.419972088,0,leflunomide
CELLULAR_RESPONSE_TO_STARVATION,-2.325097772,0.000163855,leflunomide
EUKARYOTIC_TRANSLATION_INITIATION,-2.297435043,0.000140447,leflunomide
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.295244747,0.000122891,leflunomide
SIGNALING_BY_ROBO_RECEPTORS,-2.224292047,0.001201604,leflunomide
RRNA_PROCESSING,-2.220140597,0.001179757,leflunomide
EUKARYOTIC_TRANSLATION_ELONGATION,4.544925197,0,GDC-0199
VIRAL_INFECTION_PATHWAYS,2.514995691,0,GDC-0199
MITOCHONDRIAL_PROTEIN_DEGRADATION,2.567321704,0,GDC-0199
RESPIRATORY_ELECTRON_TRANSPORT,2.610790394,0,GDC-0199
MRNA_SPLICING,2.756475943,0,GDC-0199
CELLULAR_RESPONSES_TO_STIMULI,2.776212141,0,GDC-0199
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.81563157,0,GDC-0199
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.970746088,0,GDC-0199
GPCR_LIGAND_BINDING,-2.984428659,0,GDC-0199
SARS_COV_1_INFECTION,3.319043869,0,GDC-0199
METABOLISM_OF_RNA,3.206843329,0,haloperidol
INFLUENZA_INFECTION,3.183018471,0,haloperidol
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.177991259,0,haloperidol
EUKARYOTIC_TRANSLATION_INITIATION,3.14591686,0,haloperidol
SELENOAMINO_ACID_METABOLISM,3.006442341,0,haloperidol
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.989788885,0,haloperidol
TRANSLATION,2.945815862,0,haloperidol
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.855301858,0,haloperidol
NONSENSE_MEDIATED_DECAY_NMD,2.847538907,0,haloperidol
GPCR_LIGAND_BINDING,-2.618715509,0,haloperidol
ECM_PROTEOGLYCANS,1.840802411,0.307920859,felbinac
PROTEIN_FOLDING,1.701335331,0.304882166,felbinac
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-2.607778955,0.444534054,felbinac
SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX,1.52526925,0.458504963,felbinac
CELLULAR_RESPONSE_TO_STARVATION,1.357127159,0.739921669,felbinac
COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES,-2.518629485,0.977602143,felbinac
COLLAGEN_FORMATION,-2.515439098,0.680935462,felbinac
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.511778159,0.530272278,felbinac
UNFOLDED_PROTEIN_RESPONSE_UPR,1.324249293,0.682287798,felbinac
MHC_CLASS_II_ANTIGEN_PRESENTATION,1.313041512,0.596934297,felbinac
EUKARYOTIC_TRANSLATION_ELONGATION,3.362344089,0,erythromycin
SIGNALING_BY_ROBO_RECEPTORS,2.775913873,0,erythromycin
CELLULAR_RESPONSE_TO_STARVATION,2.798143518,0,erythromycin
TRANSLATION,2.844281447,0,erythromycin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.119643331,0,erythromycin
SELENOAMINO_ACID_METABOLISM,3.128212474,0,erythromycin
INFLUENZA_INFECTION,2.912124867,0,erythromycin
RRNA_PROCESSING,3.158037566,0,erythromycin
METABOLISM_OF_RNA,3.17705676,0,erythromycin
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.329284986,0,erythromycin
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,1.479513009,1,roflumilast
EXTRACELLULAR_MATRIX_ORGANIZATION,1.270822815,1,roflumilast
CLATHRIN_MEDIATED_ENDOCYTOSIS,-1.722379448,1,roflumilast
SIGNALING_BY_NTRKS,1.190021511,1,roflumilast
SARS_COV_2_HOST_INTERACTIONS,1.161320706,0.999548957,roflumilast
TOLL_LIKE_RECEPTOR_CASCADES,1.161619116,1,roflumilast
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,-1.645407373,1,roflumilast
GASTRULATION,-1.63532869,1,roflumilast
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,1.060816104,1,roflumilast
HEDGEHOG_OFF_STATE,1.056135885,1,roflumilast
TRANSLATION,3.576207225,0,citalopram
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.676853566,0,citalopram
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.540874859,0,citalopram
INFLUENZA_INFECTION,3.121046987,0,citalopram
NONSENSE_MEDIATED_DECAY_NMD,3.214120144,0,citalopram
SIGNALING_BY_ROBO_RECEPTORS,2.723177202,0,citalopram
RRNA_PROCESSING,3.322323609,0,citalopram
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.860616808,0,citalopram
EUKARYOTIC_TRANSLATION_ELONGATION,3.377891229,0,citalopram
EUKARYOTIC_TRANSLATION_INITIATION,3.393594232,0,citalopram
INTEGRIN_CELL_SURFACE_INTERACTIONS,-3.123368207,0.052503507,lonafarnib
EXTRACELLULAR_MATRIX_ORGANIZATION,-3.03723364,0.19268787,lonafarnib
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,1.676727475,0.478539001,lonafarnib
ECM_PROTEOGLYCANS,-2.948120326,0.460980789,lonafarnib
DEVELOPMENTAL_CELL_LINEAGES,1.586069198,0.368964094,lonafarnib
CILIUM_ASSEMBLY,1.578802902,0.25484936,lonafarnib
CARDIAC_CONDUCTION,1.554584192,0.216364012,lonafarnib
EUKARYOTIC_TRANSLATION_ELONGATION,-2.797621203,0.667582088,lonafarnib
SELENOAMINO_ACID_METABOLISM,-2.742605628,0.573968335,lonafarnib
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.707359592,0.498783314,lonafarnib
CARDIAC_CONDUCTION,2.782643733,0,ubenimex
MUSCLE_CONTRACTION,2.335030481,0.004208606,ubenimex
GPCR_LIGAND_BINDING,1.957324053,0.029077638,ubenimex
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.903531767,0.033668845,ubenimex
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.829463798,1,ubenimex
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.763962623,1,ubenimex
ESTROGEN_DEPENDENT_GENE_EXPRESSION,1.428166342,0.383671788,ubenimex
CELL_CELL_COMMUNICATION,1.405603499,0.35543587,ubenimex
EUKARYOTIC_TRANSLATION_INITIATION,-2.379760857,1,ubenimex
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.364022695,1,ubenimex
RRNA_PROCESSING,3.692226515,0,mirtazapine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.622748297,0,mirtazapine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.665727838,0,mirtazapine
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,2.72328842,0,mirtazapine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,2.780504992,0,mirtazapine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.12864855,0,mirtazapine
METABOLISM_OF_RNA,3.148655014,0,mirtazapine
TRANSLATION,3.149963209,0,mirtazapine
SIGNALING_BY_ROBO_RECEPTORS,3.025035088,0,mirtazapine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.402278515,0,mirtazapine
CELL_CYCLE_MITOTIC,-2.934775349,0,romidepsin
CELL_CYCLE,-2.842548062,0,romidepsin
M_PHASE,-2.765134429,0,romidepsin
MITOTIC_SPINDLE_CHECKPOINT,-2.749825958,0,romidepsin
CELL_CYCLE_CHECKPOINTS,-2.676440873,0,romidepsin
MITOTIC_METAPHASE_AND_ANAPHASE,-2.635993031,0,romidepsin
MITOTIC_PROMETAPHASE,-2.593099418,0,romidepsin
RESOLUTION_OF_SISTER_CHROMATID_COHESION,-2.588898938,0,romidepsin
SEPARATION_OF_SISTER_CHROMATIDS,-2.504543344,0,romidepsin
RHO_GTPASES_ACTIVATE_FORMINS,-2.477610316,0,romidepsin
METABOLISM_OF_STEROIDS,2.609881238,0.001699159,cobimetinib
FATTY_ACID_METABOLISM,2.146589848,0.007646217,cobimetinib
CLATHRIN_MEDIATED_ENDOCYTOSIS,-3.091270598,0.090612812,cobimetinib
CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,-3.046613285,0.14406419,cobimetinib
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-3.037303161,0.115047728,cobimetinib
PROTEIN_LOCALIZATION,1.631645536,0.1588714,cobimetinib
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.959415505,0.258857388,cobimetinib
VESICLE_MEDIATED_TRANSPORT,-2.751634036,0.435348747,cobimetinib
TRANSPORT_OF_SMALL_MOLECULES,-2.699725039,0.375177767,cobimetinib
HEMOSTASIS,-2.636882768,0.33598009,cobimetinib
EUKARYOTIC_TRANSLATION_ELONGATION,-2.605863806,0,procainamide
NONSENSE_MEDIATED_DECAY_NMD,-2.543320908,0,procainamide
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.470372965,0,procainamide
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.390868919,0.001190049,procainamide
CELLULAR_RESPONSE_TO_STARVATION,-2.383028467,0.000952039,procainamide
SELENOAMINO_ACID_METABOLISM,-2.361661525,0.001110712,procainamide
EUKARYOTIC_TRANSLATION_INITIATION,-2.335726361,0.00122405,procainamide
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.332453983,0.001071044,procainamide
TRANSLATION,-2.330665072,0.000952039,procainamide
INFLUENZA_INFECTION,-2.325782035,0.001047243,procainamide
EUKARYOTIC_TRANSLATION_ELONGATION,-2.312029987,0.005894728,enoxacin
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.266229775,0.004912273,enoxacin
NONSENSE_MEDIATED_DECAY_NMD,-2.248265708,0.003929819,enoxacin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.202555078,0.003684205,enoxacin
SELENOAMINO_ACID_METABOLISM,-2.199702568,0.002947364,enoxacin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.186760283,0.002947364,enoxacin
NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,2.151306348,0.039146391,enoxacin
SIGNALING_BY_ROBO_RECEPTORS,-2.120812768,0.007438585,enoxacin
INFLUENZA_INFECTION,-2.115153294,0.007245603,enoxacin
CELLULAR_RESPONSE_TO_STARVATION,-2.110916278,0.006658859,enoxacin
NEURONAL_SYSTEM,1.962941935,0.056476392,bosentan
MUSCLE_CONTRACTION,1.824161747,0.067836586,bosentan
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.799092127,0.051499546,bosentan
CELLULAR_RESPONSES_TO_MECHANICAL_STIMULI,1.596114569,0.115549401,bosentan
EXTRACELLULAR_MATRIX_ORGANIZATION,1.555789635,0.112563293,bosentan
SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,1.50290336,0.123122863,bosentan
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,1.331267532,0.242319891,bosentan
INTEGRATION_OF_ENERGY_METABOLISM,1.239611802,0.319546025,bosentan
NONSENSE_MEDIATED_DECAY_NMD,-1.87870686,1,bosentan
EUKARYOTIC_TRANSLATION_ELONGATION,-1.878212219,1,bosentan
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.503676017,0.002445531,enzalutamide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.314700602,0.003668297,enzalutamide
GPCR_LIGAND_BINDING,2.016901803,0.018545279,enzalutamide
CARDIAC_CONDUCTION,1.779445401,0.060985438,enzalutamide
EUKARYOTIC_TRANSLATION_ELONGATION,-2.629350059,1,enzalutamide
SELENOAMINO_ACID_METABOLISM,-2.609670591,1,enzalutamide
EUKARYOTIC_TRANSLATION_INITIATION,-2.600912396,1,enzalutamide
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.598217125,0.846187596,enzalutamide
RRNA_PROCESSING,-2.523843382,0.723884155,enzalutamide
INFLUENZA_INFECTION,-2.519721544,0.605174764,enzalutamide
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,-3.006412725,0.065833002,rabeprazole
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.850369054,0.746461296,rabeprazole
COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC,1.491547891,1,rabeprazole
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.485533417,0.526376611,rabeprazole
CELL_CELL_COMMUNICATION,1.466415908,0.38327459,rabeprazole
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.750750019,1,rabeprazole
GPCR_LIGAND_BINDING,1.343420122,0.546455192,rabeprazole
CELL_JUNCTION_ORGANIZATION,1.343007414,0.438088635,rabeprazole
EUKARYOTIC_TRANSLATION_ELONGATION,-2.529456745,1,rabeprazole
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.487694345,1,rabeprazole
COLLAGEN_FORMATION,1.747790605,0.490176083,epinastine
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,1.524881288,0.736453872,epinastine
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,1.487478336,0.606771364,epinastine
M_PHASE,1.470496934,0.500288939,epinastine
MUSCLE_CONTRACTION,1.429752739,0.484465293,epinastine
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-2.534425548,1,epinastine
PROTEIN_FOLDING,1.35200039,0.580200331,epinastine
SIGNALING_BY_MET,1.305569266,0.616969203,epinastine
TRNA_PROCESSING,1.287011995,0.589817459,epinastine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1.239500627,0.652774945,epinastine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.783527256,0,tazarotene
NONSENSE_MEDIATED_DECAY_NMD,-2.707793937,0,tazarotene
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.702230851,0,tazarotene
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.68585442,0,tazarotene
SELENOAMINO_ACID_METABOLISM,-2.6420642,0,tazarotene
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.602472354,0,tazarotene
EUKARYOTIC_TRANSLATION_INITIATION,-2.569046562,0,tazarotene
INFLUENZA_INFECTION,-2.523873141,0,tazarotene
SIGNALING_BY_ROBO_RECEPTORS,-2.513259204,0,tazarotene
CELLULAR_RESPONSE_TO_STARVATION,-2.500464586,0,tazarotene
DNA_REPAIR,1.843116097,0.234338747,rotigotine
UNFOLDED_PROTEIN_RESPONSE_UPR,1.816153897,0.134570766,rotigotine
GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER,1.682940506,0.191802011,rotigotine
RRNA_PROCESSING,1.671303865,0.15487239,rotigotine
COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES,-2.600308396,0.46195451,rotigotine
COLLAGEN_FORMATION,-2.589902151,0.270690736,rotigotine
RAC1_GTPASE_CYCLE,1.544083091,0.251508121,rotigotine
TRNA_PROCESSING,1.52190295,0.234725445,rotigotine
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-2.547259185,0.371572106,rotigotine
DNA_DOUBLE_STRAND_BREAK_REPAIR,1.436128876,0.307921777,rotigotine
PROTEIN_FOLDING,1.486692822,0.80781878,hexachlorophene
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-2.596170056,1,hexachlorophene
RRNA_PROCESSING,1.362261216,0.72725612,hexachlorophene
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,1.279388998,0.728169529,hexachlorophene
SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX,1.260151735,0.595177201,hexachlorophene
RHO_GTPASES_ACTIVATE_FORMINS,1.242267844,0.514943369,hexachlorophene
CILIUM_ASSEMBLY,1.228673724,0.453598831,hexachlorophene
HATS_ACETYLATE_HISTONES,1.134030686,0.574977817,hexachlorophene
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.002999537,1,hexachlorophene
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,1.065333325,0.655873219,hexachlorophene
COLLAGEN_FORMATION,-2.743519639,0.08158176,BRD-K89997465
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.67788879,0.123332425,BRD-K89997465
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.637809313,0.184918656,BRD-K89997465
EPIGENETIC_REGULATION_BY_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES,1.268305264,1,BRD-K89997465
REGULATION_OF_TP53_ACTIVITY,1.244570597,1,BRD-K89997465
MITOTIC_SPINDLE_CHECKPOINT,1.231877418,1,BRD-K89997465
EXTRA_NUCLEAR_ESTROGEN_SIGNALING,1.207330943,1,BRD-K89997465
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.188323834,1,BRD-K89997465
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,1.168319166,1,BRD-K89997465
RHO_GTPASES_ACTIVATE_FORMINS,1.140126887,1,BRD-K89997465
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.493269841,0.002127253,bortezomib
PROTEIN_FOLDING,-2.468729216,0.0095971,bortezomib
TP53_REGULATES_METABOLIC_GENES,2.257963454,0.013827145,bortezomib
PYRUVATE_METABOLISM,2.247474116,0.010281724,bortezomib
MITOCHONDRIAL_PROTEIN_DEGRADATION,2.123671024,0.027122478,bortezomib
CILIUM_ASSEMBLY,-1.916721194,0.085527098,bortezomib
RHO_GTPASES_ACTIVATE_FORMINS,-1.91192259,0.058147136,bortezomib
APOPTOSIS,2.008235678,0.078495641,bortezomib
MITOTIC_SPINDLE_CHECKPOINT,-1.658369494,0.145508973,bortezomib
BIOLOGICAL_OXIDATIONS,1.851937377,0.246406823,bortezomib
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.211904551,0.033598017,veliparib
SIGNALING_BY_NOTCH,-2.140147111,0.042597486,veliparib
CHROMATIN_ORGANIZATION,-2.084683582,0.056796648,veliparib
SENSORY_PERCEPTION,-2.032581432,0.07049584,veliparib
PROTEIN_FOLDING,-2.001950784,0.078475369,veliparib
COLLAGEN_FORMATION,-1.858963868,0.201188127,veliparib
DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS,-1.835334696,0.207587749,veliparib
CELLULAR_RESPONSES_TO_MECHANICAL_STIMULI,-1.818049472,0.206237829,veliparib
INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS,-1.767284646,0.262917817,veliparib
ESR_MEDIATED_SIGNALING,-1.725206522,0.321341036,veliparib
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.987047538,0.031534872,cladribine
METABOLISM_OF_NUCLEOTIDES,2.004347959,0.133826852,cladribine
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.791419497,0.107983045,cladribine
ISG15_ANTIVIRAL_MECHANISM,1.729492639,0.259193386,cladribine
NEUTROPHIL_DEGRANULATION,1.64080691,0.27124293,cladribine
NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,1.60800486,0.235350671,cladribine
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,1.5737541,0.223352401,cladribine
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,1.553705168,0.204329504,cladribine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.668015282,0.963246985,cladribine
MHC_CLASS_II_ANTIGEN_PRESENTATION,1.361182203,0.43510208,cladribine
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.836434605,0.137252251,mepyramine
TRNA_PROCESSING,1.501194997,1,mepyramine
ESTROGEN_DEPENDENT_GENE_EXPRESSION,1.465078193,0.709372313,mepyramine
SIGNALING_BY_MET,1.45586627,0.495711798,mepyramine
ECM_PROTEOGLYCANS,-2.706882987,0.868777546,mepyramine
DISEASES_OF_METABOLISM,-2.545877363,1,mepyramine
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.410503327,1,mepyramine
MUSCLE_CONTRACTION,1.180997603,1,mepyramine
MHC_CLASS_II_ANTIGEN_PRESENTATION,1.158586257,1,mepyramine
SELENOAMINO_ACID_METABOLISM,-1.84278855,1,mepyramine
EUKARYOTIC_TRANSLATION_ELONGATION,3.08744022,0,resiquimod
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.48883343,0,resiquimod
SARS_COV_1_INFECTION,2.52095452,0,resiquimod
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.537328728,0,resiquimod
MITOCHONDRIAL_PROTEIN_DEGRADATION,2.572154623,0,resiquimod
TRANSLATION,2.63479862,0,resiquimod
SARS_COV_1_HOST_INTERACTIONS,2.651191663,0,resiquimod
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.703152601,0,resiquimod
CELLULAR_RESPONSE_TO_STARVATION,2.724517898,0,resiquimod
SIGNALING_BY_ROBO_RECEPTORS,2.4919964,0,resiquimod
COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC,-2.183003745,0.068282797,azacitidine
COPI_MEDIATED_ANTEROGRADE_TRANSPORT,-2.11270641,0.066994443,azacitidine
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.106526756,0.045951316,azacitidine
ASPARAGINE_N_LINKED_GLYCOSYLATION,-2.07632037,0.045414502,azacitidine
HCMV_INFECTION,-2.066434948,0.040969678,azacitidine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,1.979642706,0.142986506,azacitidine
NONSENSE_MEDIATED_DECAY_NMD,1.967873124,0.077156085,azacitidine
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,-1.965311348,0.088681746,azacitidine
PROTEIN_FOLDING,-1.943582849,0.091473181,azacitidine
EXTRA_NUCLEAR_ESTROGEN_SIGNALING,-1.930744079,0.089379605,azacitidine
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.273286323,0.035690733,albendazole
G2_M_CHECKPOINTS,2.093696646,0.118225554,albendazole
TCR_SIGNALING,1.976897876,0.219349299,albendazole
CELL_CYCLE_CHECKPOINTS,1.90438804,0.304765403,albendazole
DEATH_RECEPTOR_SIGNALING,1.897949928,0.257419415,albendazole
INTEGRIN_CELL_SURFACE_INTERACTIONS,1.878748137,0.250578691,albendazole
ORC1_REMOVAL_FROM_CHROMATIN,1.875202385,0.220677079,albendazole
RESPIRATORY_ELECTRON_TRANSPORT,1.823662285,0.282458695,albendazole
APOPTOSIS,1.813004075,0.27028295,albendazole
TNFR2_NON_CANONICAL_NF_KB_PATHWAY,1.810028604,0.247939064,albendazole
INTEGRIN_CELL_SURFACE_INTERACTIONS,-3.014003948,0.099245424,omeprazole
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,1.746474897,0.639633841,omeprazole
CARDIAC_CONDUCTION,1.738617537,0.327254523,omeprazole
ECM_PROTEOGLYCANS,-2.897397422,0.396981698,omeprazole
MUSCLE_CONTRACTION,1.69501736,0.281389306,omeprazole
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.850983278,0.564078586,omeprazole
SIGNALING_BY_ERBB4,1.592916938,0.360723736,omeprazole
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.543003951,1,omeprazole
RAC2_GTPASE_CYCLE,1.434175305,0.620296074,omeprazole
EUKARYOTIC_TRANSLATION_ELONGATION,-2.42987727,1,omeprazole
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.565186687,0.001033791,phentolamine
DNA_REPLICATION,2.209527052,0.02791237,phentolamine
S_PHASE,2.160903728,0.032736731,phentolamine
CELL_CYCLE_MITOTIC,2.129678728,0.034890463,phentolamine
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,2.070276039,0.047967925,phentolamine
SYNTHESIS_OF_DNA,2.067554427,0.041179361,phentolamine
DNA_REPLICATION_PRE_INITIATION,2.002294723,0.062175174,phentolamine
G2_M_CHECKPOINTS,1.971938869,0.073011525,phentolamine
CELL_CYCLE,1.921755543,0.10177103,phentolamine
ORC1_REMOVAL_FROM_CHROMATIN,1.909525683,0.10089805,phentolamine
DISEASES_OF_GLYCOSYLATION,-2.975631332,0.104363851,bendroflumethiazide
EXTRACELLULAR_MATRIX_ORGANIZATION,2.14966173,0.030100099,bendroflumethiazide
GPCR_LIGAND_BINDING,2.121545252,0.017270548,bendroflumethiazide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.08621353,0.013651957,bendroflumethiazide
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,1.980765429,0.022328352,bendroflumethiazide
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1.869446379,0.036317496,bendroflumethiazide
DISEASES_OF_METABOLISM,-2.816854612,0.679995716,bendroflumethiazide
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.665013684,0.092520795,bendroflumethiazide
C_TYPE_LECTIN_RECEPTORS_CLRS,-2.769940873,0.908835202,bendroflumethiazide
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1.538052078,0.148738193,bendroflumethiazide
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.276443959,0.046869385,midodrine
SIGNALING_BY_ROBO_RECEPTORS,2.230052806,0.037815072,midodrine
EUKARYOTIC_TRANSLATION_INITIATION,2.221106386,0.02592019,midodrine
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,2.197991569,0.025298816,midodrine
EUKARYOTIC_TRANSLATION_ELONGATION,2.162471135,0.026204247,midodrine
METABOLISM_OF_RNA,2.149446018,0.022547015,midodrine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.146725705,0.019478186,midodrine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,2.134477267,0.019173839,midodrine
RRNA_PROCESSING,2.133454558,0.01716177,midodrine
SELENOAMINO_ACID_METABOLISM,2.108787918,0.02002601,midodrine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.623073058,0,metamizole
EUKARYOTIC_TRANSLATION_ELONGATION,-2.6028637,0,metamizole
INFLUENZA_INFECTION,-2.564031034,0,metamizole
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.500574283,0,metamizole
NONSENSE_MEDIATED_DECAY_NMD,-2.49508351,0,metamizole
SIGNALING_BY_ROBO_RECEPTORS,-2.459353646,0.000166627,metamizole
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.440943556,0.000142823,metamizole
SELENOAMINO_ACID_METABOLISM,-2.409980272,0.00012497,metamizole
EUKARYOTIC_TRANSLATION_INITIATION,-2.385587782,0.000222169,metamizole
VIRAL_INFECTION_PATHWAYS,-2.233362584,0.001299688,metamizole
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,2.182426737,0.004136375,PS-178990
EPIGENETIC_REGULATION_BY_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES,1.951194803,0.030333417,PS-178990
COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC,1.874014761,0.033091,PS-178990
GLUCOSE_METABOLISM,1.649303199,0.106856355,PS-178990
COLLAGEN_FORMATION,1.61580295,0.102582101,PS-178990
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1.53724261,0.139028161,PS-178990
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,-2.540161451,1,PS-178990
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-2.514991183,0.791165283,PS-178990
RRNA_PROCESSING,1.370274448,0.290531103,PS-178990
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,1.186314189,0.591501629,PS-178990
EUKARYOTIC_TRANSLATION_ELONGATION,-3.362649568,0,isradipine
NONSENSE_MEDIATED_DECAY_NMD,-3.325819996,0,isradipine
SELENOAMINO_ACID_METABOLISM,-3.31720949,0,isradipine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-3.300206362,0,isradipine
EUKARYOTIC_TRANSLATION_INITIATION,-3.282702005,0,isradipine
CELLULAR_RESPONSE_TO_STARVATION,-3.26198792,0,isradipine
INFLUENZA_INFECTION,-3.251086426,0,isradipine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-3.169473277,0.000135173,isradipine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-3.14529571,0.000240308,isradipine
RRNA_PROCESSING,-3.042859792,0.005839492,isradipine
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-2.679010606,0.128053205,telcagepant
RHO_GTPASE_EFFECTORS,1.769999052,0.329886111,telcagepant
PROTEIN_FOLDING,1.673994396,0.273072392,telcagepant
RHO_GTPASES_ACTIVATE_FORMINS,1.516054042,0.414190339,telcagepant
UNFOLDED_PROTEIN_RESPONSE_UPR,1.499076658,0.34317319,telcagepant
COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC,1.384513862,0.47650216,telcagepant
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,-2.523578306,0.827637997,telcagepant
HCMV_INFECTION,1.352249918,0.472225859,telcagepant
EPIGENETIC_REGULATION_BY_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES,1.340122508,0.428066501,telcagepant
PI3K_AKT_SIGNALING_IN_CANCER,1.331284458,0.390594319,telcagepant
RHO_GTPASE_EFFECTORS,1.725169343,0.487815568,betahistine
ECM_PROTEOGLYCANS,1.559615946,0.624342567,betahistine
HATS_ACETYLATE_HISTONES,1.459052004,0.680078308,betahistine
DISEASES_OF_GLYCOSYLATION,1.449003653,0.543806978,betahistine
SIGNALING_BY_PTK6,1.391712929,0.571879383,betahistine
TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER,1.342392792,0.618717859,betahistine
SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3,1.312100293,0.618425666,betahistine
EPIGENETIC_REGULATION_BY_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES,1.309841238,0.548792514,betahistine
RAC3_GTPASE_CYCLE,1.293119318,0.527358968,betahistine
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,1.171815343,0.794617812,betahistine
SELENOAMINO_ACID_METABOLISM,3.302360591,0,indometacin
TRANSLATION,2.706893869,0,indometacin
SARS_COV_1_INFECTION,2.741227689,0,indometacin
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,2.76061012,0,indometacin
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,2.796580635,0,indometacin
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.882528892,0,indometacin
SIGNALING_BY_ROBO_RECEPTORS,3.077791078,0,indometacin
RRNA_PROCESSING,3.083455246,0,indometacin
SARS_COV_1_HOST_INTERACTIONS,2.742911538,0,indometacin
INFLUENZA_INFECTION,3.112494716,0,indometacin
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.626312598,0,pyrimethamine
MITOCHONDRIAL_PROTEIN_DEGRADATION,2.549467906,0,pyrimethamine
APOPTOSIS,2.147160548,0.039917993,pyrimethamine
PROGRAMMED_CELL_DEATH,2.099276509,0.0494636,pyrimethamine
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,2.084705751,0.043736235,pyrimethamine
NEUTROPHIL_DEGRANULATION,2.063548517,0.042174227,pyrimethamine
MITOCHONDRIAL_BIOGENESIS,2.033865334,0.045670151,pyrimethamine
POTENTIAL_THERAPEUTICS_FOR_SARS,2.013501733,0.047901591,pyrimethamine
FORMATION_OF_THE_CORNIFIED_ENVELOPE,1.982910224,0.055190964,pyrimethamine
ABC_TRANSPORTER_DISORDERS,1.966251271,0.057898445,pyrimethamine
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,2.381355059,0.005483959,trimetazidine
RHO_GTPASES_ACTIVATE_FORMINS,1.510525481,0.35810255,trimetazidine
TOLL_LIKE_RECEPTOR_CASCADES,-2.502168584,0.938688438,trimetazidine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.446880549,0.335983914,trimetazidine
RHO_GTPASE_EFFECTORS,1.396560969,0.330408555,trimetazidine
ESTROGEN_DEPENDENT_GENE_EXPRESSION,1.355299597,0.329914999,trimetazidine
DRUG_ADME,-2.446398105,1,trimetazidine
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,-2.431352943,0.901273343,trimetazidine
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,-2.41800187,0.803845099,trimetazidine
CHROMATIN_ORGANIZATION,1.180773624,0.601773147,trimetazidine
MITOCHONDRIAL_PROTEIN_DEGRADATION,-2.067475159,0.091160025,alisertib
EUKARYOTIC_TRANSLATION_ELONGATION,-2.038969348,0.063911105,alisertib
NONSENSE_MEDIATED_DECAY_NMD,-2.001561524,0.0657277,alisertib
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-1.986311393,0.058709038,alisertib
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-1.978833069,0.051525232,alisertib
RNA_POLYMERASE_II_PRE_TRANSCRIPTION_EVENTS,-1.957323282,0.053506971,alisertib
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-1.939311087,0.056338028,alisertib
SELENOAMINO_ACID_METABOLISM,-1.915386992,0.063044094,alisertib
SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS,1.630483948,0.743980072,alisertib
SLC_TRANSPORTER_DISORDERS,1.617036118,0.394685857,alisertib
INTEGRIN_CELL_SURFACE_INTERACTIONS,2.432647085,0.00745849,xaliproden
THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT,2.147021766,0.085772634,xaliproden
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.996119668,0.175807263,xaliproden
PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,1.912592375,0.268239264,xaliproden
COLLAGEN_DEGRADATION,1.883069556,0.270423536,xaliproden
MITOTIC_G2_G2_M_PHASES,1.85379544,0.287329446,xaliproden
HEDGEHOG_OFF_STATE,1.825272179,0.30214495,xaliproden
REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS,1.818630361,0.27636369,xaliproden
ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES,1.8040019,0.274188297,xaliproden
BIOLOGICAL_OXIDATIONS,1.796516345,0.259129251,xaliproden
INTEGRIN_CELL_SURFACE_INTERACTIONS,2.162383703,0.221944833,triclosan
MUSCLE_CONTRACTION,-1.458410495,1,triclosan
EXTRACELLULAR_MATRIX_ORGANIZATION,1.732984848,1,triclosan
TOLL_LIKE_RECEPTOR_CASCADES,1.665635177,1,triclosan
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,1.634911763,1,triclosan
ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS,-1.138417998,1,triclosan
SIGNALING_BY_FGFR,-1.101908157,1,triclosan
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1.582800399,1,triclosan
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,-1.070643628,1,triclosan
CIRCADIAN_CLOCK,-1.079743109,1,triclosan
MITOCHONDRIAL_PROTEIN_DEGRADATION,2.461822304,0.007388687,ibutilide
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.443003834,0.00633316,ibutilide
EUKARYOTIC_TRANSLATION_INITIATION,2.232456988,0.028851063,ibutilide
CELLULAR_RESPONSE_TO_HEAT_STRESS,2.190862924,0.03140192,ibutilide
TRANSLATION,2.179935505,0.027443695,ibutilide
CELLULAR_RESPONSE_TO_STARVATION,2.158930801,0.028675142,ibutilide
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.118766349,0.034380013,ibutilide
EUKARYOTIC_TRANSLATION_ELONGATION,2.100676565,0.034040736,ibutilide
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.100040603,0.030258432,ibutilide
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.095524101,0.027971458,ibutilide
EUKARYOTIC_TRANSLATION_INITIATION,-2.10899058,0.073569973,BRD-K76674262
EUKARYOTIC_TRANSLATION_ELONGATION,-2.066977768,0.061469648,BRD-K76674262
SIGNALING_BY_ROBO_RECEPTORS,-2.007345237,0.071633921,BRD-K76674262
DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA,1.927471742,0.245239137,BRD-K76674262
INTERLEUKIN_1_FAMILY_SIGNALING,1.908605499,0.140465609,BRD-K76674262
TRANSLATION,-1.978686102,0.069697869,BRD-K76674262
SELENOAMINO_ACID_METABOLISM,-1.958975641,0.067955422,BRD-K76674262
SIGNALING_BY_INTERLEUKINS,1.860446179,0.125497962,BRD-K76674262
NERVOUS_SYSTEM_DEVELOPMENT,-1.939658734,0.068407168,BRD-K76674262
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-1.933790942,0.062368529,BRD-K76674262
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.098428223,0.228291088,paricalcitol
INFLUENZA_INFECTION,2.069629951,0.149716481,paricalcitol
EUKARYOTIC_TRANSLATION_INITIATION,1.994089859,0.192189242,paricalcitol
CELLULAR_RESPONSE_TO_STARVATION,1.982149985,0.162458309,paricalcitol
CARDIAC_CONDUCTION,-1.751503893,0.332637889,paricalcitol
SARS_COV_1_INFECTION,1.97054487,0.138885927,paricalcitol
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,1.968383439,0.11803888,paricalcitol
NONSENSE_MEDIATED_DECAY_NMD,1.962541415,0.105878525,paricalcitol
EPIGENETIC_REGULATION_BY_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES,1.906709388,0.147460116,paricalcitol
EUKARYOTIC_TRANSLATION_ELONGATION,1.896281965,0.142873647,paricalcitol
EUKARYOTIC_TRANSLATION_ELONGATION,-3.443166356,0,dequalinium
VIRAL_INFECTION_PATHWAYS,-2.421085504,0,dequalinium
MITOCHONDRIAL_PROTEIN_DEGRADATION,-2.474090713,0,dequalinium
METABOLISM_OF_RNA,-2.500895125,0,dequalinium
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,-2.503526678,0,dequalinium
SARS_COV_2_HOST_INTERACTIONS,-2.521028961,0,dequalinium
NERVOUS_SYSTEM_DEVELOPMENT,-2.635336842,0,dequalinium
SARS_COV_1_INFECTION,-2.63898074,0,dequalinium
CELLULAR_RESPONSES_TO_STIMULI,-2.668461762,0,dequalinium
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.824648862,0,dequalinium
INTEGRIN_CELL_SURFACE_INTERACTIONS,2.156375045,0.127597613,naproxen
ACTIVATION_OF_APC_C_AND_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS,2.10719495,0.101423743,naproxen
SARS_COV_1_HOST_INTERACTIONS,2.081358722,0.089427387,naproxen
UCH_PROTEINASES,2.071269524,0.073886652,naproxen
THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT,2.056848175,0.066961482,naproxen
REGULATION_OF_RUNX3_EXPRESSION_AND_ACTIVITY,2.034766365,0.068706407,naproxen
ANTIGEN_PROCESSING_CROSS_PRESENTATION,2.02858551,0.062318736,naproxen
APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1,2.022446643,0.056846372,naproxen
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,1.998326508,0.061799414,naproxen
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.982637698,0.06608902,naproxen
CELLULAR_RESPONSE_TO_STARVATION,3.318151102,0,fasudil
SARS_COV_1_HOST_INTERACTIONS,2.786415141,0,fasudil
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,2.792907116,0,fasudil
TRANSLATION,2.803110736,0,fasudil
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,2.86156482,0,fasudil
SIGNALING_BY_ROBO_RECEPTORS,2.922957929,0,fasudil
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.976993779,0,fasudil
INFLUENZA_INFECTION,2.985715762,0,fasudil
SARS_COV_1_INFECTION,2.690692619,0,fasudil
EUKARYOTIC_TRANSLATION_INITIATION,3.062807599,0,fasudil
EUKARYOTIC_TRANSLATION_ELONGATION,2.644837835,0,phenylephrine
INFLUENZA_INFECTION,2.532488376,0,phenylephrine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.527220867,0,phenylephrine
SELENOAMINO_ACID_METABOLISM,2.513431116,0,phenylephrine
NONSENSE_MEDIATED_DECAY_NMD,2.456547607,0.00041109,phenylephrine
EUKARYOTIC_TRANSLATION_INITIATION,2.389091578,0.000685149,phenylephrine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.371414668,0.000880906,phenylephrine
TRANSLATION,2.370917325,0.000770793,phenylephrine
CELLULAR_RESPONSE_TO_STARVATION,2.309585001,0.001712873,phenylephrine
RRNA_PROCESSING,2.290952524,0.00215822,phenylephrine
EUKARYOTIC_TRANSLATION_ELONGATION,3.722763249,0,metoclopramide
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,2.49350402,0,metoclopramide
SARS_COV_2_HOST_INTERACTIONS,2.508876512,0,metoclopramide
SARS_COV_1_INFECTION,2.541572398,0,metoclopramide
INFECTIOUS_DISEASE,2.585025372,0,metoclopramide
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.597869205,0,metoclopramide
SELECTIVE_AUTOPHAGY,2.63723892,0,metoclopramide
VIRAL_INFECTION_PATHWAYS,2.640930559,0,metoclopramide
SARS_COV_1_HOST_INTERACTIONS,2.655309016,0,metoclopramide
METABOLISM_OF_RNA,2.692627213,0,metoclopramide
